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Abstract		
In	 the	 central	 nervous	 system,	 neuronal	 population	 size	 is	 a	 function	 of	 the	 number	 of	
neurons	 generated	 and	 the	 number	 lost	 through	 apoptosis	 or	 degeneration.	 Postnatal	
neurogenesis	 has	 been	 observed	 in	 several	 areas	 of	 the	 vertebrate	 brain	 and	 a	 reduced	
generation	 of	 neurons	 through	 life	 could	 contribute	 to	 neurodegenerative	 disease.	
Parkinson's	disease	(PD)	is	underlain	by	a	reduced	number	of	dopaminergic	(DA)	neurons,	in	
particular,	ascending	neurons	of	the	substantia	nigra	pars	compacta.	The	degeneration	of	
DA	 neurons	 is	 a	 known	 contributory	 factor,	 but	 may	 not	 account	 fully	 for	 disease	
pathogenesis.	 	 Here	 I	 examine	 the	 character	 and	 generation	 of	 DA	 neurons	 in	 the	 adult	
zebrafish	posterior	 tuberculum	 (PT)	 in	wild	 type	and	 in	a	model	of	genetic	PD,	 the	pink1	
knockout	zebrafish.		
	
I	 first	 characterise	embryonic	and	adult	DA	neuronal	populations	 in	 the	zebrafish	PT	and	
show	that	throughout	life,	DA	neuronal	populations	reside	close	to	populations	of	stem	and	
progenitor	 cells	 that	 are	 themselves	 maintained	 in	 the	 PT	 in	 adulthood.	 I	 show	 that	
ascending	DA	neurons	of	 the	PT,	 functionally-equivalent	 to	those	of	 the	substantia	nigra,	
express	 the	 transcription	 factor,	 OTPb,	 and	 that	 local-projecting	 DA	 neurons	 of	 the	
paraventricular	organ	(PVO)	in	the	ventral	PT/dorsal	hypothalamus	express	rx3.	Using	EdU	
analyses	and	lineage-tracing	studies,	I	demonstrate	that	a	subset	of	ascending	DA	neurons	
(those	 of	 the	 periventricular	 nucleus	 of	 the	 posterior	 tuberculum	 (TPp)	 and	 the	 local-
projecting	DA	neurons	of	 the	paraventricular	organ	(PVO))	are	generated	 in	adulthood	 in	
wild	type	animals	at	a	rate	that	decreases	with	age.	Using	a	robust	model	of	PD,	the	pink1-
/-	 zebrafish,	 I	 show	 that	 Pink1-deficiency	 impedes	 DA	 neurogenesis	 in	 early	 adult	 life.	
Analysis	of	population	size	shows	that	zebrafish	lacking	functional	Pink1	fail	to	expand	DA	
neuronal	 populations	 in	 adulthood	 and	 display	 reduced	 numbers	 of	 OTPb-expressing	
progenitors.		
	
Together	 this	 work	 reveals	 that	 subsets	 of	 ascending	 DA	 neurons	 of	 the	 PT	 and	 local-
projecting	 DA	 neurons	 of	 PVO	 in	 the	 ventral	 PT/dorsal	 hypothalamus	 are	 generated	
throughout	life,	demonstrates	a	novel	role	for	Pink1	in	adult	DA	neurogenesis	and	suggests	
potential	future	applications	of	stimulation	of	de	novo	neurogenesis	in	PD.		
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1.0:	Introduction		
	
My	thesis	focuses	on	the	de	novo	generation	of	ascending	dopaminergic	neurons	in	the	
adult	zebrafish	brain	and	the	effects	of	a	Parkinson’s	disease	(PD)	gene	mutation,	pink1-/-,	
on	dopaminergic	neurogenesis.	This	introduction	first	describes	PD,	from	incidence,	
symptoms	and	treatment	to	causes	and	genetic	models	of	the	disease.	Next,	I	describe	
adult	neurogenesis,	including	the	methods	used	to	investigate	adult	neurogenesis,	the	
evidence	for	de	novo	neurogenesis	in	adulthood	and	the	mechanisms	that	regulate	it.		I	
then	discuss	the	evidence	for	altered	adult	neurogenesis	in	PD.	Finally,	I	outline	the	aims	
and	hypothesis	of	my	study.		
	
1.1:	PD;	incidence,	symptoms	and	treatment	
	
1.1.1:	Overall	introduction	to	PD	
	
PD	is	classically	defined	as	a	neurodegenerative	condition	and	is	the	second	most	common	
form	of	neurodegeneration	after	Alzheimer’s	disease.	Increased	average	life-span	in	the	
human	population	means	that	PD	is	expected	to	impose	an	increasing	social	and	economic	
burden.	There	is	therefore	a	pressing	need	to	fully	understand	the	disease	(de	Lau	&	
Breteler,	2006;	Kowal	et	al.,	2013).	PD	is	pathologically	characterised	by	degeneration	of	
dopaminergic	(DA)	neurons	in	a	region	of	the	midbrain	termed	the	substantia	nigra	pars	
compacta:	the	reduced	DA	signalling	results	in	several	cardinal	motor	symptoms,	including	
tremor,	bradykinesia	and	rigidity.	PD	patients	also	often	experience	wider,	non-motor	
symptoms,	including	depression,	anosmia	and	sleep	disturbances	(Jankovic,	2008),	though	
the	cause	of	these	symptoms	is	less	well	understood.	Currently,	there	is	no	cure	for	this	
condition.	Existing	treatments	centre	on	dopamine	replacement.	Although	these	
treatments	initially	alleviate	motor	symptoms,	efficacy	reduces	with	disease	progression	
and	often	leave	patients	with	unpleasant	side	effects	such	as	dyskinesia	and	behavioural	
problems	(Connolly	&	Lang,	2014).	This	highlights	a	need	for	greater	understanding	of	the	
disease,	and	development	of	more	effective	treatments.	Despite	huge	efforts	in	the	
Parkinson’s	field,	the	aetiology	of	PD	is	not	fully	understood,	and	around	90%	of	cases	
appear	to	be	sporadic	or	environmental.	Only	around	10%	of	PD	patients	develop	the	
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disease	due	to	monogenic	gene	mutations.	However	studying	these	Mendelian	inherited	
forms	of	PD	provides	insight	into	disease	pathogenesis	(Lesage	&	Brice,	2009).	In	the	
following	sections,	the	incidence,	symptoms,	treatment,	known	pathological	mechanisms	
and	models	of	PD	will	be	discussed	in	detail.		
	
1.1.2:	Prevalence	and	incidence	of	PD	
	
PD	affects	approximately	1%	of	individuals	over	the	age	of	60,	increasing	to	4-6%	in	those	
over	85	(Van	Den	Eeden	et	al.,	2003;	de	Lau	&	Breteler,	2006;	Kowal	et	al.,	2013).	As	well	
as	the	increasing	incidence	rate	of	PD	with	age,	gender	and	ethnicity	are	also	risk	factors:	
incidence	of	PD	is	twice	as	high	for	men	compared	to	women,	and	incidence	rates	are	
highest	among	those	of	Hispanic	race	(Van	Den	Eeden	et	al.,	2003).	The	average	age	of	
diagnosis	of	PD	is	at	around	70	years	of	age	(Van	Den	Eeden	et	al.,	2003;	Hawkes,	2008),	
however	it	is	thought	that	there	is	a	reduction	of	as	many	as	50%	of	DA	neurons	before	
patients	become	symptomatic,	and	this	may	precede	diagnosis	by	several	years	(Marsden,	
1990;	Ross	et	al.,	2004).	Patients	who	exhibit	PD	symptoms	before	the	age	of	40-50	are	
defined	as	early-onset	(EOPD)	or	young-onset	(YOPD)	cases:	these	are	a	minority,	making	
up	around	5-10%	of	cases	(Golbe,	1991).	Early-onset	PD	patients	carry	Monogenically-
inherited	mutations	in	genes	such	as	PARKIN,	or	PINK1	(discussed	in	detail	in	section	1.2.1)	
more	commonly	than	late	onset	cases.	For	example,	in	one	study	examining	known	
mutations	in	patients	with	EOPD,	6.7%	carried	mutations	in	PARKIN	and	3.6%	in	LRRK2	
(Alcalay	et	al.,	2010),	with	a	separate	study	observing	a	3.7%	incidence	rate	of	mutations	in	
PINK1	(Tan	et	al.,	2006).	Around	90%	of	patients	(mostly	late-onset	cases)	have	no	known	
cause	of	the	disease,	and	these	cases	are	deemed	to	be	sporadic	(de	Lau	&	Breteler,	2006).	
Because	of	this,	the	biggest	predictive	risk	factor	for	developing	PD	is	ageing	(Van	Den	
Eeden	et	al.,	2003;	de	Lau	&	Breteler,	2006).	As	the	average	life	expectancy	of	the	
population	rises,	so	will	incidence	of	PD.	Indeed,	one	study	predicts	a	two-fold	increase	in	
the	number	of	PD	cases	by	2030	(Bach	et	al.,	2011).	Together,	this	illustrates	that	PD	is	a	
highly	prevalent	disorder	and	highlights	the	need	for	greater	understanding	of	the	disease.		
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1.1.3:	Symptoms	of	PD	
	
Tremor,	bradykinesia	(slow	movement)	and	rigidity	are	the	cardinal	motor	features	of	PD,	
all	of	which	are	related	to	loss	of	dopaminergic	signalling	in	the	nigrostriatal	system.	
Tremor	at	rest	is	often	the	first	symptom	noticed	by	the	patient,	which	may	be	worse	in	
stressful	or	exciting	situations.	In	some	individuals,	bradykinesia	manifests	first,	resulting	in	
difficulties	initiating	and	executing	movement.	Consequently,	the	patient	may	experience	a	
reduced	ability	to	perform	tasks	requiring	fine	motor	control	such	as	writing,	or	using	
utensils.	Decreased	leg	stride,	arm	swing	and	vocal	amplitude	may	also	manifest.	As	the	
disease	progresses,	existing	symptoms	gradually	worsen	and	new	motor	symptoms	
appear,	such	as	freezing	and	decreased	postural	reflex	resulting	in	postural	instability.	
Freezing	episodes	cause	patients	to	suddenly	be	unable	to	move,	whereas	postural	
instability	frequently	results	in	falls	(Fahn,	2003;	Jankovic,	2008).		
	
Non-motor	symptoms	also	manifest	in	patients	with	PD	and	are	often	underappreciated.	
The	cause	of	many	of	these	symptoms	is	not	fully	understood.	Non-motor	symptoms	in	PD	
include	autonomic	dysfunction,	mood	disorders,	cognitive	decline,	sleep	disturbances	and	
changes	in	sense	of	smell	(Poewe,	2008).	Autonomic	dysfunction	in	PD	presents	as	
orthostatic	hypotension,	sweating	dysfunction,	sphincter	dysfunction	and	erectile	
dysfunction	(Jankovic,	2008).	Mood	disorders	are	common	in	PD:	one	study	reported	58%	
of	patients	experienced	depression,	54%	experienced	apathy	and	49%	reported	anxiety	
(Aarsland	et	al.,	2007).	Sleep	disorders,	such	as	insomnia,	are	reported	in	around	55-60%	of	
patients	(Gjerstad	et	al.,	2007),	and	around	a	third	of	patients	experience	rapid	eye	
movement	sleep	disorder,	resulting	in	aggressive	dream	content	(Borek	et	al.,	2007).	
Interestingly,	disturbances	in	sleep/wake	regulation	are	thought	to	be	caused	by	a	loss	of	
orexin	neurons	in	the	hypothalamus	(Fronczek	et	al.,	2007),	suggesting	PD	affects	neuronal	
populations	other	than	DA	neurons	and	in	regions	other	than	the	midbrain.	Changes	in	
sense	of	smell,	or	olfactory	dysfunction,	affect	around	90%	of	patients	with	PD	(Ross	et	al.,	
2008),	and	are	thought	to	be	caused	by	neuropathies	in	the	olfactory	bulb	(Pearce	et	al.,	
1995).	Non-motor	symptoms	often	precede	motor	symptoms	by	decades,	with	olfactory	
dysfunction,	constipation	and	depression	indicating	increased	risk	of	PD	development	
(Abbott	et	al.,	2001;	Schuurman	et	al.,	2002;	Ross	et	al.,	2008).	From	the	wide	range	of	
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motor	and	non-motor	symptoms	experienced	in	patients	with	PD,	it	is	evident	that	PD	is	a	
multi-system	disorder,	disabling	patients	and	hugely	reducing	quality	of	life.	
	
1.1.3:	Treatment	of	PD	
	
There	is	no	cure	for	PD	and	most	commonly	prescribed	treatments	focus	on	addressing	
motor	symptoms.	Levodopa	(L-DOPA),	the	precursor	to	catecholamine	neurotransmitters	
such	as	dopamine,	revolutionised	PD	management	and	has	remained	the	most	efficient	
form	of	treatment	(Jankovic	&	Aguilar,	2008).	Although	L-DOPA	initially	reverses	motor	
symptoms	in	patients,	the	drug	has	many	limitations.	These	include	reduced	drug	efficacy	
with	disease	progression	and	additional	motor	complications	such	as	involuntary	
movements	(dyskinesia).	In	patients	who	received	L-DOPA	treatment	for	5	years,	50%	
developed	these	complications,	rising	to	80%	of	patients	treated	for	10	years	(Fahn,	2000).	
Additionally,	EOPD	patients	appear	to	be	particularly	sensitive	to	decreased	L-DOPA	
efficacy	and	dyskinesia	(Golbe,	1991).	Alternatives	to	L-DOPA	include	DA	agonists:	these	
are	associated	with	fewer	motor	complications	but	in	some	patients,	can	worsen	non-
motor	symptoms.	DA	agonists	can	also	result	in	compulsive	behaviours	and	difficulties	with	
impulse	control,	which	can	lead	to	behaviours	such	as	pathological	gambling,	compulsive	
shopping	or	hypersexuality	(Voon	et	al.,	2011;	Santangelo	et	al.,	2013;	Atmaca,	2014).	
Deep	brain	stimulation	has	also	been	established	as	an	effective	therapy,	but	carries	risk	of	
surgery-related	complications,	infection	and	neuropsychiatric	conditions	such	as	those	
observed	with	DA	agonist	treatment	(Groiss	et	al.,	2009).	Although	current	treatments	may	
be	effective	at	alleviating	motor	symptoms,	they	do	not	halt	progression	of	the	disease	and	
are	not	neuroprotective.	This	highlights	the	need	for	a	better	understanding	of	PD,	and	the	
need	to	generate	better	treatments	that	prevent	or	slow	PD	progression.		
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1.2:	Causes	and	pathogenesis	of	PD	
	
1.2.1:	Monogenically-inherited	forms	of	PD	and	genetic	risk	factors	
	
For	a	long	time,	PD	was	considered	a	non-genetic	disorder.	However,	it	is	now	known	that	
around	5-10%	of	patients	have	mutations	in	a	single	gene,	so-termed	monogenic	forms	of	
the	disease.	These	genes	include,	but	are	not	limited	to,	dominant	PD	genes	such	as	SNCA,	
LRRK2,	and	recessive	PD	genes	such	as	PARKIN	and	PINK1	(Lesage	&	Brice,	2009;	
Puschmann,	2013).	The	first	PD-causing	mutation	to	be	discovered	was	a	point	mutation	in	
the	SNCA	gene,	encoding	alpha-synuclein.	It	was	named	the	A53T	mutation	and	was	found	
in	individuals	from	a	kindred	originating	from	Contursi,	Italy	and	in	three	Greek	families	
(Golbe	et	al.,	1996;	Polymeropoulos	et	al.,	1997).	The	mutation	in	SNCA	caused	earlier	
onset	of	the	disease	than	in	typical	cases	with	similar	clinical	phenotypes	between	all	
individuals	(Polymeropoulos	et	al.,	1997).	The	A53T	mutation	has	since	been	observed	in	
several	other	families	and	individuals	(Papadimitriou	et	al.,	1999;	Papapetropoulos	et	al.,	
2001;	Bostantjopoulou	et	al.,	2001;	Michell	et	al.,	2005;	Ki	et	al.,	2007;	Choi	et	al.,	2008;	
Puschmann	et	al.,	2009).	A	second	point	mutation	in	the	SNCA	gene,	the	A30P	mutation,	
was	identified	in	a	German	family	(Krüger	et	al.,	1998),	and	a	third,	termed	the	E46K	
mutation,	was	found	in	a	family	originating	from	Spain	(Zarranz	et	al.,	2004).	Duplication	
and	triplication	SNCA	mutations	have	been	more	frequently	reported	in	families	with	PD,	
where	duplication	results	in	late-onset	PD	and	triplication	results	in	early-onset	PD,	
suggesting	a	toxic	gain	of	function	mechanism	(Singleton	et	al.,	2003;	Ibáñez	et	al.,	2004).	
The	pathogenic	mechanism	of	SNCA	mutations	is	still	not	clear,	but	is	thought	to	be,	in	
part,	related	to	inappropriate	alpha-synuclein	protein	aggregation	(pathological	
mechanisms	are	discussed	in	detail	in	section	1.2.3).		
	
Several	mutations	in	the	leucine-rich	repeat	kinase	2	(LRRK2)	gene	were	discovered	
simultaneously	in	eight	families:	a	family	originating	from	Germany,	Denmark	and	Canada	
(Y1699C	mutation),	a	family	from	Nebraska	(R1441C	mutation),	4	families	from	the	Basque	
region	of	Spain	(R1441G	mutation,	where	this	mutation	has	since	been	found	in	8%	of	
patients	with	familial	PD	in	the	Basque	region	(González-Fernández	et	al.,	2007),	one	family	
from	the	UK	(Y1699C	mutation)	and	one	family	from	Japan	(I2020T	mutation)	(Paisán-Ruıź	
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et	al.,	2004;	Zimprich	et	al.,	2004).	Since	then,	a	R1441H	mutation	was	found	in	several	
families	worldwide	(Zabetian	et	al.,	2005;	Mata	et	al.,	2005;	Spanaki	et	al.,	2006),	and	a	
N1237H	mutation	was	found	in	two	families	from	Norway	and	one	patient	from	Sweden	
(Puschmann	et	al.,	2009;	Aasly	et	al.,	2010).	Apart	from	the	R1441G	mutation,	these	LRRK2	
point	mutations	are	relatively	rare.	One	LRRK2	mutation	on	the	other	hand,	the	G2019S	
mutation,	is	the	most	commonly	found	PD-associated	mutation	worldwide,	and	is	
particularly	prevalent	among	the	North	African	Arab	population	and	the	Ashkenazi	Jewish	
population.	The	G2019S	mutation	has	been	found	in	41%	of	sporadic	PD	cases	and	37%	of	
cases	with	a	family	history	of	PD	from	the	North	African	Arab	population	(Lesage	et	al.,	
2006),	and	in	18.3%	of	Ashkenazi	Jewish	patients	exhibiting	PD	symptoms	(Ozelius	et	al.,	
2006).	In	other	populations,	the	G2019S	mutation	is	less	common	but	the	frequency	of	
patients	carrying	this	mutation	is	still	relatively	high	(around	1-2%	of	PD	patients)	(Correia	
Guedes	et	al.,	2010).	The	pathology	observed	in	LRRK2	mutation-induced	PD	is	highly	
variable,	seemingly	dependent	upon	the	specific	point	mutation	harboured	by	the	
individual.	The	biological	role,	and	the	role	of	LRRK2	in	PD,	remains	largely	unknown	
(Poulopoulos	et	al.,	2012).	LRRK2	is	a	focus	of	this	thesis,	so	recent	advances	in	the	
understanding	of		its	role	in	PD	will	be	discussed	in	section	1.2.5.	
	
Recessive	PD	genes,	such	as	PARKIN	and	PINK1,	are	frequently	found	in	families	where	
several	individuals	in	one	generation	display	PD.	This	is	particularly	common	in	
consanguineous	families	(Yamamura	et	al.,	1973;	Kitada	et	al.,	1998;	Chishti	et	al.,	2006).	
Mutations	in	the	PARKIN	gene,	encoding	Parkinson	protein	2	E3	ubiquitin	protein	ligase,	
were	originally	discovered	in	siblings	displaying	EOPD	in	two	separate	consanguineous	
families	in	Japan	and	Turkey	(Yamamura	et	al.,	1973;	Kitada	et	al.,	1998).	Since	then	
PARKIN	mutations	have	been	linked	to	(very)	early-onset	PD;	in	one	study,	77%	of	patients	
who	displayed	PD	before	the	age	of	20	carried	at	least	one	PARKIN	mutation	(Lücking	et	al.,	
2000).	PARKIN	mutations	are	highly	variable,	with	over	100	different	mutations	reported	in	
PD	patients	to	date.	These	include	deletions,	insertions,	multiplications,	missense	and	
truncating	mutations,	resulting	in	loss	of	function	of	Parkin	(Lesage	&	Brice,	2009).		The	
underlying	pathological	mechanisms	of	loss	of	function	mutations	in	PARKIN	are	not	well	
understood,	though	it	is	generally	thought	that	this	results	in	decreased	catalytic	activity,	
aberrant	ubiquitination	and	impaired	proteosomal	degradation	(Dawson	&	Dawson,	2010).	
Pathological	mechanisms	in	PD	will	be	discussed	in	greater	detail	in	section	1.2.3.		
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Loss	of	function	mutations	in	the	phosphatase	and	tensin	homolog	(PTEN)-induced	
putative	kinase	1	(PINK1)	are	associated	with	EOPD,	though	PINK1	mutations	are	less	
common,	detected	in	1-4%	of	EOPD	patients	depending	on	the	population	(Tan	et	al.,	
2006;	Brooks	et	al.,	2009).	More	than	40	different	point	mutations	have	been	detected,	
though	large	deletions	are	rarely	detected	(Lesage	&	Brice,	2009).	PINK1	is	another	focus	of	
this	study,	so	will	be	discussed	in	more	detail	later	in	this	thesis	(see	section	1.2.4).	
Mutations	in	the	genes	DJ-1,	VPS35	and	EIF4G1	have	also	been	described,	though	these	
are	extremely	rare,	accounting	for	around	0-0.4%	of	PD	cases.	Monogenic	mutations	
described	in	this	section	are	summarised	in	table	1.1.		
	
Recently,	genome	wide	association	studies	(GWAS)	using	large	numbers	of	subjects	have	
facilitated	the	discovery	of	genetic	risk	factors	for	PD.	These	studies	have	identified	genetic	
variants	that	confer	small	or	medium	increased	risk	for	PD	development.	The	most	
common	are	variants	in	LRRK2	and	SNCA,	which	confer	a	high	risk	of	PD	(Satake	et	al.,	
2009).	However,	over	40	different	genetic	risk	loci	have	now	been	identified	(Nalls	et	al.,	
2014;	Chang	et	al.,	2017).	
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Gene	 Disease	
onset	
Clinical	phenotype	 Inheritance		 Known	expression	
SNCA	 Early	 Parkinsonism,	cognitive,	
behavioural	and	
autonomic	symptoms,	
muscle	spasms,	Lewy	
body	pathology.	
Autosomal	
dominant	
Brain	(pre-synapses).		
Lewy	bodies.	
LRRK2	 Late	 Parkinsonism,	highly	
variable	additional	
symptoms	depending	on	
mutation	type.	
Autosomal	
dominant	
Brain,	liver,	kidney	and	
heart.	
Lewy	bodies.	
PARKIN	 Early	 Parkinsonism,	low	risk	of	
cognitive	symptoms,	cell	
loss	in	brain	stem.	
Autosomal	
recessive	
Weakly	expressed	
throughout	the	brain.	
Strong	expression	in	
brainstem.	
PINK1	 Early	 Parkinsonism,		
cognitive	and	psychiatric	
symptoms,	cell	loss	in	
brain	stem.	
Autosomal	
recessive	
Widely	expressed	
throughout	the	brain	at	
mitochondrial	
membranes.	
DJ-1	 Early	 Parkinsonism,	low	risk	of	
cognitive	symptoms.	
Autosomal	
recessive	
Astrocytes	in	brain	
tissue.	
VPS35	 Late	 Parkinsonism,	cognitive	
and	behavioural	
changes,	no	Lewy	body	
pathology.	
Autosomal	
dominant	
Gastrointestinal	system,	
heart,	liver,	kidney,	
white	blood	cells.	
EIF4G1	 Late	 Parkinsonism,	mild	
disease,	cognition	
preserved,	Lewy	body	
pathology.	
Autosomal	
dominant	
Brain,	gastro-intestinal	
system,	heart,	white	
blood	cells.	
Table	1.1:	List	of	genes	containing	mutations	that	are	robustly	associated	with	PD.		
Onset	of	disease,	type	of	inheritance	and	known	expression	profiles	are	also	shown	
(Puschmann,	2013).	
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1.2.2:	Environmental	causes	of	PD 
	
In	cases	where	no	clear	genetic	cause	is	discovered,	environmental	influences	are	thought	
to	play	a	role	in	disease	aetiology	(Warner	&	Schapira,	2003).	Several	studies	have	
identified	rural	living	and	exposure	to	pesticides	as	a	risk	factor	for	development	of	PD	
(Barbeau	et	al.,	1987;	Semchuk	et	al.,	1992;	Seidler	et	al.,	1996;	Gorrell	et	al.,	1996;	Fall	et	
al.,	1999).	Indeed	one	study	found	the	pesticide	Dieldrin	in	DA	neurons	in	6	of	20	PD	
patient	brains	and	none	in	control	brains	(Fleming	et	al.,	1994).	Furthermore,	exposure	to	
dithiocarbamate-containing	fungicides	has	been	shown	to	increase	the	toxicity	of	1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine	(MPTP),	a	chemical	known	to	cause	selective	
destruction	of	nigrostriatal	DA	neurons	(Tipton	&	Singer,	1993).	This	suggests	exposure	to	
environmental	pesticides	may	increase	susceptibility	to	DA	neuronal	decline.	Exposure	to	
widely	available	mitochondrial	inhibitors	has	also	been	implicated	with	increased	PD	risk.	
Rotenone	is	a	commonly	used	pesticide	and	is	an	inhibitor	of	mitochondrial	complex	I.	In	
mice,	exposure	to	Rotenone	has	been	shown	to	cause	selective	destruction	of	nigrostriatal	
DA	neurons	resulting	in	a	PD-like	motor	defect	(Betarbet	et	al.,	2000).	Together	this	data	
suggests	that	environmental	agents	may	contribute	to	the	risk	of	PD.		
	
1.2.3:	Known	pathogenic	mechanisms	in	PD	
	
In	this	section,	an	overview	of	current	understanding	of	pathological	mechanisms	
implicated	in	PD	will	be	briefly	discussed,	although	it	should	be	noted	that	many	of	these	
mechanisms	are	still	widely	debated	and	the	overall	pathogenesis	of	the	disease	is	still	not	
fully	clear.		
One	of	the	cardinal	features	of	PD	is	the	presence	of	abnormal	aggregates	of	protein	in	
nigral	DA	neurons,	first	described	by	Friedrich	Heinrich	Lewy	in	1912	and	therefore	termed	
Lewy	bodies	or	Lewy	neurites.	Lewy	bodies	are	large	spherical	or	kidney-shaped	inclusions	
in	neuronal	cell	bodies,	whereas	Lewy	neurites	are	aggregated	strands	of	protein	found	in	
the	neuronal	processes.	Both	Lewy	bodies	and	Lewy	neurites	are	primarily	formed	of	
alpha-synuclein,	and	are	found	in	DA	neurons	of	the	substantia	nigra	in	PD	patients,	but	
have	also	found	in	other	brain	regions	such	as	the	hypothalamus,	brain	stem	and	the	spinal	
cord	(Jager	&	Bethlem,	1960;	Ohama	&	Ikuta,	1976;	Oyanagi	et	al.,	1990;	Wakabayashi	et	
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al.,	2007).	Recent	reports	propose	that	alpha-synuclein	aggregates	could	be	a	protective	
mechanism,	facilitating	segregation	and	degradation	of	mutated	or	damaged	proteins	
(Olanow	et	al.,	2004),	suggesting	altered	proteasome	function	may	play	a	role	in	PD	
pathogenesis.	It	remains	possible	however,	that	Lewy	bodies	expand	with	continued	
production	of	toxic	proteins,	leading	to	excessive	protein	aggregates	and	consequently	cell	
death	(Wakabayashi	et	al.,	2007).		
Numerous	studies	provide	evidence	of	altered	proteasome	function	in	PD.	The	ubiquitin	
proteasome	system	(UPS)	is	a	protein	degradation	system,	responsible	for	protein	
turnover.	Briefly,	proteins	are	targeted	for	degradation	by	ubiquitin	ligation,	requiring	
sequential	action	by	ubiquitin	activating	(E1),	conjugating	(E2)	and	ligating	(E3)	enzymes.	
The	protein	is	then	degraded	by	a	large	protease	complex	(Hershko	&	Ciechanover,	1998;	
Lim	&	Tan,	2007).	Discovery	of	a	role	for	altered	UPS	function	came	from	the	discovery	of	
PARKIN	mutations	(Parkin	encodes	the	Parkinson	protein	2	E3	ubiquitin	protein	ligase)	in	
EOPD.	Altered	UPS	function	may	result	in	toxic	accumulation	of	intracellular	proteins,	such	
as	alpha-synuclein,	and	subsequently	neuronal	cell	death.	However,	the	UPS	system	is	not	
specific	to	DA	neurons	in	the	substantia	nigra,	and	it	remains	unclear	as	to	why	DA	neurons	
appear	to	be	selectively	vulnerable	(Lim	&	Tan,	2007).			
	
Mitochondrial	dysfunction	has	also	been	implicated	in	the	pathogenesis	of	PD.	This	
originated	from	observations	of	mitochondrial	complex	I	deficiency	in	the	substantia	nigra	
of	PD	patients	(Schapira	et	al.,	1990).	The	cause	and	result	of	complex	I	deficiency	in	PD	is	
not	well	understood.	Some	studies	suggest	that	complex	I	inhibition	results	in	increased	
oxidative	damage	in	MPTP	treated	mice	(Przedborski	et	al.,	1996;	Perier	et	al.,	2005)	and	
consequently	damage	to	intracellular	components	and	cell	death.	Other	studies	suggest	
complex	I	inhibition	also	results	in	reduced	ATP	production,	adding	an	energy	failure	
hypothesis	(Fabre	et	al.,	1999).	Both	environmental	and	genetic	factors	affect	
mitochondrial	function	(Moon	&	Paek,	2015),	and	the	role	of	mitochondrial	dysfunction	in	
PD	pathogenesis	has	been	supported	by	several	PD	gene	knockout	models,	including	those	
with	mutation	in	PINK1,	which	display	mitochondrial	defects.	PINK1	is	of	relevance	to	this	
study,	therefore,	the	role	of	PINK1	in	mitochondrial	function	will	be	discussed	in	detail	
below	(see	section	1.2.4).	Another	gene	that	is	of	interest	to	this	study	is	LRRK2.	Therefore,	
the	pathological	mechanisms	of	LRRK2	will	also	be	further	discussed	(see	section	1.2.5).	
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1.2.4:	PINK1		
	
The	PTEN-induced	putative	kinase	PINK1	is	a	581	amino	acid	protein	with	a	serine	kinase	
domain	and	an	N-terminal	mitochondrial	targeting	sequence	(Mills	et	al.,	2008).	PINK1	is	
expressed	throughout	the	human	and	mouse	brain,	and	is	thought	to	localise	to	the	
mitochondrial	membrane	(Gandhi	et	al.,	2006;	Taymans	et	al.,	2006;	Blackinton	et	al.,	
2007;	Weihofen	et	al.,	2009;	Jin	et	al.,	2010).	Interestingly,	PINK1	is	also	expressed	in	the	
heart	and	muscle,	which	together	with	the	brain,	are	all	high-energy	demand	organs	
(Blackinton	et	al.,	2007).	This	supports	the	requirement	for	PINK1	in	mitochondrial	
function.		
	
Mutations	in	PINK1	are	the	second	most	common	cause	of	autosomal	recessive	EOPD	after	
PARKIN	mutations	(Valente	et	al.,	2004);	the	majority	are	missense	mutations	in	the	kinase	
domain	of	the	gene	(Mills	et	al.,	2008).	The	kinase	domain	of	PINK1	is	essential	for	cell	
survival:	cell	lines	expressing	pathogenic	PINK1	mutations	display	increased	susceptibility	
to	apoptotic	cell	death,	which	can	be	rescued	by	overexpression	of	wild	type	PINK1	(Petit	
et	al.,	2005;	Deng	et	al.,	2005).	One	way	PINK1	has	been	shown	to	function	is	through	
phosphorylation	of	the	mitochondrial	heat	shock	protein,	TRAP1,	preventing	release	of	the	
apoptosis	initiator	cytochrome	c	and	increasing	neuronal	survival	(Pridgeon	et	al.,	2007).		
	
Studies	have	shown	that	PINK1	may	also	function	in	the	same	pathway	as	Parkin	to	initiate	
mitophagy.	In	healthy	mitochondria,	PINK1	is	rapidly	degraded	by	the	mitochondrial	
protease,	presenilin	associated	rhomboid	like	protein	(PARL),	and	finally	fully-degraded	by	
the	proteasome	(Lin	&	Kang,	2008).	Cleavage	of	PINK1	by	PARL	is	dependent	on	
mitochondrial	membrane	potential,	where	decreased	mitochondrial	membrane	potential	
(such	as	following	damage	or	stress)	results	in	no	cleavage,	and	PINK1	accumulates	on	the	
mitochondrial	membrane	where	it	recruits	Parkin.	Parkin	then	ubiquitinates	mitochondrial	
targets,	labelling	the	mitochondrion	for	mitophagic	recycling	(Deas	et	al.,	2011;	Okatsu	et	
al.,	2012).	(figure	1.1).	Functional	mitophagic	recycling	means	damaged	mitochondria	do	
not	accumulate,	an	effect	that	is	pivotal	to	cell	survival	(Zhang	et	al.,	2017).	Loss	of	
functional	PINK1	results	in	failed	mitophagic	mechanisms	and	mitochondrial	dysfunction,	
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therefore	could	contribute	to	PD	progression.	However	the	relation	of	these	factors	to	PD	
is	still	widely	debated	(Winklhofer	&	Haass,	2010;	Matsuda	et	al.,	2013).	
	
	
	
Figure	1.1:	Illustration	summarising	the	PINK1/Parkin	regulatory	pathway	for	mitophagy.		
In	healthy	mitochondria,	PINK1	is	degraded.	Upon	mitochondrial	damaged	PINK1	and	
Parkin	accumulate	on	the	mitochondrial	membrane	and	ubiquitination	targets	the	
mitochondrion	for	recycling	by	mitophagy.	Figure	reproduced	from	Matsuda	et	al.,	2013.	
	
1.2.5:	LRRK2		
	
Leucine-rich	repeat	kinase	2	(LRRK2)	is	a	large	protein,	consisting	of	around	2527	amino	
acids,	with	several	leucine-rich	repeats,	a	RAS-like	GTPase	domain	(ROC),	a	C-terminal	
domain	(COR),	a	WD40	motif	and	a	kinase	domain.	The	majority	of	PD-casing	mutations	in	
LRRK2	are	found	in	the	ROC,	COR	and	kinase	domains,	all	of	which	form	the	enzymatic	core	
of	the	protein	(Paisán-Ruiz	et	al.,	2013).	Although	it	is	clear	that	LRRK2	dysfunction	is	highly	
important	to	PD	pathology	(as	described	above,	mutations	in	LRRK2	are	the	most	
commonly	found	PD-mutation	worldwide),	there	are	large	gaps	in	the	knowledge	of	the	
biological	function	and	pathological	mechanisms	of	LRRK2.	This	may	be	in	part	due	to	
LRRK2	possessing	a	complex	domain	structure	and	two	active	enzymatic	domains,	
obfuscating	interpretation	of	its	biological	role	and	its	dysfunction	in	PD.		
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The	biological	function	of	LRRK2	is	a	widely	debated	subject,	and	LRRK2	has	been	
implicated	in	several	core	biological	functions	(Paisán-Ruiz	et	al.,	2013).	Some	studies	have	
suggested	a	role	for	LRRK2	in	regulation	of	synaptic	vesicle	endocytosis	via	interaction	with	
endophillins	(Piccoli	et	al.,	2011;	Matta	et	al.,	2012)	and	others	have	shown	a	role	in	
autophagy	(Tong	et	al.,	2010a;	Herzig	et	al.,	2011;	Bravo-San	Pedro	et	al.,	2013).	LRRK2	has	
been	implicated	in	protein	sorting	mechanisms	by	interaction	with	Rab71L,	suggesting	a	
role	in	the	regulation	of	protein	disposal	(MacLeod	et	al.,	2013).	Furthermore,	LRRK2	has	
also	been	linked	to	regulation	of	micro-RNAs	(miRNAs)	to	regulate	protein	translation	
(Gehrke	et	al.,	2010;	Cho	et	al.,	2013)	and	has	been	shown	to	interact	with	cytoskeletal	
proteins,	implicating	LRRK2	in	cytoskeletal	remodelling	such	as	during	neurite	branching	
(Parisiadou	et	al.,	2009).	LRRK2	has	additionally	been	shown	to	be	expressed	in	circulating	
immune	cells	(Hakimi	et	al.,	2011)	and	has	been	shown	to	be	crucial	for	microglial	function	
in	the	brain	(Moehle	et	al.,	2012).	Interestingly,	a	recent	study	showed	that	LRRK2	could	
interact	with	Wnt	signalling	proteins,	bridging	cytosolic	and	membrane	components	
(Berwick	&	Harvey,	2012).	LRRK2	has	also	been	shown	to	directly	interact	with	the	
mitochondrial	fission	regulator,	dynamin-related	protein-1	(Drp1)	and	the	mitochondrial	
fusion	regulators,	mitofusin	1/2	(Mfn	1/2)	and	OPA1	(Wang	et	al.,	2012;	Stafa	et	al.,	2014).	
This	suggests	that	LRRK2	may	also	play	a	role	in	mitochondrial	dynamics,	including	fusion	
and	fission.	It	is	not	yet	clear	whether	the	roles	of	LRRK2	are	converging,	or	whether	the	
complex	structure	of	LRRK2	allows	for	multiple	divergent	biological	functions.		
	
The	role	of	mutated	forms	of	LRRK2	in	PD	appears	to	be	even	more	complex.	Clearly	the	
enzymatic	core	of	LRRK2	is	crucial	to	the	role	of	mutated	forms	in	PD,	as	most	pathogenic	
mutations	are	within	enzymatic	domains,	however	different	mutations	within	the	LRRK2	
gene	appear	to	lead	to	different	effects	on	enzyme	activity	(figure	1.2).	For	example,	the	
G2019S	mutation	results	in	increased	kinase	activity,	whereas	the	I2020T	mutation	has	no	
effect	on	kinase	activity	(Paisán-Ruiz	et	al.,	2013).	Furthermore,	the	R1441C,	R1441G,	
Y1699C	and	G2019S	mutations	all	result	in	decrease	GTPase	activity.		The	overall	theme	of	
these	studies	is	that	any	type	of	disruption	of	LRRK2	enzymatic	activity	is	deleterious	and	
could	instigate	PD.	The	role	of	LRRK2	in	PD	requires	much	further	investigation.		
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Figure	1.2:	Summary	of	the	impact	of	LRRK2	mutations	on	biochemical	readouts	of	
enzymatic	function.		
a) The	enzymatic	impact	varies	depending	on	the	position	of	the	mutation	in	the	LRRK2	
gene.	Figure	reproduced	from	Paisán-Ruiz	et	al.,	2013.		
b) Schematic	demonstrating	the	position	of	known	mutations	in	the	human	LRRK2	
protein.	
	
	
	
	
	
	
	
	
a)	
b)	
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1.3:	Genetic	models	of	PD	
	
Over	the	last	two	decades,	many	animal	models	of	PD	have	been	created	that	have	been	
pivotal	to	improving	our	understanding	of	the	disease.	Despite	this,	many	of	these	models	
fall	short	of	replicating	many	of	the	pathophysiological	aspects	of	PD	(Potashkin	et	al.,	
2011).	Some	success	has	come	from	toxin-based	models	of	PD,	such	as	the	commonly	used	
MPTP	treatment	that	is	selectively	taken	in	by	midbrain	DA	neurons,	causing	DA	neuron	
death	via	inhibition	of	mitochondrial	complex	I	(Mizuno	et	al.,	1987).	However,	toxin-based	
models	of	PD	are	of	limited	usefulness,	in	that	DA	neuronal	death	is	extremely	acute,	and	
so	does	not	mimic	the	progressive	nature	of	PD.	Toxin-based	models	also	do	not	allow	for	
analysis	of	multiple	converging	mechanisms	that	are	most	likely	present	in	genetic	forms	of	
the	disease	(see	sections	1.2.3,	1.2.4,	1.2.5).	Genetic	models	of	PD	can	be	more	
informative,	allowing	insight	into	gradual	disease	progression.	Recently,	many	genetic	
models	of	PD	have	been	created	in	different	vertebrate	and	invertebrate	species.	In	this	
section,	the	recent	advances	and	limitations	in	genetic	PD	models	will	be	briefly	discussed,	
focusing	on	PINK1	and	LRRK2	mutant	models.		
	
1.3.1:	Rodent	models	of	PD	
	
The	most	widely	used	genetic	model	of	PD	are	rodents,	which	has	provided	some	insight	
into	pathogenic	mechanisms.	However,	rodent	models	of	PD	are	limited	and	many	do	not	
fully	model	all	aspects	of	PD.	Several	mouse	lines	have	been	created	that	model	SNCA	
mutations.	In	these,	a	mixed	level	of	nigrostriatal	degeneration	has	been	observed	
(Chesselet,	2008;	Nuber	et	al.,	2008;	Lam	Hoa	A.	et	al.,	2011).	Various	PARKIN	knockout	
mice	lines	have	been	created,	but	none	have	shown	substantia	nigra	dopaminergic	loss	or	
behavioural	abnormalities.	Some	show	impaired	DA	release	and	mild	mitochondrial	
dysfunction	(Goldberg	et	al.,	2003;	Palacino	et	al.,	2004;	Perez	&	Palmiter,	2005;	Zhu	et	al.,	
2007).		
	
The	success	of	developing	rodent	models	of	Pink1	and	Lrrk2	deficiency	has	been	much	
more	limited.	Mouse	lines	with	loss	of	function	Pink1	mutations	develop	very	mild	
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phenotypes.	Pink1	knockout	mice	have	reduced	striatal	DA	levels	and	exhibit	a	decrease	in	
spontaneous	movement	by	one	and	a	half	years	of	age,	but	do	not	show	abnormalities	in	
DA	neuron	number	and	showed	no	other	behavioural	changes	such	as	anxiety	or	startle	
response	(Gispert	et	al.,	2009).		Although	Pink1	knockout	mice	do	not	display	DA	neuron	
reduction,	mice	lacking	functional	Pink1	do	however	display	mitochondrial	dysfunction,	
with	decreased	ATP	production	and	reduced	activity	of	mitochondrial	complexes	(Gautier	
et	al.,	2008).		
	
Mouse	lines	with	loss	of	function	mutations	in	Lrrk2	show	no	functional	abnormalities	in	
DA	neuron	system	(Andres-Mateos	et	al.,	2009;	Tong	et	al.,	2010b;	Hinkle	et	al.,	2012).	
Furthermore,	Lrrk2	knockout	mice	show	no	increased	susceptibility	to	MPTP	treatment	
compared	to	wild	type	mice	(Andres-Mateos	et	al.,	2009).	Interestingly,	mice	lacking	
functional	Lrrk2	display	alpha-synuclein	aggregates	and	accumulation	of	ubiquitinated	
proteins	in	the	kidney	(Tong	et	al.,	2010b),	and	in	another	study	displayed	abnormal	
exploratory	and	motor	coordination	behaviour	(Hinkle	et	al.,	2012).	Overexpression	of	
G2019S	mutated	Lrrk2	results	in	reduced	DA	content	in	the	striatum,	and	mice	expressing	
the	R1441G	mutant	form	of	Lrrk2	showed	a	motor	phenotype	but	neither	displayed	DA	
neuronal	loss	(Li	et	al.,	2009,	2010).	Furthermore,	G2019S	and	R1441C	knock-in	mice	show	
no	alterations	in	DA	neuron	number	in	the	substantia	nigra	(Tong	et	al.,	2009;	Herzig	et	al.,	
2011).	Two	Lrrk2	knockout	rats	have	been	reported,	which	showed	alterations	in	kidney	
morphology	and	function,	however	the	consequences	of	Lrrk2	deficiency	in	the	brain	are	
unknown	(Baptista	et	al.,	2013;	Ness	et	al.,	2013).	
	
1.3.2:	Drosophila	models	of	PD	
	
The	limitations	observed	in	mouse	models	of	PD	prompted	the	development	of	alternative,	
non-mammalian	models.	These	models	bring	benefits	of	reduced	genetic	complexity,	ease	
of	manipulation	and	low	cost.	The	fruit	fly	(Drosophila	melanogaster)	has	emerged	as	a	
non-vertebrate,	non-mammalian	model	for	PD.	Flies	with	loss	of	function	mutations	in	
pink1	show	a	robust	phenotype,	displaying	DA	neuron	degeneration,	flying	deficits	and	
reduced	climbing	speed.	Furthermore,	analysis	of	mitochondria	in	pink1	knockout	flies	
showed	decreased	ATP	production	and	swollen	mitochondria.	Phenotypes	appeared	to	be	
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progressive,	becomes	worse	with	age	and	resulting	in	decreased	lifespan	(Clark	et	al.,	
2006).	
	
Flies	with	LRRK2	mutations	however,	have	shown	inconsistent	phenotypes.	One	study	
showed	that	flies	with	transgenic	overexpression	of	pathogenic	mutated	human	LRRK2	or	
wild	type	human	LRRK2	showed	no	overall	defects.	Whereas	loss	of	function	mutations	in	
LRRK2	resulted	in	severely	impaired	locomotive	activity,	reduced	tyrosine	hydroxylase	
staining	of	DA	neurons	and	DA	neurons	with	shrunken	morphology	(Lee	et	al.,	2007).	
However,	another	study	showed	that	flies	overexpressing	either	wild	type	human	LRRK2	or	
pathogenic	mutated	LRRK2	resulted	in	adult	onset	loss	of	DA	neurons,	locomotor	
dysfunction	and	reduced	lifespan	(Liu	et	al.,	2008)	
	
1.3.3:	The	zebrafish	as	a	model	for	PD	
	
The	zebrafish	(Danio	rerio)	has	now	also	been	established	as	a	unique	and	valuable	
vertebrate	tool	for	studying	neurodegenerative	conditions,	including	PD.	There	are	several	
reasons	for	its	popularity,	including	external	development	allowing	easy	visualisation	and	
manipulation,	high	fecundity,	relatively	short	generation	time	and	the	fact	that	the	
zebrafish	genome	has	been	fully	sequenced.	Together	these	features	allow	easy	genetic	
manipulation	and	high	throughput	studies	(Xi	et	al.,	2011).	Additional	benefits	include	
closer	genetic	homology	to	humans	compared	to	invertebrate	models	and	the	similar	
functional	organisation	of	the	DA	neuron	system.	The	DA	neuron	system	in	zebrafish	has	
been	extensively	characterised	and	this	will	be	discussed	below,	after	which	I	will	describe	
recent	advances	in	generating	zebrafish	models	of	PD.	
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1.3.3.1:	The	zebrafish	ascending	dopaminergic	system	
	
In	humans,	DA	neurons	that	form	the	nigrostriatal	pathway	originate	in	the	midbrain,	
specifically	the	substantia	nigra	(pars	compacta),	and	send	ascending	projections	rostrally	
to	the	dorsal	striatum,	specifically	the	basal	ganglial	caudate	nucleus	and	putamen.	This	
dopaminergic	system	modulates	motor	control	and	characteristically	degenerates	in	PD	
(Ayano,	2016).	In	zebrafish,	DA	neurons	do	not	develop	in	the	mesencephalon,	which	is	
attributed	to	a	positional	shift	of	DA	activity	during	evolution	of	fish	to	mammals	and	is	a	
major	difference	between	zebrafish	and	mammals	(Ryu	et	al.,	2006).	However,	specific	
regions	of	the	zebrafish	brain	do	show	striking	similarities	to	mammalian	brain	regions.	A	
region	of	the	ventral	telencephalon	in	zebrafish,	named	the	subpallium	(SP),	is	homologous	
to	the	mammalian	striatum	(Ganz	et	al.,	2010a).	Furthermore,	retrograde	dye	tracing	
studies	have	shown	that	populations	of	DA	neurons	in	a	region	of	the	ventral	diencephalon	
called	the	posterior	tuberculum	(PT)	project	to	the	subpallium	(Fig.1.3)	(Rink	&	Wullimann,	
2001a).	These	ascending	neurons	are	confined	to	the	rostral	portion	of	the	PT.	It	is	
therefore	generally	considered	that	populations	of	DA	neurons	in	the	rostral	PT	are	
analogous	to	the	mammalian	substantia	nigra,	and	these	populations	have	been	
comprehensively	characterised	(Rink	&	Wullimann,	2001a,	2002a,	2004).		
The	PT	comprises	six	discrete	populations	of	DA	neurons	that	show	distinct	morphology,	
that	can	therefore	be	grouped	into	three	different	cell	types:	small	(parvocellular)	neurons	
(type	1),	large	(magnocellular)	pear-shaped	neurons	(type	2)	and	parvocellular	bipolar	
cerebrospinal-fluid	(CSF)	contacting	neurons	(type	3).	The	DA	neurons	can	be	further	
grouped	into	subpopulations,	dependent	on	position	along	the	rostro-caudal	axis.	The	first	
population	is	a	population	of	type	1	DA	neurons	that	occupy	the	periventricular	nucleus	of	
the	PT	(TPp).	DA	neurons	in	this	population	ascend	to	the	subpallium.	Second,	is	a	
population	of	type	2	DA	neurons	that	do	not	belong	to	any	distinct	nucleus,	but	also	
project	to	the	subpallium.	Third,	is	a	population	of	locally	projecting	type	3	DA	neurons	in	
the	paraventricular	organ	(PVO).	Fourth,	a	second	more	caudal	population	of	type	2	DA	
neurons	that	ascend	to	the	subpallium,	and	do	not	belong	to	any	nucleus.	Fifth,	a	
population	of	type	1	DA	neurons,	immediately	dorsal	to	the	posterior	tuberal	nucleus	
(PTN),	and	finally	another	population	of	type	1	DA	neurons	located	within	the	PTN	(Rink	&	
Wullimann,	2001a).	The	rostral	portion	of	the	PT	contains	the	only	three	populations	of	DA	
neurons	that	are	ascending:	the	TPp	and	the	two	populations	of	type	2	magnocellular	DA	
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neurons	(figure	1.3)(Rink	&	Wullimann,	2002a,	2004).	Therefore,	the	rostral	portion	of	the	
PT	will	be	the	focus	of	this	study,	and	will	be	further	described	as	part	of	results	chapter	3.	
	
Aside	from	the	PT,	the	adult	zebrafish	brain	also	contains	DA	neurons	in	the	telencephalon	
that	are	widely	dispersed	throughout	the	olfactory	bulb,	the	ventral	telencephalon	
(subpallium)	and	the	preoptic	nucleus.	In	the	remaining	diencephalon,	DA	populations	are	
more	discrete,	and	are	found	in	the	pretectum,	the	thalamus,	the	dorsal	and	caudal	zones	
of	the	periventricular	hypothalamus,	the	lateral	hypothalamus,	the	posterior	recess	of	the	
diencephalic	ventricle	(caudal	hypothalamus)	and	the	locus	coeruleus	(Fig1.4)	(Rink	&	
Wullimann,	2001a).	Indeed,	the	overlap	between	the	ventral	part	of	the	rostral	PT	and	the	
hypothalamus	is	ill-defined,	and	it	remains	possible	that	neurons	of	the	PVO	are	
hypothalamic.	
	
	
	
Figure	1.3:	Lateral	view	of	the	adult	zebrafish	brain	showing	tracer	injections	(black)	in	
the	ventral	telencephalon.		
Three	populations	of	DA	neurons	in	the	PT	can	be	identified	to	be	retrogradely	tracer-
labelled:	the	periventricular	nucleus	of	the	PT	(TPp)	and	two	populations	of	type-2	
magnocellular	DA	neurons	adjacent	to	the	TPp	(grey).	DA	neurons	in	the	PTN	are	thought	
to	project	to	the	dorsal	pallium,	though	this	has	not	been	confirmed.	Reproduced	from	
Rink	and	Wullimann,	2002a.	
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Figure	1.4:	Lateral	view	of	the	adult	zebrafish	brain	showing	all	dopaminergic	
populations.		
DA	neurons	are	found	in	the	olfactory	bulb,	the	ventral	telencephalon	(subpallium),	the	
preoptic	region	(PO),	the	ventral	and	dorsal	thalamus	(VT,DT),	the	pretectum	(Pr),	the	PT,	
the	hypothalamus	and	the	locus	coeruleus.	Reproduced	from	Rink	and	Wullimann,	2002b.	
	
	
Dopaminergic	populations	in	the	embryonic	and	larval	zebrafish,	and	the	developmental	
time	course	of	generation	of	these	populations,	have	also	previously	been	characterised	
(Rink	&	Wullimann,	2002b;	Mahler	et	al.,	2010).	These	studies	have	shown	that	DA	neuron	
populations	in	the	embryo	are	observed	in	positions	that	correspond	to	adult	populations	
and	have	comparable	morphology	to	these	corresponding	adult	populations.	It	is	therefore	
thought	that	dopaminergic	clusters	in	the	embryo	originate	in	their	final	adult	topological	
position,	although	importantly,	this	has	not	been	directly	lineage	traced	(Rink	&	
Wullimann,	2002b).	When	describing	embryonic	or	larval	diencephalic	DA	populations,	
previous	studies	have	used	numbered	format.	In	the	rest	of	this	thesis,	I	have	applied	this	
nomenclature	to	describe	embryonic	DA	neuron	populations.	This	numbering	system	is	
shown	in	Table	1.2	and	shown	in	Fig.1.4.	
	
In	the	embryonic	zebrafish,	several	DA	neuron	populations	found	in	the	adult	zebrafish	are	
also	discernible	at	2dpf,	in	particular	those	in	the	olfactory	bulb,	the	ventral	telencephalon,	
the	preoptic	area	and	diencephalic	populations	1-6	and	the	locus	coeruleus.	Diencephalic	
DA	neurons	in	the	pretectum	(8),	the	lateral	hypothalamus	(11),	the	periventricular	
hypothalamus	(5),	two	populations	in	the	caudal	hypothalamus	(10,	7)	and	one	small	
population	next	to	the	posterior	tuberal	nucleus	(9)	are	not	discernible	at	2dpf	(Fig.1.5).	In	
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larval	zebrafish	(5dpf),	DA	neurons	in	the	pretectum	(8)	and	one	of	the	populations	in	the	
caudal	hypothalamus	(7)	are	now	also	present,	but	those	in	the	lateral	hypothalamus	(11),	
the	small	population	adjacent	to	the	posterior	tuberal	nucleus	(9)	and	one	of	the	
populations	in	the	caudal	hypothalamus	(10)	are	not	(Fig.1.6)	(Rink	&	Wullimann,	2002b).		
It	should	be	noted	that	at	both	2dpf	and	5dpf,	DA	neurons	in	the	periventricular	nucleus	of	
the	PT	and	the	ventral	thalamus	form	a	contiguous	population	and	cannot	be	distinguished	
from	one	another	(Rink	&	Wullimann,	2002b).	Here,	and	for	the	remainder	of	this	thesis,	
this	population	is	termed	population	1	(figure	1.5,	1.6,	table	1.2).	
	
Notably,	all	DA	neuron	populations	in	the	rostral	PT	are	present	by	2dpf,	including	
ascending	DA	neuron	populations.	The	developmental	time	course	of	some	of	these	
populations	has	also	previously	been	described	(Mahler	et	al.,	2010)	and	is	summarised	in	
Table	1.2.	
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Figure	1.5:	Illustration	showing	DA	neuron	populations	in	the	2-day	old	zebrafish	
embryo.		
Telencephalic	populations	are	present,	as	well	as	diencephalic	populations	1-6.	
Reproduced	from	Rink	and	Wullimann,	2002b.	
	
	
Figure	1.6:	Illustration	showing	DA	neuron	populations	in	the	5-day	old	zebrafish	
embryo.		
Telencephalic	populations	are	present,	as	well	as	diencephalic	populations	1-8.	
Reproduced	from	Rink	and	Wullimann,	2002b.	
	
	 35	
Table	1.2:	Adult	DA	neuron	populations	in	the	zebrafish	and	the	corresponding	group	
number,	used	for	embryonic	and	larval	terminology,	and	the	order	that	these	
populations	appear	during	development.	
Populations	in	the	telencephalon	and	the	locus	coeruleus	are	named	as	adult	populations	
(labelled	with	a	dash).	Ascending	DA	neuron	populations	are	shown	in	red.	Greyed	boxes	
show	the	populations	investigated	in	this	study	(i.e.	the	rostral	posterior	tuberculum).	
Question	marks	are	shown	for	populations	where	no	data	showing	order	of	appearance	is	
available.	Group	numbers	are	taken	from	Rink	and	Wullimann,	2002b,	order	of	appearance	
data	is	taken	from	Mahler	et	al.,	2010.		
	
	
	
	
Adult	population	name	 Group	
number	
(0-11)	
Order	of	
appearance	(A-
F)	
Olfactory	bulb	 -	 ?	
Ventral	telencephalon	(SP)	 -	 E	(42hpf)	
Preoptic	area	 -	 E	(42hpf)	
Ventral	thalamus		 1	 E	(42hpf)	
Periventricular	nucleus	of	the	posterior	tuberculum	 1	 E	(42hpf)	
Large	pear	shaped	neurons	of	the	posterior	tuberculum	(rostral	
population)	
2	 A	(18hpf)	
Paraventricular	organ	 3	 D	(30hpf)	
Large	pear	shaped	neurons	of	the	posterior	tuberculum	(caudal	
population)	
4	 C	(24hpf)	
Periventricular	hypothalamus	 5	 E	(42hpf)	
Posterior	tuberal	nucleus	 6	 E	(42hpf)	
Posterior	recess	of	the	diencephalic	ventricle	(caudal	
hypothalamus)	
7	 F	(54hpf)	
Pretectum	 8	 ?	
Small	round	DA	neurons	adjacent	to	the	posterior	tuberal	nucleus		 9	 ?	
Caudal	hypothalamus	 10	 ?	
Lateral	hypothalamus	 11	 ?	
Locus	coeruleus	 -	 B	(20hpf)	
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1.3.3.2:	Zebrafish	models	of	PD	
	
Treatment	of	zebrafish	embryos	with	MPTP	results	in	reduced	numbers	of	DA	neurons	in	
the	diencephalon	and	movement	deficits,	giving	a	robust	PD	phenotype	(Bretaud	et	al.,	
2004;	Sallinen	et	al.,	2009).	Several	studies	have	also	treated	zebrafish	embryos	with	
morpholinos,	allowing	knockdown	of	PD-genes	including	parkin,	pink1	and	lrrk2	(Anichtchik	
et	al.,	2008;	Sallinen	et	al.,	2009;	Flinn	et	al.,	2009;	Xi	et	al.,	2010;	Sheng	et	al.,	2010;	Ren	et	
al.,	2011).	However,	this	data	has	provided	conflicting	results,	with	varied	levels	of	
reduction	in	DA	neuron	number	and	movement	phenotype,	where	some	studies	show	no	
reduction	at	all.	This	could	be	explained	by	the	fact	that	morpholinos	can	give	many	off-
target	effects	and	phenotypic	outcome	also	depends	on	the	knockdown	efficiency.	
Furthermore,	morpholinos	lose	their	effect	by	3-5dpf,	preventing	investigation	of	the	
effects	of	gene	dysfunction	in	adulthood.		
	
Our	group	has	created	a	pink1	knockout	zebrafish	line	using	the	targeting	induced	local	
lesions	in	genomes	(TILLING)	approach.	TILLING	involves	chemical	mutagenesis	using	a	
mutagen	such	as	ethyl	methanesulfonate	(EMS),	followed	by	a	sensitive	DNA	screening	
technique	to	identify	single	base	mutations	in	the	target	gene.	Identification	of	mutations	
relies	on	the	formation	of	DNA	heteroduplexes,	formed	by	genetic	recombination	of	
complementary	strands	after	amplification	by	PCR,	where	one	strand	includes	a	slightly	
different	sequence	caused	by	the	mutagenesis.	This	forms	a	“bubble”	at	the	mismatch	of	
the	DNA	strands,	which	is	cleaved	by	a	DNA	nuclease,	resulting	in	the	separation	of	the	
different	sized	PCR	products	in	gel	electrophoresis	(Kurowska	et	al.,	2011).	TILLING	
mutagenesis	by	Flinn	et	al.	(2013)	resulted	in	the	generation	of	a	zebrafish	line	that	carries	
a	point	mutation	in	the	kinase	domain	of	pink1,	resulting	in	the	introduction	of	a	
premature	stop	codon,	reduced	catalytic	activity	of	Pink1	and	decreased	mRNA	stability.	
Furthermore,	it	was	demonstrated	that	this	pink1	knockout	line	displays	loss	of	
dopaminergic	neurons	in	the	embryo	and	in	the	adult,	along	with	mitochondrial	
impairment.	Flinn	et	al.	showed	that	the	TP53-induced	glycolysis	and	apoptosis	regulator,	
TigarB,	was	upregulated;	furthermore,	knockdown	of	TigarB	resulted	in	the	rescue	of	DA	
neuronal	number	and	mitochondrial	function	(Flinn	et	al.,	2013).	This	provides	an	
extremely	robust	model	of	monogenic-inherited	PD,	and	a	marked	improvement	on	
previous	mouse	models	that	have	failed	to	fully	recapitulate	pink1-mediated	PD.		
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In	this	thesis,	the	pink1	mutant	zebrafish	line	will	be	used	to	study	the	effect	of	Pink1	
deficiency	on	neurogenesis.	In	addition,	a	lrrk2	mutant	line	was	made	to	allow	future	
investigations	of	lrrk2	in	a	novel	model	organism.		
	
1.4:	PD	and	neurogenesis	
	
Recent	evidence	has	suggested	that	one	pathogenic	mechanism,	contributing	to	PD	onset	
or	progression	may	be	dysregulated	neurogenesis.	Neurogenesis	is	defined	as	the	process	
of	generating	functional	neurons	from	neural	stem	and	progenitor	cells.	Until	the	1990s,	it	
was	believed	that	neurogenesis	in	most	of	the	CNS	was	restricted	to	embryonic/foetal	life,	
but	in	the	last	three	decades,	evidence	has	mounted	to	suggest	that	neurogenesis	may	
continue	in	adulthood	in	distinct	regions	of	the	brain	(Ming	&	Song,	2011).	Evidence	for	the	
hypothesis	that	neurogenesis	may	become	dysregulated	in	PD	arises	from	studies	showing	
that	PD-genes	can	regulate	neural	stem	and	progenitor	cells.	However,	although	some	
studies	have	begun	to	show	dysregulated	neurogenesis	in	PD	models,	none	has	
investigated	the	generation	of	DA	neurons	themselves.	Furthermore,	ageing	is	the	biggest	
risk	factor	for	developing	PD,	and	ageing	also	negatively	regulates	neurogenesis.		
	
In	this	section,	I	briefly	summarise	our	current	understanding	of	the	neurogenesis	of	
dopaminergic	neurons	in	prenatal	life	in	mammals	and	zebrafish,	then	summarise	our	
current	understanding	of	adult	neurogenesis	in	mammals	and	zebrafish.	I	will	also	discuss	
the	role	of	ageing	in	regulation	of	adult	neurogenesis,	and	finally,	I	will	discuss	the	current	
evidence	for	PD-gene	regulation	of	neural	stem	and	progenitor	cells.	
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1.4.1:	DA	neurogenesis	in	embryonic	life	
	
The	transcriptional	control	of	developmental	specification	of	ventral	midbrain	(VM)	DA	
neurons	in	mammals	is	complex,	though	key	signalling	pathways	have	been	shown	to	be	
crucial	to	DA	neurogenesis.	FGF8,	Sonic	Hedgehog	(Shh)	and	Wnt1	are	required	for	
induction	of	VM	patterning,	Lmx1a,	Lmx1b	and	FoxA2	expression	is	essential	to	induce	VM	
DA	progenitors,	and	Nurr1	and	Pitx3	are	crucial	for	the	transition	of	VM	DA	progenitors	to	
DA	neurons	(Hegarty	et	al.,	2013).	However,	in	zebrafish	the	roles	of	these	factors	do	not	
appear	to	comparatively	regulate	ventral	diencephalic	(vDC)	DA	neuron	populations	
(summarised	in	table	1.3).		
	
One	transcription	factor	that	has	been	shown	to	be	crucial	to	zebrafish	ascending	DA	
populations	is	OTP:	loss	of	OTP	results	in	the	absence	of	the	ascending	populations	DC2	
and	DC4	(Ryu	et	al.,	2007a).	The	role	of	OTP	in	development	of	mammalian	ascending	
neurons	is	not	clear,	though	one	study	has	shown	OTP	expression	in	the	nigrostriatal	
bundle	in	the	postnatal	mouse	ventral	midbrain	(Wang	&	Lufkin,	2000).	Another	
transcription	factor	that	is	crucial	to	the	development	of	ventral	diencephalic	DA	neurons	
in	zebrafish	is	the	Rax	orthologue,	rx3:	DA	neurons	in	the	rostral	posterior	tuberculum	are	
missing	in	rx3	knockout	zebrafish	embryos	(Muthu	et	al.,	2016).	However,	the	role	of	Rax	in	
the	development	of	mammalian	ascending	populations	is	not	clear.	
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Table	1.3:	Summary	of	the	effects	of	knocking	out	genes	involved	in	ventral	midbrain	
(VM)	or	ventral	diencephalon	(vDC)	formation	in	mouse	and	zebrafish.	
1.4.2:	Common	methods	used	for	investigating	adult	neurogenesis:	nucleotide	analogues	
and	conditional	genetic	lineage	tracing	
	
	
Gene	 Effect	of	knockout	in	mouse	on	VM	
development	
Effect	of	knockdown/	knockout	in	
zebrafish	on	vDC	development	
FGF	 Loss	of	FGFR:	absent	VM	DA	neurons	
(Lahti	et	al.,	2012).		
Loss	of	FGF2:	Post-natal	increase	in	VM	
DA	neurons	(Ratzka	et	al.,	2012)	
Loss	of	FGF8:	absent	DC1	DA	neurons.	
No	other	groups	affected	(Holzschuh	et	
al.,	2003)	
Gli1/2	
(Shh	
effector)
/Shh	
Deficient	VM	neurogenesis	(Park	et	al.,	
2000)	
No	defects	in	vDC	initiation	
Reduced	proliferation	and	survival	of	DA	
progenitors	
(Holzschuh	et	al.,	2003)	
Wnt	 Severe	reduction	of	VM	neurogenesis	
and	of	DA	neurons	(Prakash	et	al.,	2006)	
Wnt	antagonist	causes	an	increase	in	DA	
cell	number	(Russek-Blum	et	al.,	2008)	
Lmx1a	 Reduction	of	VM	DA	neurons	(Deng	et	al.,	
2011)	
Unknown	
Lmx1b	 Reduction	of	VM	DA	neurons	(Deng	et	al.,	
2011)	
Reduction	of	DA	neurons	in	DC1	
population	(Filippi	et	al.,	2007)	
FoxA2	 Increase	in	Nurr1+Th-	neurons	in	VM	
(Ferri	et	al.,	2007)	
Unknown	
Nurr1	 No	Th,	VMAT2,	DAT	expression	in	VM	DA	
neurons,	DA	neurons	are	subsequently	
lost		(Smits	et	al.,	2003)	
Altered	spatial	organisation	of	vDC	
groups,	no	apparent	reduction	in	
number	(Filippi	et	al.,	2007)	
Pitx3	 No	SNpc	DA	neurons		
VTA	unaffected	(Hwang	et	al.,	2003)	
No	effect	on	DA	neurons	(Filippi	et	al.,	
2007)	
OTP	 Absent	A11	neurons	(hypothalamus)	(Ryu	
et	al.,	2007)	
Absent	DC2,	DC4,	DC5	and	DC6	DA	
neurons	DC1	and	DC3	unaffected	(Ryu	et	
al.,	2007)	
Rax/rx3	 Unknown	 Absent	DC1,	DC2,	DC3	(potentially	DC4)	
neurons	(Muthu	et	al.,	2016)	
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In	the	1950s	a	new	method	allowed	labelling	of	dividing	cells	using	[H3]-thymidine,	a	
radioactive	nucleoside	that	is	incorporated	into	replicating	DNA	during	the	S-phase	of	
proliferation,	which	can	be	detected	by	autoradiography.	Using	this	technique,	several	
studies	were	published	that	showed	[H3]-thymidine	incorporation	in	various	regions	of	the	
adult	rat	brain	(Altman	&	Das,	1965,	1966;	Altman,	1969).	Subsequently,	studies	of	adult	
neurogenesis	in	songbirds	began	to	provide	evidence	for	a	functional	role	of	neurogenesis	
in	song	learning	(Nottebohm,	1980;	Brenowitz	&	Larson,	2015)	and	later,	neural	stem	cells	
were	isolated	from	the	adult	mammalian	brain	(Reynolds	&	Weiss,	1992).	The	field	of	adult	
neurogenesis	was	transformed	by	the	introduction	of	novel	techniques,	such	as	labelling	
with	the	S-phase	marker,	bromodeoxyurine	(BrdU)	and	conditional	lineage	tracing	
methods,	allowing	the	tracing	of	neurons	from	resident	stem	and	progenitor	cells.	These	
techniques	will	be	briefly	discussed.	
	
Nucleotide	analogues,	such	as	[H3]-thymidine	and	BrdU,	are	incorporated	into	replicating	
DNA	during	the	S-phase	of	proliferation,	labelling	the	cell	that	is	proliferating,	but	also	all	
progeny	from	that	cell.	Variations	of	both	pulse	frequency	(i.e.	frequency	of	injection	of	
analogues)	and	chase	time	(the	time	after	injection	and	before	culling)	allows	analysis	of	
proliferation	and	differentiation	of	newborn	cells.	In	recent	years,	BrdU	labelling	has	
become	more	common	for	analysing	neurogenesis	than	[H3]-thymidine,	as	BrdU	can	be	
detected	by	immunohistochemistry,	whereas	[H3]-thymidine	requires	autoradiographic	
detection.	However,	there	are	several	limitations	to	BrdU	labelling.	Firstly,	DNA	
denaturation	is	required	to	expose	BrdU	for	detection,	which	can	reduce	tissue	quality	and	
hinder	labelling	with	other	markers.	Recently	the	thymidine	analogue	5-ethynyl-2´-
deoxyuridine	(EdU)	has	been	introduced	to	combat	this	problem,	requiring	no	
denaturation.		
	
However,	with	both	these	techniques,	cells	that	undergo	multiple	rounds	of	proliferation	
can	gradually	dilute	the	label	and	may	become	undetectable.	In	addition	to	this,	as	
nucleotide	analogues	indicate	DNA	synthesis,	they	may	also	be	incorporated	into	cells	
undergoing	repair,	though	incorporation	through	repair	tends	to	be	on	a	much	smaller	
scale	(Ming	&	Song,	2005).		
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To	combat	these	limitations,	many	studies	combine	nucleoside	analogue	studies	with	
lineage	tracing.	One	way	to	lineage	trace	dividing	cells	is	through	retroviral	labelling.	In	this	
technique,	retroviruses	carrying	reporter	genes	are	injected	into	model	animals.	The	
retroviral	DNA	is	incorporated	into	the	host	genome	during	the	M-phase	of	cell	cycle,	and	
so	are	only	infectious	to	dividing	cells	(Imayoshi	et	al.,	2009).	However,	this	technique	is	
also	limited:	retroviruses	have	to	be	directly	injected	into	the	brain,	and	generally	this	
causes	injury,	and	only	allowing	infection	of	small	populations.	Another	method	is	genetic	
lineage	tracing.	In	this	technique,	a	recombinase	enzyme	is	expressed	in	a	cell	specific	
manner,	and	activates	the	expression	of	a	reporter	gene.	This	permanently	labels	the	cell	
of	interest,	and	all	progeny	derived	from	that	cell.	One	example	of	this	system	is	the	Cre-
loxP	recombination	system.	Cre	is	a	recombinase,	originally	isolated	from	bacteriophage,	
that	recognises	and	excises	a	specific	DNA	sequence	termed	loxP.	LoxP	sites	are	absent	
from	vertebrate	genomes	so	can	be	synthetically	introduced	to	allow	Cre-mediated	
recombination.	In	this	system,	Cre	recombinase	is	expressed	under	the	control	of	a	specific	
promotor.	In	a	variation	of	this	method	that	allows	for	temporal	conditional	lineage	
tracing,	Cre	can	also	be	fused	to	the	human	estrogen	receptor	(ERT2),	so	that	Cre	is	only	
activated	by	the	tamoxifen	ligand.	This	results	in	specific	Cre	expression	only	in	cells	
expressing	the	gene	of	interest	and	only	upon	addition	of	tamoxifen.	This	line	is	then	
crossed	to	another	line	in	which	a	reporter	gene	(for	example	GFP)	is	preceded	by	a	stop	
sequence,	flanked	by	loxP	sites	(loxP-STOP-loxP).	In	double	transgenic	animals,	conditional	
expression	of	Cre	results	in	excision	of	loxP	sites	along	with	the	stop	sequence,	and	
subsequent	expression	of	the	reporter	gene.	Progeny	can	then	be	robustly	traced	back	to	
the	original	stem	or	progenitor	cell	expressing	the	gene	of	interest	(Fig.1.7)	(Kretzschmar	&	
Watt,	2012).			
	
These	methods	have	revolutionised	the	field	of	neurogenesis,	allowing	robust	labelling	and	
lineage	tracing	of	newly	generated	neurons	in	the	adult	brain.	
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Figure	1.7:	Illustration	showing	the	mechanism	of	conditional	lineage	tracing	using	the	
Cre-loxP	recombination	system.		
Cre	recombinase	(purple),	bound	to	an	estrogen	receptor,	is	driven	by	a	cell-specific	
promotor	(blue).	This	line	is	crossed	to	a	reporter	line,	that	has	a	stop	sequence	(grey)	
flanked	by	loxP	sites	(red	triangles)	upstream	of	a	genetic	reporter	(green).	Upon	addition	
of	tamoxifen,	Cre	recombinase	excises	the	stop	codon,	allowing	permanent	expression	of	
the	reporter	gene	in	the	desired	cell	and	its	progeny.	
	
	
1.4.3:	Evidence	for	neurogenesis	in	the	adult	mammalian	brain	
	
The	renewed	interest	in	adult	neurogenesis	was	initially	sparked	by	the	demonstration	of	
new	neuron	production	in	the	dentate	gyrus	of	adult	humans	(Eriksson	et	al.,	1998).	In	this	
study,	patients	with	cancer	were	injected	with	BrdU	to	examine	proliferating	cells	in	their	
tumours.	This	revealed	numerous	BrdU-positive	neurons	in	the	hippocampus.	Since	then,	
numerous	studies	have	demonstrated	neurogenesis	in	the	SGZ	of	the	hippocampus	
(Cameron	&	McKay,	2001;	van	Praag	et	al.,	2002;	Zhao	et	al.,	2006;	Ramirez-Amaya	et	al.,	
2006)	and	have	revealed	the	different	cell	subtypes	associated	with	de	novo	neurogenesis.	
Type	B-cells	have	long	radial	processes	that	project	through	the	granule	cell	layer	and	
express	glial	fibrillary	acidic	protein	(GFAP)	and	type	D-cells	have	short	processes,	and	are	
GFAP-negative.	Both	type	B-cells	and	type	D-cells	express	Nestin	and	both	are	progenitor	
populations	for	new	granule	neurons	(termed	G	cells)	(Seri	et	al.,	2001),	that	migrate	a	
short	distance	to	the	granule	cell	layer	GCL	(Imayoshi	et	al.,	2009)	(Fig.1.8A).	Previous	
studies	have	shown	that	very	few	neurons	die	in	the	dentate	gyrus,	and	that	the	number	of	
granule	cells	increases	during	adulthood,	suggesting	adult	neurogenesis	contributes	to	
expanding	populations	in	the	hippocampus	(Bayer	et	al.,	1982;	Crespo	et	al.,	1986;	
Kempermann	et	al.,	2003).	Furthermore,	conditional	lineage	tracing	of	Nestin-expressing	
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progenitors	showed	an	expansion	of	labelled	granule	neurons	in	early	life,	and	blockade	of	
neurogenesis	prevented	this	expansion.	Blockade	of	neurogenesis	was	performed	using	a	
NSE-DTA	mouse	line,	which	carry	a	loxP-STOP-loxP-IRES-diptheria	toxin	fragment	(DTA)	
gene	cassette	in	a	neuron	specific	gene.	When	crossed	to	Nestin:CreERT2	mice,	and	upon	
administration	of	tamoxifen,	the	STOP	region	was	deleted.	This	results	in	expression	of	
DTA	in	developing	neurons,	and	subsequently	cell	death.	Interestingly,	blockade	of	
neurogenesis	in	this	manner	resulted	in	impaired	contextual	and	spatial	memory,	
suggesting	neurogenesis	in	the	adult	dentate	gyrus	is	required	for	functional	hippocampus-
dependent	memory	(Imayoshi	et	al.,	2008).		
	
Another	region	generally	accepted	to	harbour	cells	with	neurogenic	potential	in	the	adult	
brain	is	the	SVZ	of	the	lateral	ventricles.	The	SVZ	is	a	layer	of	cells	that	extends	along	the	
wall	of	the	lateral	ventricles,	and	contains	many	proliferating	cells.	Cell	subtypes	within	the	
SVZ	are	identified	by	morphological	features	and	expression	of	distinct	markers,	and	are	
termed	A,	B,	C	and	E	cells.	A-cells	are	defined	as	migrating	neuroblasts	(migrating	
immature	neurons,	committed	to	a	neuronal	fate	but	not	terminally	differentiated),	
expressing	doublecortin	(DCX)	and	polysialylated-neural	cell	adhesion	molecule	(PSA-
NCAM).	B-cells	express	GFAP,	and	can	be	split	into	two	distinct	populations	–	radial	glial-
like	cells	that	contact	the	ventricle	(B1)	and	cells	that	have	stellate	morphology	and	do	not	
contact	the	ventricle	(B2).	C-cells	express	Nestin	and	are	highly	proliferative	and	are	also	
termed	transit	amplifying	cells.	E-cells	are	ependymal	cells,	lining	the	ventricular	wall	
(Fig1.8B).	Previous	studies	using	retroviral	lineage	tracing	techniques	have	shown	that	B1-
cells	function	as	neural	stem	cells	in	the	adult	SVZ,	giving	rise	to	C-cells	(transit	amplifying	
cells),	which	subsequently	give	rise	to	type	A-cells	(neuroblasts)	(Doetsch	et	al.,	1999).	
Neuroblasts	generated	from	the	SVZ	migrate	through	the	rostral	migratory	stream	to	the	
olfactory	bulb	and	differentiate	into	interneurons	(Imayoshi	et	al.,	2009).	In	contrast	to	the	
dentate	gyrus,	studies	show	that	in	the	olfactory	bulb	old	neurons	are	replaced	by	new	
neurons,	as	evidenced	by	unchanged	neuron	number	and	high	levels	of	apoptosis	(Kaplan	
et	al.,	1985;	Biebl	et	al.,	2000;	Petreanu	&	Alvarez-Buylla,	2002).	This	suggests	that	
olfactory	bulb	population	numbers	are	tightly	regulated	through	the	rate	of	cell	death.	
Indeed,	conditional	lineage	tracing	of	Nestin-positive	progenitors	in	mice	revealed	the	
presence	of	labelled	neurons	in	the	olfactory	bulb,	where	long-term	lineage	tracing	
showed	that	almost	the	entire	population	in	the	olfactory	bulb	was	replaced	over	a	12-
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month	period.	Furthermore,	blockage	of	neurogenesis	in	the	SVZ	resulted	in	a	gradual	
decrease	in	population	number,	suggesting	death	of	olfactory	neurons	occurs	independent	
of	the	generation	of	new	neurons	and	that	continued	neurogenesis	is	essential	for	
maintenance	of	cell	number.	Interestingly	however,	blockage	of	SVZ	neurogenesis	showed	
no	effect	on	simple	tests	of	olfactory	discrimination	of	odours,	though	more	complex	tasks	
were	not	investigated	(Imayoshi	et	al.,	2008).		
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	1.8:	Illustration	showing	the	organisation	of	the	neural	stem	cell	niche	in	the	SGZ	
(A)	of	the	lateral	ventricles	and	the	SVZ	(B)	of	the	dentate	gyrus.		
A:	In	the	SGZ,	type	B-cells	are	defined	as	neural	stem	cells,	type	D	cells	as	transit	amplifying	
progenitors,	and	type	G-cells	as	granule	neurons.		
B:	In	the	SVZ,	type	B-cells	are	defined	as	neural	stem	cells,	type	C	cells	as	transit	amplifying	
progenitors,	type	A-cells	as	neuroblasts	and	type	E-cells	as	ependymal	cells.	Figure	
reproduced	from	Li	and	Xie,	2005.		
	
	
A	 B	
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More	recent	studies	have	shown	the	hypothalamus	to	be	a	neurogenic	region	in	the	adult	
mammalian	brain.	The	hypothalamus	acts	as	a	homeostatic	regulator	of	many	core	bodily	
functions,	including	energy	balance,	stress	regulation	and	reproduction.	The	hypothalamus	
is	centred	around	the	third	ventricle,	which	is	lined	by	radial-glial	like	cells	named	
tanycytes.	Tanycytes	are	specialised	ependymal	cells,	thought	to	bridge	the	gap	between	
the	central	nervous	system	and	the	cerebrospinal	fluid,	allowing	transfer	of	
neuroendocrine	signals.	To	achieve	this,	tanycytes	project	a	basal	extension	to	surrounding	
nuclei,	and	apically,	contact	the	cerebrospinal	fluid	(CSF).	Tanycytes	are	classed	into	
subgroups,	dependent	on	their	position	along	the	ventricle	and	their	expression	of	distinct	
markers.	These	groups	are:	α1-,	α2-	and	β-tanycytes	(Fig.1.9).		
	
	
	
	
	
	
	
	
	
	
	
	
Figure	1.9:	Tanycyte	subgroups	in	the	hypothalamus.		
Tanycytes	lining	the	third	ventricle	in	the	hypothalamus	can	be	grouped	into	different	
classes	depending	on	their	position	in	the	ventricle.	
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Tanycytes	of	the	hypothalamic	third	ventricle	have	been	suggested	to	be	potential	stem	
and	progenitor	cells,	due	to	shared	similarities	with	stem/progenitor	cells	of	the	SVZ	and	
SGZ,	including	similarities	in	morphology	and	in	gene	expression,	for	instance,	a	radial	glial-
like	morphology	and	expression	of	GFAP	and	Nestin	(Recabal	et	al.,	2017).		Indeed,	several	
studies	using	conditional	lineage	tracing	techniques	have	shown	that	subsets	of	tanycytes	
give	rise	to	other	tanycytes	and	neurons	in	the	surrounding	parenchyma	(Robins	et	al.,	
2013;	Haan	et	al.,	2013).	These	studies,	together	with	neurospherogenic	assays	ex	vivo	
confirm	their	role	as	neural	stem	and	progenitor	cells	in	the	adult	brain.	The	basal	rate	of	
neurogenesis	in	the	adult	hypothalamus	is	lower	than	in	the	SVZ	and	the	SGZ	(Migaud	et	
al.,	2010),	however	this	niche	appears	to	be	extremely	responsive	to	a	number	of	growth	
factors,	including	insulin-like	growth	factor	(IGF),	brain-derived	neurotrophic	factor	(BDNF),	
ciliary	neurotrophic	factor	(CNTF)	and	fibroblastic	growth	factor	(FGF)	(Pencea	et	al.,	2001;	
Kokoeva	et	al.,	2005;	Pérez-Martín	et	al.,	2010	p.1;	Robins	et	al.,	2013),	all	of	which	
markedly	enhance	proliferation	of	resident	cells	in	the	ventricular	and	subventricular	zone	
of	the	third	ventricle.	Interestingly,	changes	in	metabolic	conditions	can	also	modify	
hypothalamic	progenitor	proliferation,	including	high	temperature,	exercise	and	a	high	fat	
diet	(Kokoeva	et	al.,	2005;	Matsuzaki	et	al.,	2009;	Nascimento	et	al.,	2016;	Niwa	et	al.,	
2016).	This	suggests	that	progenitors	in	the	adult	mammalian	hypothalamus	are	part	of	an	
environmentally	responsive	niche.	Although	the	precise	functional	relationships	between	
different	cell	types	in	the	adult	SGZ,	SVZ	and	hypothalamus	is	still	not	fully	understood,	the	
studies	described	above	support	the	idea	that	cells	with	radial	glial	morphology	give	rise	to	
transit	amplifying	progenitors	and	neurons,	suggesting	their	role	as	neural	stem	cells	in	the	
adult	brain.	
	
Aside	from	the	SVZ,	the	SGZ	and	the	hypothalamus,	several	other	adult	mammalian	brain	
regions	have	been	shown	to	show	some	level	of	neurogenic	potential,	though	it	should	be	
noted	that	these	studies	are	controversial	and	highly	disputed.	In	the	adult	neocortex,	
several	studies	have	combined	BrdU	labelling	with	antibodies	that	detect	neuronal	
markers,	such	as	NeuN,	in	mammalian	species.	These	studies	have	shown	evidence	for	
newly	generated	neurons	in	the	adult	neocortex	in	rats	and	primates	(Gould	et	al.,	1999,	
2001,	2001;	Bernier	et	al.,	2002).	However,	other	studies	have	failed	to	replicate	this	
finding	in	mice	and	in	primates	(Kornack	&	Rakic,	2001;	Ehninger	&	Kempermann,	2003).	
Several	studies	have	also	reported	adult	neurogenesis	in	the	striatum	(Dayer	et	al.,	2005;	
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Luzzati	et	al.,	2006;	Bédard	et	al.,	2006),	however	others	have	only	found	such	evidence	
after	stimulation	with	growth	factors	or	pharmacological	manipulations	(Gould,	2007).	
	
Most	pertinent	to	this	study	are	investigations	into	neurogenesis	of	dopaminergic	neurons	
in	the	mammalian	substantia	nigra.	One	study	by	Zhao	et	al.	(2003)	demonstrated	the	
addition	of	new	DA	neurons	to	the	substantia	nigra	in	adult	mice.	In	this	study,	the	number	
of	DA	neurons	in	the	substantia	nigra	was	quantified:	there	was	no	change	in	numbers	of	
DA	neurons	between	2-	and	20-months	of	age.	However,	analysis	of	cell	death	showed	
that	a	proportion	of	DA	neurons	were	dying.	This	provided	initial	evidence	that	DA	neurons	
were	generated	in	adulthood.	Analysis	with	BrdU	labelling	then	showed	the	presence	of	a	
small	number	of	newly	generated	DA	neurons	in	the	16-week-old	mouse.	Furthermore,	
dye	labelling	of	cells	lining	the	lateral	ventricles	resulted	in	dye	labelled	DA	neurons	in	the	
substantia	nigra	(Zhao	et	al.,	2003).	This	study	suggests	the	possibility	of	de	novo	DA	
neurogenesis	in	the	substantia	nigra.	However	it	has	been	disputed	by	a	study	using	similar	
experimental	procedures	that	could	not	replicate	this	data	(Frielingsdorf	et	al.,	2004).	
Furthermore,	other	studies	have	shown	no	evidence	for	DA	neurogenesis	using	BrdU	
analyses	(Kay	&	Blum,	2000;	Lie	et	al.,	2002).	On	the	other	hand,	two	studies	have	provided	
evidence	that	DA	neurogenesis	can	be	stimulated	under	specific	conditions:	first,	rat	
midbrain	progenitors	can	give	rise	to	DA	neurons	in	vitro	(Lie	et	al.,	2002);	second,	
lesioning	the	substantia	nigra	with	MPTP	stimulates	DA	neurogenesis	in	mice	(Shan	et	al.,	
2006).	Finally,	rodent,	primate	and	human	substantia	nigra	contain	DA	neurons	with	
polysialic-like	immunoreactivity,	indicative	of	newly	differentiated	neurons	(Yoshimi	et	al.,	
2005).		
	
There	could	be	numerous	reasons	for	such	discrepancies.	Firstly,	it	is	possible	that	any	
neurogenesis	in	the	substantia	nigra	occurs	at	an	extremely	low	rate,	raising	the	question	
of	whether	negative	results	result	from	a	lack	of	sensitivity	in	technique:	Lie	et	al.	used	
sections	sampled	infrequently:	every	6th	section	was	examined,	therefore	may	not	have	
detected	new-born	DA	neurons.	Secondly,	small	differences	in	analytical	technique	could	
explain	some	discrepancies.	For	example,	Zhao	et	al.	analysed	male	mice	at	16	weeks	of	
age,	whereas	Frielingsdorf	et	al.	analysed	male	mice	at	9-10	weeks	of	age.	It	is	possible	
that	there	are	differences	in	the	rate	of	generation	at	different	ages.	Additionally,	
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Frielingsdorf	et	al.	used	a	lower	concentration	of	BrdU	in	their	experiments.	Thirdly,	
differences	in	housing	conditions	could	result	in	discrepancies:	as	discussed	above	in	other	
neurogenic	regions	such	as	the	hypothalamus,	environmental	conditions	can	influence	
neurogenesis.	Finally,	none	of	these	studies	utilise	a	conditional	genetic	lineage	tracing	
approach,	which	would	definitively	determine	whether	new	DA	neurons	are	generated	
from	resident	stem	and	progenitor	cells.	In	summary,	then,	from	these	studies,	it	is	not	
clear	whether	DA	neurons	can	be	generated	in	the	adult	mammalian	substantia	nigra.	
Together	with	other	studies	showing	that	murine	models	do	not	effectively	recapitulate	all	
aspects	of	PD,	particularly	DA	neurodegeneration	(see	section	1.3.1),	this	suggests	that	
murine	models	may	not	be	the	best	animal	to	model	the	ascending	dopaminergic	neuron	
system.	It	is	unknown	whether	adult	DA	neurogenesis	of	ascending	populations	occurs	in	
non-mammalian	models,	such	as	zebrafish,	and	this	was	one	of	the	aims	of	my	study.		
	
1.4.4:	Regulation	of	vertebrate	neurogenesis	
	
Homeostatic	regulation	of	neurogenesis	requires	the	balance	of	maintaining	a	stem	cell	
pool	whilst	also	generating	neurons.	Both	intrinsic	and	extrinsic	mechanisms	regulate	adult	
neurogenesis.	Many	of	these	mechanisms	have	been	characterised,	and	extensively	
studied,	through	analyses	of	embryonic	development.	Such	studies	have	elucidated	the	
signalling	pathways	that	regulate	proliferation	and	differentiation	of	neural	stem	and	
progenitor	cells.	in	both	embryonic	and	adult	life.	
	
Several	secreted	ligands	have	been	shown	to	act	as	regulators	of	stem	and	progenitor	cells	
in	the	central	nervous	system,	including	Notch,	Sonic	hedgehog	(Shh),	Wnts	and	bone-
morphogenetic	proteins	(BMPs)(Ming	&	Song,	2011).	These	ligands	regulate	
stem/progenitor	cell	maintenance,	proliferation	and	differentiation.	For	example,	studies	
showed	that	in	the	embryonic	CNS,	Notch	signalling	plays	a	crucial	role	in	the	maintenance	
of	stem	and	progenitor	populations	(Lasky	&	Wu,	2005).	Notch	signalling	has	also	been	
shown	to	be	required	for	maintenance	of	stem	and	progenitor	populations	in	the	adult	
SVZ.	Conditional	deletion	of	a	downstream	mediator	of	the	Notch	receptor,	RBPj,	results	in	
premature	differentiation	of	neural	stem/progenitor	cells	and	depletion	of	the	
stem/progenitor	cell	pool	in	both	embryonic	and	adult	mice	(Imayoshi	et	al.,	2010).	
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Another	study	also	implicated	Notch	in	the	maintenance	of	ependymal	cell	fate.	Upon	
injury	of	the	SVZ,	ependymal	cells	give	rise	to	astrocytes,	and	vice	versa.	Blockage	of	
another	downstream	mediator	of	Notch,	Ephrin,	resulted	in	the	differentiation	of	
ependymal	cells	to	astrocytes	(Nomura	et	al.,	2010).	Shh,	well-known	for	its	ability	to	
govern	progenitor	patterning,	proliferation	and	even	neurogenesis	in	the	embryo	(Ingham	
&	Placzek,	2006)	has	also	been	shown	to	play	a	role	in	regulation	of	adult	neurogenesis:	
Shh	signalling	in	the	SVZ	and	the	SGZ	is	required	for	the	formation	and	maintenance	of	
neural	stem	cells.	In	the	SGZ,	mutant	mice	that	lack	primary	cilia	(which	is	required	for	Shh	
signalling)	in	a	subset	of	embryonic	stem	cells,	results	in	reduced	numbers	of	type	D-cells	in	
the	postnatal	SGZ	and	an	absence	of	type	B-cells,	the	stem-like	radial	glial	population	in	the	
SGZ.	This	suggests	that	functional	cilia	and	Shh	signalling	are	required	for	establishment	of	
neural	stem	cells	and	neurogenesis	in	postnatal	life	(Han	et	al.,	2008).	In	another	study,	
conditional	knockout	of	the	Shh	mediator	Smoothened	(Smo)	in	the	postnatal	mouse	SVZ	
resulted	in	the	depletion	of	the	stem	cell	population,	suggesting	Shh	is	required	for	
maintaining	neural	stem	cells	in	a	quiescent	state.	In	addition,	the	authors	observed	a	
reduction	in	proliferation	of	transit	amplifying	cells	and	failed	migration	of	neuroblasts.	
This	suggests	Shh	signalling	mediates	diverse	functions	in	different	cell	types	in	the	SVZ	
(Balordi	&	Fishell,	2007).	Wnt	signalling,	originally	characterised	in	the	embryo	and	shown	
to	be	required	for	early	embryonic	patterning	events	and	cell	fate	determination	in	the	
embryo	(Bielen	&	Houart,	2014;	Noelanders	&	Vleminckx,	2017)	has	also	been	shown	to	
promote	proliferation	and	specification	of	progenitors	to	a	neuronal	fate	in	adult	mice:	
overexpression	of	Wnt3	increases	proliferation	and	neurogenesis	(Lie	et	al.,	2005).	BMPs,	
described	to	promote	non-neuronal	ectoderm	in	the	developing	embryo,	where	inhibition	
of	BMPs	is	required	to	establish	neuroectoderm	(Bond	et	al.,	2012),	have	been	shown	to	
promote	gliogenesis	and	block	neuronal	differentiation	in	the	adult	SVZ.	Overexpression	of	
BMP4	increases	the	number	of	astrocytes	but	depletes	astrocyte	progenitor	pools.	
Furthermore,	inhibition	of	BMP4	results	in	expansion	of	the	astrocyte	progenitor	pool	and	
decreases	the	number	of	astrocytes	(Bonaguidi	et	al.,	2005).		
	
Several	growth	factors	have	also	been	implicated	in	the	regulation	of	adult	neurogenesis.	
Epidermal	growth	factor	(EGF)	and	fibroblast	growth	factor	2	(FGF2)	both	promote	
proliferation	in	the	SVZ;	FGF2	increases	the	number	of	newly	generated	neurons	in	the	
olfactory	bulb,	and	EGF	increases	the	number	of	astrocytes	in	the	olfactory	bulb	(Kuhn	et	
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al.,	1997).	In	the	hypothalamus,	FGF2	has	also	been	shown	to	increase	tanycyte	
proliferation	(Robins	et	al.,	2013).	Furthermore,	BDNF	is	also	a	key	regulator	of	adult	
neurogenesis:	adult	mice	lacking	the	BDNF	receptor,	p75,	display	deceased	neurogenesis	in	
the	SVZ	and	BDNF	enhances	survival	of	newborn	neurons	in	the	hippocampus	(Zhao	et	al.,	
2008).		
	
Several	external	stimuli	also	influence	neurogenesis.	For	example,	physical	exercise	
increases	cell	proliferation	in	the	adult	mouse	SGZ	(van	Praag	et	al.,	1999)	and	high	
temperature,	exercise	or	a	high	fat	diet	can	influence	progenitor	behaviour	in	the	adult	
hypothalamus	(Kokoeva	et	al.,	2005;	Matsuzaki	et	al.,	2009;	Nascimento	et	al.,	2016;	Niwa	
et	al.,	2016).	Ageing	has	also	been	previously	shown	to	negatively	regulate	adult	
neurogenesis	in	several	studies	(Smith	et	al.,	2017).	As	ageing	remains	the	biggest	risk	
factor	for	developing	PD,	the	role	of	ageing	in	the	regulation	of	neurogenesis	is	particularly	
relevant	to	this	study	and	will	be	discussed	below.		
	
In	the	rodent,	the	rate	of	proliferation	and	neurogenesis	decreases	with	age	in	both	the	
SGZ	and	the	SVZ	(Seki	&	Arai,	1995;	Kuhn	et	al.,	1996;	Kempermann	et	al.,	2002;	Jin	et	al.,	
2003;	Luo	et	al.,	2006).	The	major	decrease	in	neurogenesis	occurs	between	3-	and	12-
months	of	age	(Kuhn	et	al.,	1996).	Interestingly,	age-related	decline	in	neurogenesis	in	the	
SVZ	has	been	linked	to	functional	decline	in	olfaction	in	adult	mice	(Enwere	et	al.,	2004).	In	
humans,	one	study	measured	the	level	of	nuclear	bomb	test-derived	14C	in	the	nuclear	
DNA	of	neurons.	By	comparing	neuronal	14C	levels	to	yearly	atmospheric	measurements,	
neurons	could	effectively	be	birth-dated.	Not	only	did	this	study	show	evidence	for	
addition	of	SVZ-derived	neurons	to	the	striatum	in	adulthood,	the	authors	also	
demonstrated	an	age-related	decrease	in	neurogenesis	(Spalding	et	al.,	2013).	By	contrast,	
one	recent	study	showed	that	young	neurons	could	not	be	detected	in	the	dentate	gyrus	
of	adults	aged	18-77,	with	numbers	of	proliferating	cells	(measured	by	expression	of	the	
transient	proliferation	marker,	Ki67)	declining	sharply	during	infancy	(Sorrells	et	al.,	2018).	
However,	the	patient	tissue	analysed	in	this	study	was	obtained	either	48-hours	after	
patient	death	or	from	patients	with	epilepsy	undergoing	brain	surgery.	It	is	not	clear	how	
neurogenesis	is	affected	by	subsequent	death	or	by	diseases	such	as	epilepsy,	though	
epileptic	seizures	have	been	shown	to	induce	proliferation	of	neural	stem	cells,	suggesting	
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repeated	seizures	may	cause	depletion	of	the	stem	cell	pool	(Lugert	et	al.,	2010).	If	true,	
this	study	suggests	that	neurogenic	potential	falls	rapidly	in	the	first	year	after	birth.	Due	
to	the	difficulty	in	obtaining	enough	tissue	from	human	patients	that	are	healthy,	the	
implications	of	these	studies	are	not	yet	clear,	though	understanding	the	limitations	of	
adult	human	neurogenesis	is	pivotal	to	the	interpretation	of	findings	from	other	animal	
models.			
	
The	cause	of	an	age-related	decline	in	neurogenesis	is	not	yet	understood,	though	several	
studies	have	proposed	various	mechanisms	to	explain	the	decrease	(Riddle	&	
Lichtenwalner,	2007).	One	theory	is	that	neural	stem	and	progenitor	cells	in	the	adult	brain	
may	stop	cycling,	or	cycle	less	frequently,	due	to	a	decrease	in	environmental	cues	or	the	
accumulation	of	inhibitory	factors.	Indeed,	the	addition	of	growth	factors	such	as	IGF,	EGF	
or	FGF	can	negate	the	effects	of	age	on	proliferation	in	mice	(Lichtenwalner	et	al.,	2001;	Jin	
et	al.,	2003).	This	suggests	that	responsive	neural	stem	and	progenitor	cells	are	still	present	
in	the	aged	brain.	Furthermore,	reduction	of	corticosteroid	levels	by	adrenalectomy	also	
results	in	increased	proliferation	in	aged	mice	(Cameron	&	McKay,	1999),	suggesting	
increased	corticosteroid	levels	with	age	may	contribute	to	neurogenic	decline.	Another	
theory	is	that	the	decline	is	due	to	a	reduction	in	the	number	and	proliferation	rate	of	
more	committed	progenitor	cells.	Decreases	in	BrdU	labelling	in	aged	animals	most	likely	
reflect	a	decrease	in	the	proliferation	of	rapidly	dividing	progenitor	cells,	i.e.	transit	
amplifying	cells,	and	in	theory,	could	reflect	smaller	populations	of	progenitor	cells	or	a	
slower	progenitor	cell	cycle.	Studies	have	shown	that	cell	cycle	length	increases	with	age	in	
the	SVZ	(Luo	et	al.,	2006),	though	this	occurs	later	in	life	than	does	the	decline	in	
proliferation.	This	suggests	that	the	decrease	in	proliferation	is	more	likely	due	to	smaller	
populations	of	rapidly	proliferating	progenitors.	In	addition	to	this,	neuronal	commitment	
and	differentiation	also	appear	to	be	affected	by	age.	For	example,	middle-age	rats	show	
approximately	a	60%	decrease	in	the	percentage	of	newborn	cells	in	the	SGZ	that	express	
neuronal	markers	compared	to	young	rats	(Lichtenwalner	et	al.,	2001).	The	number	of	
newborn	cells	expressing	the	neuroblast	marker	DCX	does	not	change	with	age,	implying	
that	alterations	arise	in	late	stages	of	differentiation	or	maturation	(Rao	et	al.,	2005).		
Interestingly,	studies	show	that	levels	of	gliogenesis	are	not	reduced	with	ageing	in	mice,	
with	no	age	related	decrease	in	the	number	of	newly	generated	oligodendrocytes	in	the	
olfactory	bulb	(Capilla-Gonzalez	et	al.,	2015).	Together	this	suggests	that	an	age-related	
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decline	in	neurogenesis	may	be	caused	by	several	factors,	including	alterations	to	
environmental	cues,	reduced	progenitor	populations,	impeded	differentiation	of	late-stage	
neurons	and	an	alteration	in	the	balance	of	neurogenesis	and	gliogenesis.		
In	summary,	this	data	shows	that	multiple	signalling	pathways	and	environmental	cues	act	
on	adult	neural	stem	and	progenitor	cells	to	allow	tight	regulation	of	the	number	of	
quiescent	stem	cells	and	the	number	of	new	neurons	and	astrocytes	generated,	and	shows	
that,	in	general,	there	is	an	age-related	decline	in	de	novo	adult	neurogenesis.	
	
1.4.5:	Using	zebrafish	to	investigate	adult	neurogenesis		
	
In	my	PhD	thesis,	I	used	the	zebrafish	to	analyse	the	generation	of	dopaminergic	neurons	
in	the	posterior	tuberculum	(PT)	in	both	wild	type	and	a	genetic	model	of	PD	(see	chapters	
5	and	6).	Zebrafish	have	recently	emerged	as	a	useful	tool	for	analysing	adult	
neurogenesis,	as	they	harbour	many	similarities	to	mammals.	Firstly,	zebrafish	and	
mammals	share	many	molecular	and	cellular	regulatory	mechanisms	of	neurogenesis.	
Secondly,	neurogenesis	in	zebrafish	is	confined	to	distinct	regions	in	the	adult	brain,	
suggesting	the	presence	of	defined	neurogenic	niches	comparable	to	the	adult	mammalian	
brain.	Although	there	are	some	differences,	including	more	widespread	proliferation	zones	
in	zebrafish,	understanding	the	mechanisms	that	allow	increased	generation	could	result	in	
the	development	of	treatments	to	stimulate	endogenous	neurogenesis	in	humans	(Alunni	
&	Bally-Cuif,	2016),	or	to	direct	the	differentiation	of	pluripotent	cells	towards	defined	
adult	neuronal	populations.	In	this	section,	the	similarities	and	differences	between	
zebrafish	and	mammalian	neurogenesis	will	be	described.		
	
One	of	the	most	well	studied	neurogenic	regions	in	the	adult	zebrafish	is	the	dorsal	
telencephalon,	also	called	the	pallium,	which	contains	regions	that	bear	similarity	to	the	
mammalian	SVZ,	SGZ	and	neocortex.	In	the	zebrafish	pallium,	populations	of	cells	with	
radial	glial	morphology	line	the	ventricle,	covering	a	large	majority	of	the	ventricular	zone	
(VZ).	Radial	glia	organise	into	a	monolayer,	contacting	the	CSF	and	projecting	long	
processes	into	the	surrounding	parenchyma	of	the	pallium	(Than-Trong	&	Bally-Cuif,	2015).	
Radial	glial	cells	form	a	heterogeneous	population,	and	
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embryonic	progenitor	populations	(Dirian	et	al.,	2014).	Adult	telencephalic	radial	glia	show	
differences	in	the	expression	of	glial	markers	such	as	Nestin,	GFAP,	S100B,	BLBP	and	
Vimentin;	the	functional	significance	of	pallial	VZ	heterogeneity	remain	poorly-understood.		
Analysis	of	BrdU	and	proliferative	markers	such	as	PCNA,	have	shown	that	dividing	cells	
along	the	ventricle	include	pallial	radial	glia.	After	longer	chase	times,	neurons	in	the	
pallium	also	express	BrdU,	indicating	they	are	newly	generated	(Adolf	et	al.,	2006).	
Furthermore,	conditional	lineage	tracing	studies	have	shown	that	pallial	radial	glial	cells	
can	self-renew	and	generate	multipotent	progenitors	which	subsequently	give	rise	to	new	
neurons	in	the	pallium	and	the	olfactory	bulb	(Kroehne	et	al.,	2011).	Lineage	tracing	was	
performed	using	a	genetic	strategy	(section	5.2.3),	in	which	Cre	recombinase	was	driven	by	
the	Her4	gene.	Her4	(the	zebrafish	orthologue	of	Hes5)	is	a	transcription	factor	of	the	
Hairy/Enhancer-of-split	family.	Expression	of	Hes	genes	is	induced	by	Notch	signalling	
(Fig.10),	and	Hes5/Her4	act	to	promote	self-renewal	and	maintenance	of	neural	stem	cells	
(Kageyama	et	al.,	2008;	Chapouton	et	al.,	2010,	2011).	The	extent	of	the	neuronal	subtypes	
that	are	generated	in	the	pallium,	and	their	function,	are	not	yet	fully	understood.	
However,	the	finding	that	neurogenesis	is	driven	from	radial	glial	stem	and	progenitor	cells	
suggests	a	similarity	to	mammalian	neurogenesis.		
	
	
	
	
	
	
	
	
	
	
Figure	1.10:	Notch	induced	Hes1/Hes5	signalling.		
Upon	activation	of	Notch	by	one	of	its	ligands,	for	example	Delta,	the	intracellular	domain	
(ICD)	is	cleaved	and	enters	the	nucleus.	ICD	forms	a	complex	with	the	DNA-binding	protein	
RBP-J.	In	the	absence	of	nuclear	ICD,	RBP-J	represses	Hes1/Hes5	by	binding	to	their	
promoters.	Upon	Notch	activation	and	subsequent	RBP-J	binding,	Hes1	and	Hes5	
expression	is	induced.	Figure	reproduced	from	Kageyama	et	al.,	2008.			
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In	addition	to	similarities	in	stem	and	progenitor	populations	between	mammals	and	
zebrafish,	many	regulatory	factors	of	neurogenesis	are	also	conserved	between	species.	
One	of	the	most	studied	is	the	Notch	signalling	pathway.	Much	like	adult	mammals,	Notch	
is	also	crucial	for	maintaining	quiescence	in	neural	stem	cells	in	adult	zebrafish.	This	is	
evidenced	by	expression	of	Notch	target	genes	in	quiescent	radial	glia	in	the	pallium	
(Chapouton	et	al.,	2010,	2011)	and	by	experiments	that	show	that	blockage	of	Notch3	
signalling	by	inhibition	of	γ-secretase	results	in	increased	proliferation	of	pallial	radial	glia	
and	overgrowth	of	the	pallial	VZ	(Alunni	et	al.,	2013).	Expression	of	her4	is	widespread	in	
the	zebrafish	brain,	suggesting	that	the	majority	of	radial	glial	cells	are	in	a	quiescent	state	
(Chapouton	et	al.,	2011).	Indeed,	the	average	time	between	two	divisions	in	the	same	
pallial	radial	glial	cell	has	been	estimated	to	be	one	month	(Rothenaigner	et	al.,	2011).	
Another	similarity	between	zebrafish	and	mammalian	neurogenesis	is	that	zebrafish	also	
display	an	age-related	decline	in	telencephalic	neurogenesis.	One	study	showed	that	
between	2	and	20	months	of	age,	the	number	of	BrdU-labelled	cells	significantly	decreased	
in	the	VZ	of	the	telencephalon,	with	an	additional	decrease	in	the	number	of	newly	
generated	neurons	in	the	olfactory	bulb.	The	authors	also	showed	that	restricted	regions	
of	the	VZ	became	devoid	of	progenitors	in	aged	zebrafish,	with	a	decrease	in	the	number	
of	cycling	progenitors	(Edelmann	et	al.,	2013).	This	suggests	that	fewer	radial	glia	enter	the	
cell	cycle	in	the	aged	brain,	and	therefore	reduce	the	number	of	transit	amplifying	
progenitors	that	are	generated.		
	
The	diencephalon	of	the	zebrafish	has	received	much	less	attention,	in	terms	of	adult	
neurogenesis.	However,	it	is	clear	that	in	the	diencephalon,	radial	glial	cells,	including	her	
expressing	radial	glia,	similarly	populate	the	ventricular	zone,	though	their	density	varies,	
depending	on	the	precise	location	within	the	diencephalon	(Menuet	et	al.,	2005;	
Chapouton	et	al.,	2011;	Than-Trong	&	Bally-Cuif,	2015).	Furthermore,	it	is	known	that	the	
diencephalon	retains	several	proliferative	zones,	including	distinct	proliferative	zones	in	
the	posterior	tuberculum	(Grandel	et	al.,	2006).	One	such	proliferative	zone	is	the	TPp,	
which	contains	ascending	DA	neurons.	It	is	not	clear	from	these	studies	however,	whether	
DA	neurons	are	generated	in	this	region	in	adulthood.	Interestingly,	a	second	proliferative	
zone	within	the	posterior	tuberculum,	the	paraventricular	organ,	has	been	described	to	be	
particularly	rich	in	radial	glial	cells.	Unusually,	the	nuclei	of	the	radial	glia	in	this	zone	are	
located	away	from	the	VZ,	and	project	a	short	process	toward	the	ventricle	(Pérez	et	al.,	
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2013).	Again,	the	extent	of	de	novo	neurogenesis	in	the	adult	paraventricular	organ	is	not	
known.		
	
Although	the	mammalian	and	zebrafish	brain	display	many	similarities,	some	key	
differences	are	also	present.	The	mammalian	telencephalon	develops	by	evagination	of	the	
neural	tube,	whereas	the	zebrafish	telencephalon	develops	by	eversion	(outward	folding	of	
the	neural	tube).	Therefore	the	proliferative	zones	in	zebrafish	are	present	in	the	internal	
ventricle,	but	also	cover	the	external	pallial	surface	(Schmidt	et	al.,	2013).	This	means	that	
proliferative	zones	in	the	zebrafish	possess	different	architecture	to	those	in	mammals:	in	
mammals,	the	proliferative	zones	are	covered	by	an	epithelium	(ependymal	cell	layer),	
whereas	in	zebrafish,	the	ependymal	layer	is	restricted	to	dorsal	proliferative	zones	and	
more	ventral	zones	are	devoid	of	this	layer.	Perhaps	the	most	crucial	difference	between	
zebrafish	and	mammalian	neurogenesis	is	the	rate	of	de	novo	cell	generation:	zebrafish	
display	more	widespread	proliferation	zones,	a	more	constitutive	form	of	neurogenesis	
and	more	efficient	regeneration	after	injury	(Grandel	et	al.,	2006;	Chapouton	et	al.,	2011;	
Than-Trong	&	Bally-Cuif,	2015).	The	reasons	behind	this	are	not	fully	understood,	though	
studies	investigating	the	effect	of	injury	in	the	telencephalon	have	shown	that	zebrafish	
possess	an	ability	to	stimulate	reactive	neurogenesis	from	quiescent	radial	glia,	which	
contributes	to	regenerative	potential	in	the	telencephalon	(Kroehne	et	al.,	2011;	Schmidt	
et	al.,	2013).	Interestingly,	this	regenerative	potential	does	not	appear	to	negate	the	
effects	of	ageing	on	neurogenesis	(Edelmann	et	al.,	2013),	suggesting	common	
mechanisms	may	exist	between	mammals	and	zebrafish	in	regulation	of	neurogenesis	with	
age.	Understanding	the	mechanisms	that	underlie	adult	neurogenesis	in	zebrafish	is	crucial	
to	understanding	the	mechanisms	and	limitations	of	human	neurogenesis,	and	
subsequently	to	the	development	of	treatments	that	can	harness	an	endogenous	potential	
to	repair.	However	currently,	the	shared	attributes	of	mammalian	and	zebrafish	
neurogenesis	allow	insight	into	neural	stem	and	progenitor	cell	biology	in	brain	regions	
that	share	homology	with	mammalian	counterparts.	Furthermore,	with	the	recent	
generation	of	a	robust	zebrafish	model	of	PD,	the	zebrafish	provides	a	unique	opportunity	
to	study	adult	neurogenesis	in	the	context	of	the	disease.		
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1.4.6:	PD-genes	regulate	neural	stem	and	progenitor	cells	
	
Non-motor	symptoms	such	as	anosmia,	depression,	anxiety	and	sleep	disturbances	are	not	
thought	to	be	directly	associated	with	the	degeneration	of	the	nigrostriatal	DA	system.	
Instead,	these	processes	rely	directly	on	function	of	the	olfactory	system,	the	hippocampus	
and	the	hypothalamus:	regions	that	display	neurogenesis	in	adult	life	(Winner	et	al.,	
2011a).	It	is	therefore	conceivable	that	some	non-motor	symptoms	experienced	by	
patients	with	PD	may	be	related	to	altered	neurogenesis	in	these	regions.	This	idea	is	
strengthened	by	recent	studies	that	show	that	genes	found	to	be	mutated	in	cases	of	PD,	
including	SNCA,	PINK1	and	LRRK2,	also	play	a	role	in	regulation	of	neural	stem	and	
progenitor	cells.	This	begins	to	suggest	that	dysregulated	neurogenesis	may	be	one	
pathological	mechanism	in	PD,	and	could	contribute	to	disease	onset,	progression	or	
development	of	non-motor	symptoms.		
	
Alpha-synuclein,	encoded	by	SNCA,	has	been	implicated	in	the	regulation	of	neural	
stem/progenitor	cells	in	the	adult	brain.	In	one	study,	the	pathogenic	role	of	alpha-
synuclein	inclusions	in	neurogenesis	was	investigated	by	overexpressing	human	SNCA	in	
adult	mice.	No	overall	difference	in	proliferation	was	observed	in	the	SVZ	or	the	SGZ,	
however	a	cell	fate	analysis	after	1-month	of	BrdU	injection	showed	around	50%	fewer	
newly-generated	cells	in	the	olfactory	bulb	and	the	dentate	gyrus	in	SNCA	overexpressing	
mice	and	around	60%	fewer	newly-generated	DA	neurons	in	the	olfactory	bulb.	
Furthermore,	around	a	50%	increase	in	the	number	of	apoptotic	cells	in	the	dentate	gyrus	
(but	no	difference	in	the	SVZ)	in	mice	overexpressing	SNCA	was	observed.	Analysis	of	the	
number	of	early	and	mature	neural	progenitors	in	the	SGZ	revealed	no	difference	in	the	
number	of	early	progenitors,	but	around	a	60%	decrease	in	the	number	of	mature	
progenitors.	Together	this	study	suggests	that	overexpression	of	human	SNCA	results	in	
reduced	survival	of	progenitors	in	the	SGZ	and	the	olfactory	bulb	(OB),	and	consequently	
reduced	DA	neurogenesis	in	the	dentate	gyrus	and	the	OB	(Winner	et	al.,	2004).	In	another	
study,	the	effect	of	overexpressing	a	mutant	form	of	human	SNCA	(A53T)	on	adult	
neurogenesis	was	analysed	in	mice,	showing	that	expression	of	mutant	SNCA	aggravates	
the	reduced	neurogenesis	observed	in	mice	overexpressing	wild	type	human	SNCA.	Mice	
expressing	A53T	SNCA	displayed	a	more	pronounced	reduction	in	the	number	of	newly	
generated	neurons	compared	to	mice	overexpressing	human	wild	type	SNCA.	This	was	
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combined	with	increased	levels	of	cell	death	in	the	SVZ	and	an	added	phenotype	of	
reduced	levels	of	proliferation.	Interestingly,	cell	death	was	observed	in	the	SVZ	and	the	
OB	in	mice	expressing	A53T	SNCA,	but	only	in	the	OB	in	mice	overexpressing	wild	type	
SNCA.	This	suggests	that	an	excess	of	wild	type	alpha-synuclein	diminishes	survival	of	new	
neurons,	but	that	A53T	mutant	alpha-synuclein	decreases	survival	at	an	earlier	stage,	
potentially	in	migrating	neuroblasts	(Winner	et	al.,	2008).	It	is	not	clear	from	this	study	
whether	overexpression	of	mutant	or	wild	type	SNCA	results	in	diminished	neurogenesis	
due	to	cell	intrinsic	toxicity,	or	due	to	changes	in	microenvironment.	However,	these	
studies	clearly	show	that	increased	levels	of	both	wild	type	and	mutated	forms	of	alpha-
synuclein	are	deleterious	to	adult	neurogenesis.	Interestingly,	investigations	into	the	
effects	of	the	loss	of	alpha-synuclein	show	that	SNCA	knockout	results	in	increased	
numbers	of	newly	generated	neurons	in	the	SGZ	(Winner	et	al.,	2012).	Together,	this	data	
suggests	that	alpha-synuclein	may	negatively	regulate	adult	neurogenesis,	such	that	
overexpression	may	cause	reduced	survival	of	neural	progenitors.	The	underlying	
mechanisms	however,	are	not	clear.		
	
PINK1	has	also	been	implicated	in	the	regulation	of	adult	neurogenesis.	PINK1	mRNA	is	
detected	throughout	the	adult	brain,	including	the	substantia	nigra,	but	is	also	strongly	
expressed	in	regions	that	have	been	shown	to	display	adult	neurogenesis,	such	as	the	
dentate	gyrus	and	the	hypothalamus	(Taymans	et	al.,	2006).	One	study	in	Drosophila	has	
shown	that	PINK1	can	interact	with	Notch,	in	a	noncanonical	Notch	signalling	pathway,	to	
directly	regulate	the	self-renewal	and	differentiation	of	neuroblasts	(the	Drosophila	
equivalent	of	neural	stem	cells)(Lee	et	al.,	2013).	In	this	study,	the	authors	showed	that	
Notch	gain	of	function	resulted	in	increased	self-renewal	of	neuroblasts,	correlating	with	
increased	levels	of	phosphorylated	AKT	(protein	kinase	B),	and	increased	activation	of	the	
kinase	that	is	responsible	for	AKT	phosphorylation,	mammalian	target	of	rapamycin	
complex	2	(mTORC2).	In	Notch	loss	of	function	mutants,	mTORC2	was	inhibited.	This	
suggests	that	Notch	activation	of	mTORC2/AKT	signalling	results	in	the	increased	self-
renewal	of	neuroblasts.	The	authors	next	showed	that	Notch	was	localised	at	the	
mitochondrial	membrane,	suggesting	that	Notch	exerts	its	effect	at	the	mitochondrial	
membrane.	Since	PINK1	is	involved	in	the	recruitment	of	proteins	to	the	mitochondrial	
surface,	the	authors	next	assessed	the	interaction	of	Notch	with	PINK1.	Interestingly,	
Notch	mitochondrial	localisation	was	decreased	in	PINK1	knockout	Drosophila,	and	Notch	
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and	PINK1	were	also	shown	to	associate	in	co-immunoprecipitation	studies.	This	suggests	
that	the	mitochondrial	localisation	of	Notch,	and	therefore	mTORC2/AKT	signalling	is	
dependent	on	PINK1,	and	that	activation	of	this	pathway	results	in	self-renewal	of	
neuroblasts	(Lee	et	al.,	2013).	More	recently,	PINK1	has	been	implicated	in	the	regulation	
of	neural	progenitors	in	the	mouse	hippocampus.	Cultured	neural	stem/progenitor	cells	
from	the	mouse	PINK1-/-	hippocampus	displayed	lower	mitochondrial	membrane	
potential,	suggesting	mitochondrial	dysfunction,	and	an	upregulation	of	glycolysis.	
Cultured	cells	from	PINK1-/-	mice	also	showed	impeded	differentiation	to	neurons,	and	
neurons	derived	from	PINK1-/-	neural	stem/progenitor	cells	displayed	fewer	dendritic	
branches.	Interestingly,	oligodendrocytes	were	generated	from	PINK1-/-	neural	
stem/progenitor	cells,	but	were	not	observed	in	wild	type	cultures	and	the	number	of	
astrocytes	generated	was	not	different	between	genotypes.	In	vivo	experiments	showed	
an	increase	in	the	proportion	of	early	neuroblasts	and	transit	amplifying	progenitors,	with	
reduced	numbers	of	intermediate	and	late	stage	neuroblasts	in	PINK1-/-	mice.	
Furthermore,	EdU	pulse/chase	analyses	showed	fewer	newly	generated	neuroblasts	and	
neurons	in	the	hippocampus	in	PINK1-/-	mice,	whilst	overall	levels	of	proliferation	were	
not	changed	(Agnihotri	et	al.,	2017).	Together,	this	suggests	that	loss	of	PINK1	results	in	
mitochondrial	dysfunction	in	SGZ	neural	stem	cells,	increased	propensity	for	NSCs	to	
differentiate	into	oligodendrocytes	and	impeded	differentiation	of	neurons	in	vitro	and	in	
vivo.		
	
Another	gene	commonly	found	to	be	mutated	in	PD,	LRRK2,	has	also	been	shown	to	play	a	
role	in	neural	stem	and	progenitor	cell	regulation.	LRRK2	mRNA	is	expressed	throughout	
the	adult	brain,	including	expression	in	neurogenic	regions	such	as	the	dentate	gyrus,	the	
SVZ	and	the	hypothalamus	(Taymans	et	al.,	2006;	Winner	et	al.,	2011b).	In	one	study,	the	
role	of	LRRK2	in	the	regulation	of	stem	and	progenitor	cells	was	investigated	using	human	
midbrain-derived	neural	progenitor	cell	(hmNPC)	cultures.	This	showed	that	cultured	
hmNPCs	that	expressed	Nestin	also	expressed	LRRK2	and	furthermore	that	knockdown	of	
LRRK2	using	small	interfering	RNA	(siRNA)	resulted	in	impeded	ability	to	differentiate	into	
DA	neurons,	but	not	to	other	neuronal	or	glial	cell	types.	The	authors	further	showed	that	
LRRK2	knockdown	results	in	DA	neurons	expressing	the	cell	death	marker,	cleaved	
caspase-3,	indicating	that	DA	neurons	are	lost	via	apoptosis	(Milosevic	et	al.,	2009).	This	
study	suggests	a	biological	role	for	non-mutated	LRRK2	in	the	differentiation	and	survival	
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of	DA	neurons,	where	knockdown	of	LRRK2	results	in	impeded	differentiation	and	cell	
death.	Another	study	has	shown	that	adult	mice	expressing	human	LRRK2	with	the	G2019S	
mutation	also	display	decreased	proliferation	in	the	SGZ	and	the	SVZ,	and	reduced	
generation	of	neurons	in	the	hippocampus	and	OB,	including	DA	neurons	in	the	OB.	
Reduced	neurogenesis	was	accompanied	by	structural	defects	of	hippocampal	neurons,	
including	decreased	neurite	length	and	decreased	number	of	spines	(Winner	et	al.,	2011b).	
The	G2019S	mutation	is	thought	to	be	a	toxic	gain	of	function	mutation	(see	section	1.2.5),	
suggesting	that	overexpression	of	LRRK2	results	in	reduced	neurogenesis.	Together	with	
reduced	neurogenesis	observed	in	LRRK2	knockdown	(Milosevic	et	al.,	2009),	this	supports	
the	idea	that	any	type	of	disruption	of	LRRK2	enzymatic	activity	is	deleterious,	be	it	
overexpression	or	loss	of	function.	Recently,	a	lrrk2	knockout	zebrafish	line	was	created.	
Lrrk2	knockout	zebrafish	displayed	no	differences	in	DA	neuron	number	in	the	ascending	
posterior	tuberculum,	however	did	show	decreased	levels	of	DA	and	serotonin,	and	
increased	levels	of	their	catabolites,	suggesting	perturbed	amine	catabolism.	Furthermore,	
lrrk2	knockout	zebrafish	displayed	reduced	proliferation	in	the	telencephalon	at	5dpf,	and	
in	both	the	telencephalon	and	the	diencephalon	at	10dpf.	Intriguingly,	overexpression	of	a	
Lrrk2	protein	fragment	containing	the	catalytic	core	rescued	the	proliferation	defect	in	
lrrk2	knockout	zebrafish	embryos,	suggesting	the	enzymatic	function	of	lrrk2	may	play	a	
role	in	proliferation	regulation.	In	6-month	old	zebrafish,	levels	of	proliferation	in	the	
telencephalon	were	modestly	reduced	and	upon	telencephalic	injury,	30%	fewer	new	
neurons	were	generated.	However,	constitutive	neurogenesis	in	the	uninjured	
telencephalon	was	unaltered	(Suzzi	et	al.,	2017).	Together	this	shows	that	lrrk2	is	required	
both	for	proliferation	of	neural	stem	and	progenitor	cells,	amine	catabolism	and	
regeneration	upon	injury.		
	
Altogether,	these	studies	demonstrate	that	monogenic-inherited	PD-genes	play	divergent	
roles	in	regulating	neural	stem	and	progenitor	cell	proliferation	and	differentiation	in	the	
adult	brain.	Although	these	investigations	provide	insight	into	the	regulation	of	
neurogenesis	in	the	context	of	PD,	adult	dopaminergic	neurogenesis	has	not	yet	been	
examined.	Thus,	the	extent	to	which	production	of	new	DA	neurons	contributes	to	existing	
populations	that	are	affected	in	PD	remains	unclear.	Further,	the	question	of	whether	PD-
genes	alter	DA	neurogenesis	in	the	adult	brain	has	not	been	addressed.	
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1.5:	Thesis	hypotheses	and	aims		
	
I	hypothesise	that	DA	neurons	of	the	zebrafish	posterior	tuberculum	are	generated	in	adult	
life,	and	that	generation	of	ascending	DA	neurons	is	impeded	in	a	genetic	model	of	PD.		
	
To	address	these	hypotheses,	my	aims	were	as	follows:	
1.	To	characterise	DA	neurons	in	the	embryonic	and	the	adult	zebrafish	posterior	
tuberculum,	to	define	distinct	DA	neuronal	populations	and	to	test	the	previous	suggestion	
that	embryonic	and	adult	populations	are	related.		
2.	To	examine	the	expression	of	neural	stem/progenitor	cell	markers	in	the	posterior	
tuberculum	at	different	stages	through	life,	to	provide	evidence	for	the	existence	of	neural	
stem/progenitor	cells	in	this	region.		
3.	To	perform	EdU	pulse/chase	analyses	and	conditional	genetic	lineage	tracing	to	address	
whether	new	DA	neurons	are	added	to	existing	populations	of	DA	neurons	at	different	
stages	throughout	adult	life.	
4.	To	perform	EdU	pulse/chase	analyses	to	assess	whether	generation	of	DA	neurons	is	
impeded	in	a	zebrafish	model	of	PD,	the	pink1	knockout	zebrafish.	
5.	To	create	a	new	model	of	genetic	PD,	the	lrrk2	knockout	zebrafish	which	at	the	start	of	
this	study	was	entirely	novel.		
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Chapter	2	
	
	
Materials	and	Methods	
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2.1	Zebrafish	
	
2.1.1	Zebrafish	husbandry	
Adult	and	larval	zebrafish	were	housed	at	The	Bateson	Centre,	University	of	Sheffield;	
experimental	procedures	were	in	accordance	with	UK	Home	Office	Animals	(Scientific	
Procedures)	Act	1986	(Project	license	number:	PPL70/8437,	held	by	Professor	Oliver	
Bandmann.	Personal	license:	PILI5B38EB05,	held	by	Sarah	Brown).	Zebrafish	were	housed	
in	tanks	at	a	density	of	no	more	than	four	zebrafish	per	litre,	at	a	constant	temperature	of	
28°c	and	on	a	14-hour	light,	10-hour	dark	cycle.	
	
2.1.2	Collection	and	maintenance	of	zebrafish	embryos	
To	collect	zebrafish	embryos,	a	marble	tank	was	put	into	the	tank	in	the	evening	to	
stimulate	mating	at	the	beginning	of	the	light	cycle	the	following	morning.	Alternatively,	
zebrafish	were	pair	mated	by	putting	a	male	and	a	female	in	a	divided	tank	overnight.	The	
divider	was	removed	to	allow	fertilization	at	a	specific	time.	Zebrafish	embryos/larvae	
were	kept	at	28°c	in	10cm	petri	dishes	filled	with	E3	media	(500µM	NaCl,	17µM	KCL,	33µM	
CaCl	and	33µM	MgSO4	and	2	drops	per	litre	of	methylene	blue	antifungal	agent).	Zebrafish	
embryos/larvae	were	kept	at	a	density	of	no	more	than	60	zebrafish	per	plate.	
	
2.1.3	Zebrafish	anesthesia	and	culling	
For	procedures,	adult	zebrafish	were	briefly	anaesthetized	using	tricane	(PharmaQ	
Hampshire)	(0.016%	w/v).	Once	the	procedure	is	complete,	zebrafish	were	placed	back	
into	a	clean	tank	in	a	quiet	area	of	the	aquarium	to	recover.	For	adult	brain	dissections,	
zebrafish	were	anaesthetized	with	a	stronger	solution	of	tricane	(0.4%	w/v)	to	allow	
immediate	anesthesia,	and	culled	by	decapitation.	This	allowed	quick	dissection	of	the	
brain	to	give	the	best	possible	tissue	quality	for	histological	techniques.			
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2.1.4	Fin	clipping	
Adult	zebrafish	were	genotyped	by	fin	clipping.	Zebrafish	were	anaesthetized	using	tricane	
and	a	small	clip	of	tailfin	was	cut	with	sterilized	surgical	scissors.	The	clipped	fish	was	put	
into	an	individual	tank	to	allow	genotyping	of	tissue,	and	the	tail	clip	was	put	into	the	
corresponding	well	of	a	96-well	plate.	Once	genotypes	had	been	determined,	fish	were	
separated	back	into	tanks	by	genotype.		
	
2.1.4	Adult	EdU	Injections	
For	EdU	analysis	in	this	study,	wild	type	zebrafish	at	3	months,	6	months,	12	months	and	
22	months	old	or	pink1-/-	zebrafish	at	3	months	old	were	injected	with	5µl	of	10mM	EdU	
(C10339;	ThermoFisher	Scientific)	in	HBSS	(14025-092;	ThermoFisher	Scientific).	Zebrafish	
were	anaesthetized	with	tricane	(0.016%	w/v)	and	injected	intraperitoneally	with	EdU	
(figure	2.1)	once	daily	for	3	consecutive	days.	After	an	additional	5	days,	zebrafish	were	
sacrificed	and	brains	were	collected.	EdU	injected	zebrafish	were	checked	regularly	for	
health	problems,	none	were	observed.		
	
	
	
	
	
	
	
	
	
Figure	2.1:	Intraperitoneal	injection	of	EdU	into	adult	zebrafish.		
The	zebrafish	was	anaesthetized	and	placed	on	a	tricane-soaked	sponge.	EdU	was	injected	
into	the	peritoneal	cavity.	
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2.1.5	Embryonic	EdU	Injections	
5nl	of	5mM	EdU	(2	volumes	10mM	EdU:1	volume	0.3x	HBSS:1	volume	Phenol	Red)	was	
microinjected	into	the	yolk	sac	of	embryos	31hpf.	The	embryos	were	left	to	develop	at	
28°c	until	55hpf.	At	this	point	the	embryos	were	sacrificed	and	collected.	EdU	injected	
zebrafish	embryos	were	checked	regularly	for	health	problems,	none	were	observed.	
	
2.1.6	Transgenic	zebrafish	
The	Nestin:GFP	transgenic	line	was	kindly	provided	to	The	University	Of	Sheffield	by	Dr.	
Uwe	Strahle	(Karlsruhe	Institute	of	Technology,	Germany)	(Lam	et	al.,	2009).	The	
Tg(her4:ERT2CreERT2)	and	Tg(ubi:loxGFPloxmCherry)	transgenic	lines	were	a	kind	gift	from	
Laure	Bally-Cuif	(Dirian	et	al.,	2014).		
	
2.1.7	Conditional	recombination	
To	induce	recombination	of	the	Tg(her4:ERT2CreERT2);Tg(ubi:loxGFPloxmCherry)	line,	5µl	
of	10mM	tamoxifen	(T5648-1G)	diluted	1:5	in	sunflower	oil	was	injected	intraperitoneally	
once	and	zebrafish	were	replaced	in	tanks	and	chased	for	32-days.	A	control	group	was	
injected	with	oil	alone	alongside	experimental	animals.	After	the	chase	period,	zebrafish	
were	sacrificed	and	brains	were	collected.	Tamoxifen	injected	zebrafish	were	checked	
regularly	for	health	problems.	None	were	observed.		
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2.2	Molecular	Biology	
	
2.2.1	Basic	local	alignment	search	tool	(BLAST)	
To	identify	zebrafish	orthologues	of	human	genes,	the	human	protein	sequence	was	
searched	for	in	ENSEMBL	and	then	searched	for	in	the	Basic	Local	Alignment	Search	Tool	
(BLAST)	in	ENSEMBL.	Sensitivity	was	selected	at	no	optimization.	The	result	with	the	
greatest	homology	was	selected.	The	zebrafish	and	human	gene	were	compared	by	genetic	
architecture	(exon	number,	gene	length,	genomic	regions).	Gene	synteny	was	calculated	
using	the	‘compare	region’	function	in	ENSEMBL.		
	
2.2.2	DNA	extraction	
Genomic	DNA	(gDNA)	was	extracted	from	adult	tail	clips	or	whole	embryos	using	sodium	
hydroxide	extraction.	100µl	of	50mM	NaOH	was	added	to	a	zebrafish	tail	clip	in	each	well	
of	a	96-well	plate	and	heated	at	98°c	for	5	minutes.	The	solution	was	neutralized	with	10µl	
of	1M	Tris-HCl	(pH	8),	vortexed	and	centrifuged	at	4200rpm	for	10	minutes.	
	
2.2.3	RNA	extraction	
RNA	was	extracted	from	either	20	whole	zebrafish	larvae	or	1	whole	adult	zebrafish	brain	
using	Trizol.	Tissue	was	placed	in	a	microcentrifuge	tube	with	250µl	of	TRIzol®	(Life	
Technologies)	and	homogenized	using	a	23g	needle.	Homogenized	tissue	was	incubated	at	
room	temperature	for	5	minutes,	followed	by	addition	of	50µl	of	chloroform,	inversion	of	
the	tube	8	times	to	mix	and	further	incubation	at	room	temperature	for	5	minutes.	
Samples	were	centrifuged	at	13,000rpm	for	15	minutes	at	4°c.	The	top	layer	of	
supernatant	(100µl)	was	removed	and	transferred	to	a	fresh	centrifuge	tube.	100µl	of	
isopropanol	was	added,	the	tube	was	mixed	by	inversion	and	incubated	at	room	
temperature	for	10	minutes.	Samples	were	centrifuged	at	13,000rpm	for	15	minutes	at	4°c	
and	the	supernatant	discarded	to	leave	an	RNA	pellet.	The	pellet	was	washed	with	70%	
EtOH,	centrifuged	for	5	minutes	at	7,000rpm	at	4°c	and	the	supernatant	was	discarded.	
The	pellet	was	air	dried	for	1	minute	and	resuspended	in	20ul	DEPC	H20	(RNase	free).	RNA	
concentration	and	purity	was	determined	using	a	Nanodrop	(Thermo	Scientific).		
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2.2.4	Reverse	transcription	(cDNA	synthesis)	
cDNA	was	made	using	Verso	cDNA	Synthesis	Kit	(Thermo	Scientific).	1µg	of	RNA	was	made	
in	10µl	DEPC	H20.	A	20ul	reaction	mix	was	composed	of;	4µl	5x	cDNA	synthesis	buffer,	2µl	
dNTP	mix,	1µl	RNA	primer,	1µl	Verso	enzyme	mix,	10µl	RNA	in	DEPC	H20.	Samples	were	
incubated	for	30	minutes	at	42°c	then	2	minutes	at	95°c	to	inactivate	the	Verso	enzyme.	
	
2.2.5	Polymerase	Chain	Reaction/Reverse	Transcriptase	PCR	
PCR	or	RT-PCR	was	used	to	amplify	gDNA	and	cDNA	respectively	in	a	Biorad	DNA	Gradient	
Thermo	Cycler	(Biorad).	A	10ul	PCR	reaction	mix	was	composed	of;	5µl	Biomix	Red™	
(Bioline),	1µl	forward	primer	(10µM),	1µl	reverse	primer	(10µM),	2µl	ddH20	and	1µl	of	
gDNA/cDNA.	The	reaction	was	heated	to	95°c	for	3	minutes,	followed	by	34	cycles	of;	95°c	
for	30	seconds,	60°c	for	30	seconds,	72°c	for	1	minute	and	a	final	single	incubation	at	72°c	
for	5	minutes.	Primers	were	designed	using	Primer3	software	(http://primer3.ut.ee)	and	
produced	by	Integrated	DNA	Technologies	Ltd.	For	a	list	of	primer	sequences,	see	table	2.1.	
	
2.2.6	DNA	gel	electrophoresis	
To	visualize	PCR	products,	gel	electrophoresis	was	used.	A	2%	agarose	gel	was	made	with	
2g	of	agarose	powder	in	100ml	of	TAE	buffer	(40mM	Tris,	20mM	acetic	acid,	1mM	EDTA)	
and	heated	until	dissolved.	Ethidium	bromide	was	added	to	the	agarose	solution,	and	the	
solution	was	poured	into	a	gel	tray	and	left	to	cool	and	set.	The	solidified	gel	was	placed	
into	an	electrophoresis	tank	and	covered	with	TAE	buffer.	2µl	of	each	sample	was	pipetted	
into	gel	wells	alongside	a	single	well	containing	2µl	of	Hyper	ladder	IV	(Bioline)	for	product	
size	reference.	A	current	was	applied	to	the	gel	(150v	for	10-30	minutes)	and	DNA	was	
visualized	and	imaged	by	applying	UV	light	to	the	gel.	
	
2.2.7	Genotyping	
PCR	was	used	to	amplify	the	region	of	the	gene	containing	the	mutation	using	gDNA,	
primers	are	listed	in	table	2.1.	The	pink1	line	was	genotyped	using	sequencing	at	The	
University	of	Sheffield	Core	Genomics	Facility.	PCR	product	was	sequenced	using	the	
reverse	primer	only,	and	sequencing	data	was	analysed	using	FinchTV	software,	version	
1.5.0	(Geospiza	Inc.).	The	pink1	sequences	were	reverse	complemented	and	the	lead	up	
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sequence;	GCGATCGCTTA	was	searched	for.	Wild	type	pink1:	GCGATCGCTTAT,	
heterozygous	pink1	Y431*	stop	mutation:	GCGATCGCTTAN,	homozygous	pink1	Y431*	stop	
mutation:	GCGATCGCTTAG.	The	pink1	line	was	maintained	as	a	heterozygote	colony.	For	
raising	adult	pink1	Y431*	homozygote	mutants,	heterozygotes	were	incrossed.	For	
generating	homozygote	mutant	embryos,	homozygote	mutants	were	incrossed.	The	lrrk2	
line	was	genotyped	by	restriction	digest.	PCR	product	was	digested	with	Bsl1	for	2	hours	at	
55°c	to	identify	mutation	site.	Bsl1	recognises	and	cuts	DNA	with	the	sequence	
CCNNNNN▽NNGG.	The	lrrk2	5	base	pair	insertion	interrupts	the	Bsl1	cut	site,	therefore	
Bsl1	does	not	digest	lrrk2	5bp	insertion	homozygous	DNA,	partially	digests	lrrk2	5bp	
insertion	heterozygous	DNA	and	fully	digests	wild	type	lrrk2	DNA	(figure	2.2).	
	
	
Figure	2.2:	lrrk2	5bp	insertion	genotyping.		
Genomic	PCR	illustrating	Bsl1	digestion	of	wild	type	lrrk2,	giving	products	of	100bp	and	a	
92bp.	In	zebrafish	that	are	heterozygous	for	the	lrrk2	5bp	insertion,	the	wild	type	lrrk2	
gene	is	digested	by	Bsl1	giving	products	of	100bp	and	a	92bp,	and	the	lrrk2	5bp	insertion	
gene	is	not	digested	by	Bsl1,	giving	a	product	of	192bp.	gDNA	from	zebrafish	that	are	
homozygous	for	the	lrrk2	5bp	insertion	is	not	digested	by	Bsl1,	giving	a	192bp	product.	
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2.2.8	Quantitative	PCR		
Quantitative	PCR	(qPCR)	was	used	to	measure	relative	quantities	of	mRNA	transcripts.	
Fluorescent	SYBR	green	dye	(Agilent)	incorporates	into	double-stranded	DNA	upon	
replication,	and	fluorescence	intensity	can	be	measured	after	each	PCR	cycle	to	measure	
the	quantity	of	PCR	product.	This	gives	a	Ct	value,	which	is	defined	as	the	number	of	cycles	
required	for	fluorescence	intensity	to	reach	a	threshold.	Primers	were	optimized	for	qPCR	
by	testing	primer	pairs	are	varying	concentrations	(100nM,	300nM	and	500nM).	A	
standard	curve	was	created	using	cDNA	standard	dilutions	for	each	primer	concentration,	
this	ensured	primer	efficiency	was	as	close	to	100%	(±10%).	A	dissociation	curve	was	also	
generated,	ensuring	there	is	a	single	peak	and	that	only	one	PCR	product	is	being	
produced.	For	qPCR	reactions,	a	20µl	reaction	mix	contained	10µl	SYBR	green,	primers	and	
cDNA	at	required	concentrations	and	made	up	to	20µl	with	nuclease	free	ddH20.	Reactions	
were	put	into	a	96-well	qPCR	plate	(Geneflow)	and	centrifuged	at	1760rpm	for	1	minute.		
Zebrafish	ef1α	was	used	as	housekeeper	genes	in	primer	optimisation	and	to	calculate	fold	
changes	in	quantities	of	mRNA	transcripts.	To	calculate	fold	changes,	reference	gene	Ct	
value	was	subtracted	from	gene	of	interest	(GOI)	Ct	value.	Delta-delta-Ct	value	was	
calculated	by	subtracting	the	dCt	value	from	the	dCt	value	of	mutant	mRNA	transcripts.	
Fold	change	in	mRNA	transcript	quantity	was	calculated	by	using	the	formula:	2(-ddCt).	This	
can	be	converted	to	percentage	by	multiplying	the	fold	change	value	by	100.		
	
2.2.9	CRISPR-Cas9	design	
ENSEMBL	was	used	to	provide	the	sequence	of	the	gene	of	interest	(GOI)	in	zebrafish.	
CRISPR-Cas9	sites	were	identified	by	location	of	PAM	sites	(5’NGG	or	3’NCC)	within	exons	
of	the	GOI,	where	Cas9	cuts	the	DNA	3	base	pairs	upstream	from	the	PAM	site.	Cut	sites	
were	chosen	if	they	disrupted	a	restriction	site,	allowing	for	confirmation	of	successful	
CRISPR-Cas9	cuts	by	restriction	digest	(table	2.2)	(restriction	site	is	underlined).	The	
reverse	complement	of	the	18bp	upstream	of	the	PAM	site	was	placed	into	a	guide	RNA	
template,	which	allows	specific	binding	of	CRISPR-Cas9	to	the	region	of	interest,	where	the	
guide	RNA	template	contains	sequences	for	recruitment	of	Cas9	and	the	T7	promotor	
(figure	2.3)	(table	2.2)	(T7	promotor	is	shown	in	bold).	
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Primer	 Sequence	(5'-3')	 Description	
pink1	genotyping	F	 AAAGCAGATGTGTGGGCTGT	 Pink1	line	genotyping	
pink1	genotyping	R	 AGCTTCACCACCAGCTGAAC	 Pink1	line	genotyping	
lrrk2	genotyping	F	 CTTCAGGCGTTCATGAGCAG	 Lrrk2	line	genotyping	
lrrk2	genotyping	R	 GAGGCCTTCATGTGTCCGAT	 Lrrk2	line	genotyping	
ef1α	qPCR	F	 TGGTACTTCTCAGGCTGACT	 qPCR	Housekeeper	
ef1α	qPCR	R	 TGACTCCAACGATCAGCTGT	 qPCR	Housekeeper	
lrrk2	qPCR	F	 CCACAGGAGCGCGATATTCA	 Lrrk2	NMD	qPCR	
lrrk2	qPCR	R	 TTTGTGTTTCCGCACAGAGC	 Lrrk2	NMD	qPCR	
Table	2.1:	Primers	used	for	genotyping	in	this	study	
	
	
	
	
Figure	2.3:	Schematic	demonstrating	binding	and	cutting	of	CRISPR-Cas9	constructs	to	
the	gene	of	interest	
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Primer	 Sequence	(5'-3')	
Ultramer	F	 AAAGCACCGACTCGGTGCCAC		
Ultramer	R	 GCGTAATACGACTCACTATAG		
lrrk2	exon	19	Bsl1	
cut	site	
AAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACT
AGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAACCCGTCTGGG
ACTTGACCACCCTATAGTGAGTCGTATTACGC	
Table	2.2:	Primers	used	for	CRISPR-Cas9	construction	in	this	study	
	
2.2.10	Ultramer	amplification	
Upon	arrival,	ultramers	were	amplified	(table	2.2)	in	a	100µl	PCR	mix	containing;	50µl	
Biomix	red™	(Bioline),	38µl	ddH20,	5µl	forward	primer,	5µl	reverse	primer	and	2µl	of	
ultramer.	Reaction	mix	was	95°c	for	3	minutes,	followed	by	40	cycles	of;	95°c	for	30	
seconds,	60°c	for	30	seconds,	72°c	for	1	minute	and	a	final	single	incubation	at	72°c	for	5	
minutes.	A	successful	reaction	was	confirmed	by	electrophoresis	(2.2.6).	PCR	product	was	
then	purified.		
	
2.2.11	PCR	purification	of	ultramer	
PCR	product	was	purified	using	a	QIAquick	PCR	purification	kit	(28104;	Qiagen).	PCR	
reaction	was	diluted	by	adding	5	volumes	of	PB	buffer	to	1	volume	of	PCR	product	and	
placed	in	a	QIAquick	column.	The	column	was	centrifuged	for	1	minute	and	the	flow-
through	discarded.	750µl	of	PE	buffer	was	added;	the	column	was	centrifuged	for	1	minute	
and	the	flow	through	discarded.	The	column	was	centrifuged	1	minute	and	the	flow-
through	discarded.	The	column	was	put	into	a	clean	microcentrifuge	tube	and	20µl	of	
elution	buffer	was	added	to	the	column.	The	column	was	centrifuged	for	1	minute	to	
produce	the	purified	DNA.	Purified	DNA	was	stored	at	-20°c	until	use.	
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2.2.12	Transcription	of	purified	ultramer	
Purified	ultramer	was	transcribed	using	the	MEGAshortscript	T7	kit	(AM1354,	Life	
Technologies)	in	a	20µl	reaction	mix:	2µl	buffer,	2µl	of	each	dNTP,	2µl	enzyme	mix,	1µl	
amplified	and	purified	ultramer,	7µl	nuclease-free	water.	Reaction	was	incubated	at	37°c	
for	4	hours,	followed	by	degradation	of	remaining	ultramer	by	addition	of	1µl	of	DNAse	for	
30	minutes	at	37°c.	A	successful	reaction	run	was	confirmed	by	electrophoresis	and	
volume	was	made	up	to	100µl	with	nuclease-free	water.	RNA	was	purified	by	addition	of	
33µl	10M	NH4Ac	and	350µl	ice	cold	EtOH,	and	mixture	was	precipitated	for	2	hours	at	-
80°c.	Purified	RNA	was	centrifuged	at	13000rpm	for	30	minutes	at	4°c	to	form	an	RNA	
pellet.	Supernatant	was	removed	and	the	RNA	pellet	was	washing	with	70%	ice	cold	EtOH.	
The	supernatant	was	removed	and	the	pellet	briefly	air	dried,	followed	by	resuspension	in	
10µl	nuclease-free	water.	The	concentration	of	RNA	was	measured	using	a	Nanodrop	
(Thermo	Scientific)	and	guide	RNA	was	diluted	to	a	concentration	of	4-8µg/µl	and	stored	at	
-80°c.	
	
2.2.13	Microinjection	of	CRISPRs		
Guide	RNA	and	Cas9	protein	(NEB)	was	injected	into	zebrafish	embryos	at	the	one-cell	
stage.	2.5µl	Injection	mixture	contains;	1µl	of	guide	RNA,	1µl	of	Cas9	protein	(18µM	stock	
concentration)	and	0.5µl	phenol	red	(to	allow	visualization	of	the	mixture).	1nl	of	injection	
mixture	was	injected	into	the	yolk	sac.	After	injection,	zebrafish	embryos	were	incubated	
until	5dpf,	and	then	transferred	to	aquarium	tanks.	A	selection	of	embryos	at	1dpf	were	
used	for	determination	of	CRISPR-Cas9	efficiency.	
	
2.2.14	Assessment	of	CRISPR-Cas9	efficiency	
DNA	was	extracted	from	8	injected	and	8	uninjected	embryos	at	1dpf	(described	in	2.2.2)	
and	DNA	was	amplified	by	PCR	(described	in	2.2.5)	with	primers	specific	to	the	region	of	
interest	(table	2.1).	PCR	product	was	digested	with	restriction	enzymes	that	have	cut	sites	
within	the	CRISPR-Cas9	cut	site.	Efficient	CRISPR-Cas9	results	in	no	digestion	of	PCR	
product	by	relevant	restriction	enzyme.	
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2.2.	Ligation	independent	cloning	and	transformation	(TOPO)	(cloning	for	sequencing)	
Cloning	was	performed	using	the	TOPO®	TA	cloning	kit	(K4500,	Life	Technologies)	and	
allowed	separation	of	different	mutations	created	by	the	CRISPR-Cas9	to	analyse	types	of	
mutations	generated.	PCR	products	from	1dpf	CRISPR-Cas9	injected	embryos	were	mixed	
together	and	product	was	purified	using	the	QIAquick	PCR	purification	kit	(described	in	
2.2.11).	4µl	of	purified	DNA	was	added	to	1µl	of	TOPO®	vector	and	1µl	of	supplied	salt	
solution,	and	the	reaction	was	incubated	at	room	temperate	for	30	minutes.	Reaction	was	
then	transformed	into	competent	cells.	Competent	cells	were	defrosted	on	ice	and	5µl	of	
TOPO®	mix	was	added	to	30µl	of	cells,	followed	by	incubation	for	30	minutes	on	ice	and	
then	heatshocked	at	42°c	for	30	seconds.	Reaction	mix	was	incubated	on	ice	for	5	minutes,	
followed	by	addition	of	950µl	SOC	outgrowth	medium	(B9020S;	NEB)	and	cells	were	
incubated	at	37°c	for	1	hour	with	agitation.	100µl	of	cells	in	suspension	were	spread	onto	
Ampicillin	LB	Agar	plates	(0.1%	(v/v)	Ampicillin).	Plates	were	incubated	overnight	at	37°c.	
Individual	colonies	were	picked	from	the	plate	the	following	morning	and	placed	into	
individual	PCR	reaction	mixes	(described	in	2.2.5).	The	PCR	product	was	visualized	using	
electrophoresis	to	show	large	deletions/insertions	and	PCR	product	was	digested	with	
restriction	enzymes	to	visualize	smaller	deletions/insertions.	Samples	that	contained	
deletions/insertions	were	sequenced	at	The	University	of	Sheffield	Core	Genomics	Facility	
and	analysed	using	FinchTV	software	to	determine	if	insertions/deletions	could	disrupt	
gene	expression.	
	
2.3	Histological	techniques	
	
2.3.1	Fixation	of	tissue	
All	tissues	were	fixed	using	ice	cold	4%	(w/v)	paraformaldehyde	(P6148;	Sigma)	in	0.1M	
phosphate	buffer.	Adult	zebrafish	brains	were	dissected	and	fixed	overnight	at	4°c.	Whole	
embryonic/larval	zebrafish	were	fixed	overnight	at	4°c.	
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2.3.2	Cryosectioning	of	tissue	
Adult	brains	and	zebrafish	embryos/larvae	were	washed	with	phosphate	buffered	saline	
(PBS)	(P4417;	Sigma)	and	incubated	in	30%	(w/v)	sucrose	(S0389;	Sigma)	in	0.2M	
phosphate	buffer	overnight	at	4°c.	Tissue	was	then	briefly	placed	in	OCT	(361603E;	VWR	
International)	in	a	petri	dish,	and	then	placed	into	a	mold	and	orientated	for	sectioning.	
Tissue	mounted	in	OCT	was	frozen	on	dry	ice	and	stored	at	-20°c.	Brains	were	sectioned	
using	a	cryostat	(OFT5000;	Bright)	at	a	thickness	of	15µm.	Tissue	was	collected	directly	on	
superfrost	slides	(J1800AMNZ;	ThermoFisher	Scientific)	and	air	dried.	For	
immunohistochemistry,	OCT	was	washed	from	slides	with	PBS,	and	for	in	situ	
hybridization,	slides	were	frozen	at	-20°c.		
	
2.3.3	Immunohistochemistry	
For	immunohistochemistry	on	sections,	sections	were	first	incubated	in	blocking	solution	
(5%	(w/v)	heat-inactivated	goat	serum	(HINGS)	(16210-072;	Gibco)	and	0.5%	(v/v)	Triton	
(T8787;	Sigma)	in	PBS	for	1	hour	at	room	temperature.	Sections	were	then	incubated	in	
primary	antibodies,	diluted	in	blocking	solution,	overnight	at	4°c.	Primary	antibody	
solution	was	removed	and	slides	were	washed	3	times	in	PBS.	Slides	were	incubated	in	
secondary	antibody	solution,	diluted	in	blocking	buffer,	for	1	hour	at	room	temperature	
and	covered	from	light.	Secondary	antibody	was	removed	and	slides	were	washed	3	times	
in	PBS.	Slides	were	mounted	with	Fluoroshield	mounting	medium	containing	4’,6-
diamidino-2-phenylindole	(DAPI)	(F6057;	SLS)	and	glass	coverslipped	(MIC3228;	SLS).	
Secondary	antibody	only	controls	were	performed	to	ensure	there	was	no	non-specific	
binding,	which	was	never	detected.	For	a	list	of	primary	antibodies	used,	see	table	2.3.	For	
a	list	of	secondary	antibodies	used,	see	table	2.4.	
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Primary	antibody	 Species	 Dilution	 Source	
Cleaved	Caspase-3	 Rabbit	polyclonal	 1:400	 9661;	Cell	Signalling	
DsRed2/mCherry	 Rabbit	polyclonal	 1:500	 632496;	Clontech	
GFP	 Rabbit	polyclonal	 1:200	 TP401;	Chemokine	
OTPb	 Rabbit	polyclonal	 1:400	
A	kind	gift	from	Prof.	
Gil	Levkowitz	
Th1	 Mouse	IgG	 1:1000	 22941;	Immunostar		
Table	2.3:	Primary	antibodies	used	in	this	study	
	
Secondary	antibody	 Dilution	 Source	
Alexa-488	 1:500	 Molecular	Probes	
Alexa-594	 1:500	 Molecular	Probes	
Alexa-647	 1:500	 Molecular	Probes	
Table	2.4:	Secondary	antibodies	used	in	this	study	
	
2.3.4	EdU	detection	
For	detection	of	EdU	in	tissue	sections	from	EdU	injected	zebrafish,	the	Click-iT™	EdU	Alexa	
Fluor™	594	Imaging	Kit	(C10339;	ThermoFisher	Scientific)	was	used.	EdU	is	an	alternative	
for	BrdU	(5-bromo-2’-deoxyuridine),	and	is	a	thymidine	analogue	that	incorporates	into	
DNA	during	active	DNA	synthesis,	therefore	allowing	labelling	of	newly	generated	cells.	
Detection	of	EdU	is	based	on	a	Cu(I)-catalysed	[3	+	2]	cycloaddition	reaction	(“click”	
chemistry):	briefly	the	alkyne	ring	in	the	EdU	molecule	reacts	with	an	azide-containing	
detection	reagent,	forming	a	triazole	ring	and	fluorescently	labelling	cells	that	have	
incorporated	EdU.	The	benefits	of	the	EdU	assay	over	the	BrdU	assay	are	(a)	no	heat	DNA	
denaturation	is	required	to	expose	the	label	for	antibody	detection	allowing	good	
structural	preservation	and	(b)	the	EdU	Click-iT	is	a	simple	and	quick	protocol,	allowing	
robust	analysis	of	proliferation	(Salic	&	Mitchison,	2008).	After	sectioning	and	drying	of	
sections,	slides	were	blocked	in	3%	(w/v)	bovine	serum	albumin	(BSA)	(A3059;	Sigma).	
	 75	
Block	solution	was	removed	and	slides	were	permeabilised	with	Triton	(0.5%	(v/v)	at	room	
temperature	for	20	minutes.	Slides	were	washed	in	blocking	solution	and	developed	with	
fresh	Click-iT™	reaction	cocktail	for	30	minutes	at	room	temperature.	Slides	were	washed	
once	more	with	blocking	solution,	followed	by	antibody	labeling	as	in	2.3.3.	
	
2.3.5	Fluorescent	In	situ	hybridization	(sections)	
Fluorescent	in	situ	was	achieved	using	the	Tyramide	amplification	kit	(B40915,	
ThermoFisher	Scientific).	Sections	were	post-fixed	with	4%	PFA	for	10	minutes	at	room	
temperature,	followed	by	PBS	washes.	Acetylation	mix	(11.2µl	triethanolamine	and	2.5µl	
acetic	anhydride	per	1ml	of	ddH20)	was	added	to	slides	and	incubated	for	10	minutes	at	
room	temperature,	followed	by	PBS	washes.	Slides	were	incubated	in	hybridisation	
solution	(50%	formamide,	5x	SSC	(pH	7),	2%	blocking	powder	(11096176001,	Sigma),	0.1%	
Triton	X-100,	0.5%	CHAPS,	1mg/ml	Yeast	RNA,	5mM	EDTA,	50µg/ml	Heparin)	for	at	least	2	
hours	at	68°c	in	a	humidified	chamber.	Probes	were	diluted	in	hybridisation	solution	and	
200µl	was	added	to	each	slide.	Slides	were	glass	coverslipped	to	prevent	evaporation	and	
incubated	overnight	at	68°c	in	a	humidified	chamber.	The	following	day,	slides	were	
washed	in	warmed	solution	1	(25ml	formamide,	12.5ml	5xSSC	pH	4.5,	5ml	10%	SDS,	7.5ml	
ddH20)	for	1	hour	at	68°c.	Slides	were	transferred	to	warmed	solution	2	(25ml	formamide,	
5ml	5xSSC	pH	4.5,	0.5ml	Tween20,	19.5ml	ddH20)	for	1	hour	at	68°c.	Slides	were	washed	
with	PBS-T	(PBS,	0.1%	triton)	twice	at	room	temperature	and	rinsed	with	MABT	(malic	acid	
buffer,	0.1%	triton).	Slides	were	blocked	in	2x/2%	(w/v)	blocking	reagent	diluted	in	MABT	
for	1	hour	at	room	temperature.	Slides	were	incubated	in	anti-DIG-POD	(1:500)	
(11207733910,	Sigma)	diluted	in	blocking	buffer	overnight	at	4°c.	Slides	were	washed	6	
times	for	20	minutes	at	room	temperature	in	PBS-T,	followed	by	rinsing	of	slides	in	boric	
acid	solution	(100mM	boric	acid	(pH	8.5),	0.1%	triton).	Tyramides	were	diluted	(1:150)	in	
TSA	buffer	(100mM	boric	acid	(pH	8.5),	0.1%	triton,	2%	dextran	sulphate,	0.003%	H202,	
0.15mg/ml	iodophenol)	and	250µl	was	added	to	each	slide	with	a	parafilm	coverslip.	Slides	
were	incubated	for	25	minutes	at	room	temperature,	protected	from	light.	Slides	were	
rinsed	in	PBS-T	4	times.	Slides	were	then	processed	for	immunohistochemistry	(described	
in	2.3.3).	
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2.3.6	Image	acquisition	and	analyses	
Immunofluorescent	images	were	captured	with	an	AxioImager.Z1	with	Apotome	(Zeiss),	
and	Axiovision	4.8	software.	For	sections,	z-stacks	were	taken	and	processed	to	give	a	
maximum	intensity	projection	(MIP).	Chromogenic	images	were	taken	with	an	Olympus	
microscope	with	Q-Capture	Pro	7.0	software	(Q-Imaging).	Images	were	processed	in	
Photoshop	(CC;	Adobe)	and	brightness	and	contrast	of	whole	images	were	adjusted	to	
produce	optimal	images.	Exposures	were	not	modified	in	quantification	experiments.	Cells	
were	quantified	using	the	Photoshop	count	tool.	Prism	7	was	used	to	perform	statistical	
analyses	(unpaired	t-test	unless	otherwise	stated)	and	graphs	were	generated	using	Prism	
7	and	R	(version	3.3.3).	Significance	values	are	denoted	as	follows;	Not	significant	p>0.05,	*	
p<0.05,	**	p<0.01,	***	p<0.001.	
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Chapter	3	
	
	
Distinct	dopaminergic	populations	in	the	
posterior	tuberculum	increase	in	size	from	
embryonic	to	adult	stages	
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3.1:	Introduction		
	
As	described	in	the	main	Introduction,	PD	is	characterised	by	a	reduced	number	of	
midbrain	dopaminergic	(DA)	neurons,	specifically	within	the	substantia	nigra	pars	
compacta	(SNpc).	In	mammals,	SNpc	DA	neurons	form	the	nigrostriatal	pathway,	ascending	
from	the	midbrain	to	the	dorsal	striatum	in	the	forebrain.	Functionally-equivalent	DA	
populations	are	thought	to	exist	in	the	zebrafish:	previous	studies	have	described	distinct	
populations	of	DA	neurons	that	ascend	from	the	posterior	tuberculum	(PT)	to	the	
subpallium	and	are	therefore	thought	to	correspond	to	mesostriatal	systems	in	the	
mammalian	brain	(Rink	&	Wullimann,	2001a,	2002a,	2002b,	2004).	Thus,	the	zebrafish	PT	is	
a	valuable	system	for	modelling	mammalian	midbrain	DA	neurons.	
	
DA	neuronal	populations	in	the	PT	have	been	comprehensively	characterised	in	both	the	
adult	(Fig.3.1)	and	the	embryonic	(Fig.3.5)	zebrafish.	However,	as	yet,	no	study	has	
simultaneously	characterised	embryonic	and	adult	populations.	In	this	chapter,	I	describe	
immunohistochemical	analyses	of	the	adult	and	the	embryonic	PT,	using	an	antibody	
against	a	protein	marker	for	DA	neuronal	status.	I	focused	on	the	rostral	portion	of	the	PT,	
as	this	harbours	the	DA	neurons	that	have	been	shown	to	ascend	to	the	subpallium	(Rink	&	
Wullimann,	2001b,	2002a,	2004).	For	embryonic	stages,	55hpf	embryos	were	examined,	as	
all	DA	populations	have	been	established	by	this	stage.	For	adult	stages,	12-month	old	and	
3-month	old	zebrafish	were	examined,	to	investigate	DA	populations	in	the	adult	and	the	
young	adult	zebrafish.	
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3.2.1	Dopaminergic	populations	in	the	adult	zebrafish	PT	
	
The	zebrafish	PT	is	situated	in	the	centre	of	the	diencephalon,	bordered	by	the	
hypothalamus	and	the	thalamus	(Fig.3.1A).	The	distinct	morphological	features	of	the	
hypothalamus	and	thalamus	mean	that	the	PT	can	be	accurately	located	after	sagittal	
sectioning.		To	confirm	and	extend	previous	findings,	I	used	an	antibody	against	the	DA	
neuronal	marker,	tyrosine	hydroxylase-1	(Th1).	Immunohistochemical	analysis	for	Th1	in	
sagittal	sections	through	a	12-month	old	zebrafish	brain	confirmed	that	distinct	DA	
populations	could	be	clearly	identified	as	previously	described	(Fig.3.2).	Small	
(parvocellular)	round	DA	neurons	occupy	the	TPp	and	small	(parvocellular)	bipolar	DA	
neurons	occupy	the	PVO	(Fig.3.2A,B).	Situated	between	the	TPp	and	the	PVO	is	the	most	
rostral	population	of	large	(magnocellular),	pear-shaped	DA	neurons,	and	adjacent/caudal	
to	the	PVO	is	the	more	caudal	population	of	magnocellular	DA	neurons.	In	shape	and	
position,	the	magnocellular	neurons	highly	resemble	embryonic	populations,	termed	DC2	
and	DC4	neurons	(Fig.3.5)	and	hereafter	I	therefore	refer	to	these	as	DC2A	and	DC4A	
populations,	where	A	indicates	an	adult	population	(Fig.3.2A,B).	
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Fig.	3.1:	Dopaminergic	populations	in	the	adult	zebrafish	rostral	PT.		
A. Schematic	demonstrating	the	location	of	the	PT	in	the	adult	zf	brain.	
B. Schematic	showing	subpopulations	of	DA	neurons	within	the	adult	zebrafish	rostral	
PT.	Previous	studies	have	described	four	populations	of	DA	neurons	in	the	rostral	
portion	of	the	PT,	three	of	which	are	ascending	(Rink	&	Wullimann,	2001b,	2002a,	
2004):	the	periventricular	nucleus	of	the	PT	(TPp)	(blue	oval)	and	two	sets	of	
magnocellular	neurons	that	do	not	belong	to	any	defined	nucleus,	one	rostral	
population	(orange	oval)	and	one	caudal	population	(pink	oval).	Immediately	
adjacent	to	these	ascending	populations	are	locally-projecting	DA	neurons	of	the	
paraventricular	organ	(PVO)	(purple	oval).	Illustration	adapted	from	Rink	and	
Wullimann,	2002.			
	
	
	
Fig.3.2:	Dopaminergic	populations	in	the	adult	zebrafish	rostral	PT	–	a	sagittal	view.		
A. Schematic	showing	subpopulations	of	DA	neurons	within	the	adult	zebrafish	rostral	
PT:	the	TPp	(blue),	DC2A	(orange)	and	DC4A	(pink)	populations	and	the	PVO	
(purple).	Illustration	adapted	from	Rink	and	Wullimann,	2002.			
B. Fluorescent	MIP	of	a	sagittal	section	through	a	12-month	old	PT,	labelled	with	the	
DA	neuron	marker,	Th1.	Th1	labels	DA	neurons	in	distinct	subpopulations	within	
the	PT.	Subpopulations	are	outlined	and	colour	coding	coordinates	with	the	
populations	schematised	in	A’.	Scale	bar	represents	50μm.	
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Next	I	performed	Immunohistochemical	analysis	for	Th1	on	consecutive	transverse	
sections	through	the	rostral	PT	of	a	12-month	old	fish,	to	describe	the	position	of	PT	DA	
populations	in	relation	to	the	diencephalic	ventricle	and	the	lateral	ventricle	(Fig.3.3).	
These	analyses	showed	that	the	diencephalic	ventricle	displays	characteristic	changes	in	
morphology,	from	rostral-most	to	caudal-most	parts	of	the	rostral	PT	(Fig.3.3	schematics).	
In	caudal-most	parts	of	the	rostral	PT,	the	diencephalic	ventricle	branches	laterally	to	form	
the	lateral	ventricles,	whereas	the	ventricle	is	central	and	linear	in	rostral-most	parts	of	the	
PT.	Alongside	the	shape	of	the	ventricle,	cell	size	and	shape	can	also	be	used	to	distinguish	
DA	neuron	populations:	the	numerous,	small,	round	DA	neurons	of	the	TPp	and	the	
numerous	small	bipolar	DA	neurons	of	the	PVO	lie	extremely	close	to	the	ventricle	
(Fig.3.3A-A”	and	Fig.3.3C-C”);	magnocellular	DC2A	neurons	reside	just	beyond	the	ventricle,	
and	lie	between	the	TPp	and	the	PVO	(Fig.3.2B-B”)	and	magnocellular	DC4A	neurons	reside	
further	away	from	the	ventricle	(Fig.3.2C-C”).	Magnocellular	neuronal	populations	(DC2A	
and	DC4A)	are	composed	of	far-fewer	Th1+	neurons	than	either	of	the	parvocellular	
populations	(TPp	and	PVO).	
	
Together	this	data	confirms	that	four	DA	neuronal	populations	in	the	rostral	PT	can	be	
identified	in	the	12-month	old	zebrafish	brain	based	on	their	number	(see	below),	
morphology,	position	along	the	rostro-caudal	and	dorso-ventral	axes	and	position	relative	
to	the	diencephalic	and	lateral	ventricles	(Table	3.1).	
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Fig.3.3:	Dopaminergic	populations	in	the	adult	zebrafish	rostral	PT	–	a	transverse	view.		
A,	B,	C.								Schematics	showing	transverse	views	through	the	rostral	PT:	positions	and	
planes	indicated	in	top	schematic.	The	diencephalic	ventricle	shows	distinct	
change	in	morphology	from	rostral	to	caudal.	DA	neurons	are	represented	in	
green.		
A’,	B’,	C’.					Fluorescent	MIP	of	a	transverse	section	through	a	12-month	old	PT,	labelled	
with	the	nuclear	marker,	DAPI	(blue)	and	Th1	(green).	Th1	labels	DA	neurons	
in	distinct	subpopulations	within	the	PT.	Scale	bars	represent	50μm.	
A”,	B”,	C”.			Fluorescent	MIPs	for	Th1	are	shown	as	magnifications	of	the	boxed	regions	in	
A’,	B’,	C’.	Subpopulations	in	the	PT	are	outlined	and	labelled.	Scale	bars	
represent	50μm.	Small	round	cells	occupy	the	TPp,	large	pear	shaped	cells	in	
DC2	and	DC4	populations	and	small	bipolar	cells	in	the	PVO.		
	
	
	
	
	
I	next	asked	if	similar	DA	populations	in	the	rostral	PT	can	be	identified	in	the	3-month	old	
zebrafish	brain.	At	3-months	of	age,	zebrafish	have	just	reached	sexual	maturity	and	are	
classed	as	young	adult	fish.	Immunohistochemical	analysis	for	Th1	was	performed	in	
transverse	sections	through	the	3-month	old	PT	(Fig.	3.4).	Th1+	neurons	with	the	same	
morphology,	similar	population	sizes	(see	below)	and	the	same	relative	positions	were	
detected	as	had	been	observed	at	12	months.	Thus,	the	TPp	(Fig.3.4-A”,B-B”),	DC2A	(Fig.	
3.4B-B”),	DC4A	(Fig.3.4C-C”)	and	PVO	(Fig.3.4C,C’C”)	populations	can	be	clearly	identified	
and	distinguished	from	one	another	at	3-months	of	age.		
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Fig.	3.4:	Dopaminergic	populations	in	the	young	adult	zebrafish	rostral	PT	–	a	transverse	
view.		
A,	B,	C.									Illustrations	showing	the	orientation	and	rostral	PT	population	location	for	
coronal	planes	in	A’,	B’,	C”	and	A”,	B”,	C”.	DA	neurons	are	represented	in	
green.	
A’,	B’,	C’.					Fluorescent	MIP	of	a	transverse	section	through	a	3-month	old	PT,	labelled	
with	the	nuclear	marker,	DAPI	(blue)	and	Th1	(green).	Th1	labels	DA	neurons	
in	distinct	subpopulations	within	the	PT.	Scale	bars	represent	50μM.	
A”,	B”,	C”.			Fluorescent	MIPs	for	Th1	are	shown	as	magnifications	of	the	boxed	regions	in	
A’,	B’,	C’.	Subpopulations	in	the	PT	are	outlined	and	labelled.	Scale	bars	
represent	50μM.	Small	round	cells	occupy	the	TPp,	large	pear	shaped	cells	in	
DC2	and	DC4	populations	and	small	bipolar	cells	in	the	PVO.		
	
	
	
	
To	determine	whether	a	mixed	gender	population	could	be	used	in	these	studies,	
therefore	allowing	a	higher	number	of	replicates	in	future	experiments,	I	next	quantified	
the	number	of	Th1+	DA	neurons	in	each	subpopulation	of	the	rostral	PT	in	male	and	female	
3-month	old	zebrafish.	Quantification	revealed	no	significant	difference	between	the	
number	of	DA	neurons	in	the	male	TPp	(346±13,	n=4)	and	the	female	TPp	(348±13,	n=4),	
the	number	of	male	DC2A	neurons	(10±0.29,	n=4)	and	female	DC2A	neurons	(10±0.29,	n=4),	
male	DC4A	neurons	(21±0.29,	n=4)	and	female	DC4A	neurons	(19±0.63,	n=4)	or	the	number	
of	male	PVO	(419±46,	n=4)	compared	to	female	PVO	(383±21,	n=4)	neurons	(Fig.3.4).	
Nonetheless,	these	quantitative	analyses	confirmed	that	there	are	significant	differences	in	
DA	neuronal	numbers	in	the	different	populations	that	reside	in	the	rostral	PT.	The	PVO	is	
most	numerous	(401±69)	then	the	TPp	(347±63).	DC2A	and	DC4A	populations	are	relatively	
small	(9±0.7	and	20±1.1	respectively).		
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Fig.3.5:	No	significant	difference	in	the	number	of	Th1+	DA	neurons	in	any	subpopulation	
of	the	rostral	PT.		
Quantitative	analyses	of	the	mean	number	of	Th1+	cells	in	each	population	of	the	rostral	
PT,	analysed	from	serial	15μm	sections	of	3-month	old	male	and	female	zebrafish.	There	is	
no	significant	difference	between	the	number	of	DA	neurons	in	any	population	in	male	and	
female	zebrafish	(error	bars	represent	standard	deviation,	n=4	males,	n=4	females,	
statistically	analysed	by	unpaired	t-test).	
	
	
In	summary,	these	results	confirm	that	distinct	populations	of	DA	neurons	within	the	adult	
rostral	PT	can	be	robustly	identified	and	categorised	as	described	previously	in	the	
literature	(Rink	&	Wullimann,	2001b).	My	results	also	provide,	for	the	first	time,	an	
estimation	of	the	numbers	of	DA	neurons	in	each	population	and	show	that	there	is	no	
significant	difference	in	DA	neuronal	number	in	rostral	PT	subpopulation	in	male	versus	
female	zebrafish.		
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3.2.2	Dopaminergic	populations	in	the	embryonic	zebrafish	PT	
	
Previous	studies	have	suggested	that	DA	neurons	in	the	PT	of	the	developing	zebrafish	
embryo	can	be	related	to	those	of	the	adult,	due	to	their	position	and	morphology.	In	
particular,	it	has	been	suggested	that	the	embryonic	DC1	population	is	equivalent	to	the	
adult	TPp,	and	that	the	embryonic	DC3	is	equivalent	to	the	adult	PVO	(Rink	&	Wullimann,	
2002b).	I	therefore	confirmed	that	DC1	and	DC3	neurons,	as	well	as	2	magnocellular	
embryonic	populations	(termed	DC2	and	DC4)	could	be	identified	as	previously	described.	I	
analysed	zebrafish	embryos	that	were	55	hours	post	fertilization	(hpf),	as	previous	studies	
show	that	DA	neurons	in	DC1,	DC2,	DC3	and	DC4	populations	have	begun	to	differentiate	
and	express	Th1	by	this	time	point	(Rink	&	Wullimann,	2002b).	
	
As	in	the	adult,	the	embryonic	rostral	PT	overlaps	with,	and	lies	dorsal	to,	the	
hypothalamus	(Fig.3.6),	a	morphologically-distinct	region	of	the	brain.	This	allows	accurate	
identification	of	the	rostral	PT	in	sagittal	cryosections.		Using	the	anti-Th1	antibody,	I	
labelled	DA	neurons	in	sagittal	cryosections	through	the	55hpf	zebrafish	brain,	and	
compared	these	to	sagittal	sections	through	the	adult	PT.	Direct	comparison	of	adult	and	
embryonic	sagittal	sections	through	the	rostral	PT	confirms	previous	reports	that	suggest	
that	embryonic	and	adult	DA	populations	are	related.	Certainly,	there	are	similarities	in	the	
morphology	of	DA	neurons	and	in	their	relative	positions	along	the	rostro-caudal	axis	(Fig.	
3.6).	Embryonic	DC1	neurons	are	the	rostral-most	population	and	are	small	and	round	in	
morphology;	DC2	neurons	are	large	and	pear-shaped	and	reside	caudal	to	the	DC1	
population;	small,	bipolar	DC3	neurons	lie	caudal	to	these,	and	a	population	of	large	pear-
shaped	DC4	neurons	lies	most-caudally	(Fig.	3.6B,B’).	Notably,	however,	there	appear	to	be	
far	fewer	numbers	of	Th1+	DC1	and	DC3	neurons	in	comparison	to	the	numerous	Th1+	
neurons	that	occupy	the	TPp	and	the	PVO	(Fig	3.6B’).	
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Fig.	3.6:	Dopaminergic	populations	in	the	adult	zebrafish	rostral	PT	compared	to	the	
embryonic	rostral	PT	
A-A’.		 As	in	Fig.3.2	
B.	 Schematic	showing	subpopulations	of	DA	neurons	within	the	embryonic	zebrafish	
rostral	PT.	The	embryonic	PT	comprises	4	populations,	DC1	(blue),	DC2	(orange),	
DC3	(purple)	and	DC4	(pink)	populations.	Illustration	adapted	from	Rink	and	
Wullimann,	2002.		
B’.	 Fluorescent	MIP	of	a	sagittal	section	through	a	55hpf	PT,	labelled	with	the	DA	
neuron	marker,	Th1.	Th1	labels	DA	neurons	in	distinct	subpopulations	within	the	
PT.	Subpopulations	are	outlined	and	colour	coding	coordinates	with	the	
populations	labelled	in	A.	Scale	bar	represents	50μm.	
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To	seek	further	evidence	that	distinct	embryonic	and	adult	DA	neuronal	populations	are	
related,	I	examined	transverse	sections,	to	ask	if	embryonic	DA	populations	occupy	similar	
positions	relative	to	the	D-V	axis	and	the	ventricle	as	described	for	adult	populations.	
Consecutive	transverse	sections	through	the	55hpf	zebrafish	brain	were	immunolabelled	
to	detect	Th1	(Fig.3.7).	This	revealed	the	small,	round	DC1	neurons	(Fig.	3.7A-A”),	the	
rostral	magnocellular	DC2	neurons	(Fig.3.7B-B”),	the	small	bipolar	DC3	neurons	(Fig.3.7C-
C”)	and	the	caudal	magnocellular	DC4	neurons	(Fig.3.7C-C”).	Their	relative	positions	along	
the	dorso-ventral	axis	were	similar	to	those	of	adult	populations.	Further,	the	position	of	
DC2,	DC3	and	DC4	populations	with	respect	to	the	ventricle	was	similar	to	those	observed	
in	adult	populations:	DC2	neurons	were	just	beyond	the	ventricle,	DC3	neurons	were	
immediately	adjacent	to	the	ventricle	and	DC4	neurons	were	some	distance	from	the	
ventricle	(i.e.	similar	positions	as	DC2A,	PVO	and	DC4A	respectively)(Table	3.1).		
	
In	summary,	based	on	morphology,	relative	position	along	the	DV	and	rostro-caudal	axes,	
and	position	relative	to	the	ventricle,	my	results	confirm	previous	reports	that	DC1/TPp,	
DC2/DC2A	populations,	DC3/PVO	and	DC4/DC4A	populations	are	likely	to	be	related.		
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Fig.3.7:	Dopaminergic	populations	in	the	embryonic	zebrafish	rostral	PT	–	a	transverse	
view.		
A,	B,	C.									Illustrations	showing	the	orientation	and	rostral	PT	population	location	for	
transverse	planes	in	A’,	B’,	C”	and	A”,	B”,	C”.	DA	neurons	are	represented	in	
green.	
A’,	B’,	C’.						Fluorescent	MIP	of	a	transverse	section	through	a	55hpf	PT,	labelled	with	the	
nuclear	marker,	DAPI	(blue)	and	Th1	(green).	Different	populations	in	the	PT	
are	outlined	and	labelled.	Th1	labels	DA	neurons	in	distinct	populations	within	
the	PT.	Scale	bars	represent	50μm.	
A”,	B”,	C”.			Fluorescent	MIPs	for	Th1	are	shown	as	magnifications	of	A’,	B’,	C’.	Distinct	
populations	in	the	PT	are	outlined	and	labelled.	Scale	bars	represent	10μm.	
Small	round	cells	occupy	the	TPp,	large	pear	shaped	neurons	form	the	DC2	
and	DC4	populations	and	small	bipolar	cells	occupy	the	PVO.		
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I	next	counted	DA	neurons	in	the	different	DA	populations	at	55hpf	and	compared	these	to	
the	numbers	detected	in	the	3-month	old	fish	(Fig.	3.8).	This	analysis	shows	that	a	
significant	increase	in	the	number	of	DC1/TPp	neurons	(from	2±0	to	363±9.8;	Fig	3.8A),	
DC3/PVO	neurons	(18±0.89	to	356±18;	Fig.	3.8C)	and	DC4/DC4A	neurons	(7.3±1.5	to	
18.7±0.89;	Fig.	3.8D)	over	this	period.	By	contrast,	the	numbers	of	DC2/DC2A	neurons	do	
not	increase	significantly	(from	7.3±0.67	to	8±0.6;	Fig.	3.8B).	Together	this	shows	that	two	
ascending	populations	expand	in	number	in	early	stages	of	life:	The	TPp	and	the	DC4/DC4A	
population,	together	with	the	locally	projecting	DC3/PVO	population,	however	the	third	
ascending	DC2/DC2A	population	does	not	increase	in	size	(Table	3.1).	
	
	
	
	
	
	
	
	
	
	 92	
	
Fig.3.8:	The	number	of	Th1+	DA	neurons	increases	in	DC1/TPp,	DC3/PVO	and	DC4/DC4A	
between	55hpf	and	3	months	of	age.		
Quantitative	analyses	of	the	mean	number	of	Th1+	cells	in	each	population	of	the	rostral	
PT,	analysed	from	serial	15μm	sections	of	55hpf	and	3-month	old	zebrafish	(error	bars	
represent	standard	deviation,	statistically	analysed	by	unpaired	t-test).	
A. The	number	of	DA	neurons	significantly	increases	in	the	DC1/TPp	population	
(p=<0.0001,	n=4).	
B. The	number	of	DA	neurons	does	not	significantly	increase	in	the	DC2/DC2A	population	
(n=4).	
C. The	number	of	DA	neurons	significantly	increases	in	the	DC3/PVO	population	
(p=<0.0001,	n=4).	
D. The	number	of	DA	neurons	significantly	increases	in	the	DC4/DC4A	population	
(p=0.0026,	n=4).	
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Table	3.1:	Summary	of	the	position	and	morphology	of	embryonic	(DC1,	DC2,	DC3,	DC4)	
and	adult	(TPp,	DC2A,	PVO,	DC4A)	rostral	PT	populations	
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3.3	Discussion	
	
The	aim	of	this	chapter	was	to	robustly	define	distinct	DA	neuronal	populations	in	the	adult	
and	the	embryonic	rostral	PT,	and	to	test	the	previous	suggestion	(Rink	&	Wullimann,	
2002b)	that	embryonic	and	adult	populations	are	related.	To	achieve	this,	adult	and	
embryonic	zebrafish	brains	were	sectioned	in	sagittal	and	transverse	planes,	and	sections	
were	analysed	with	the	dopaminergic	neuronal	marker,	Th1.		
	
Rostral	PT	DA	populations	were	successfully	identified	and	characterised	in	the	12-month	
(adult)	and	3-month	(young	adult)	zebrafish	brain.	These	consisted	of	the	TPp,	DC2A	
neurons,	the	PVO	and	DC4A	neurons.	My	data	adds	to	previous	studies	(Rink	&	Wullimann,	
2001a,	2002a,	2004),	providing	an	estimation	of	the	numbers	of	DA	neurons	in	each	
population	and	showing	that	there	is	no	significant	difference	in	DA	neuronal	number	in	
rostral	PT	subpopulation	in	male	versus	female	zebrafish.		
	
Rostral	PT	DA	populations	were	likewise	successfully	identified	and	characterised	in	the	
55hpf	embryo	and,	in	agreement	with	published	studies	(Rink	&	Wullimann,	2002b),	
assigned	to	DC1,	DC2,	DC3	and	DC4	populations.	My	studies	add	to	previous	data	by	
directly	comparing	embryonic	and	adult	populations	side	by	side.	My	comparative	analysis	
of	the	55hpf	and	adult	rostral	PT	shows	that	DA	neurons	in	ascending	populations	
(DC1/TPp,	DC2/DC2A	and	DC4/DC4A)	and	local-projecting	neurons	(DC3/PVO)	are	similar	in	
morphology	and	position	between	embryo	and	adult.		
	
My	data	further	shows	for	the	first	time	that	two	ascending	populations	(TPp/DC1	and	
DC4/DC4A)	increase	in	Th1+	neuronal	number	over	the	first	3	months	of	age,	where	the	
TPp	is	the	largest	ascending	population.	Likewise,	DA	neurons	in	the	locally	projecting	
DC3/PVO	population	also	show	a	significant	increase	in	number	over	the	first	3	months	of	
age.			
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My	studies	confirm	the	morphological	and	positional	similarities	between	embryonic	and	
adult	PT	populations,	though	future	lineage	tracing	experiments	should	be	performed	to	
confirm	these	populations	are	directly	related.	In	addition,	my	analyses	have	led	me	to	
understand	overall	morphology	of	the	PT,	and	appreciate	its	growth	from	embryonic	to	
adult	stages.	I	next	sought	to	determine	whether	the	rostral	PT	contains	stem/progenitor	
cells	in	embryonic	and	adult	stages.		
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Chapter	4	
	
	
Neural	stem/progenitor	cells	are	retained	in	the	
rostral	PT	in	adulthood		
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4.1:	Introduction		
	
Adult	neurogenesis	has	been	described	in	most	vertebrates	and	is	a	highly	regulated	
process,	driven	by	resident	stem	and	progenitor	cells	that	occupy	specialised	niches.	In	
mammals,	neurogenesis	is	restricted	to	discrete	regions	of	the	adult	brain,	in	particular	the	
SGZ	of	the	hippocampus	and	the	SVZ	of	the	lateral	ventricles.	Low	levels	of	neurogenesis	
have	also	been	described	in	other	regions	of	the	CNS,	including	the	hypothalamus	(see	
introduction	section	1.4.3).	In	zebrafish,	neurogenesis	is	likewise	detected	in	these,	and	
other	brain	regions,	and	adult	de	novo	neurogenesis	is	thought	to	occur	at	significantly	
greater	levels	than	in	mammals	(see	introduction	section	1.4.5).	Nonetheless,	proliferation	
sites	still	appear	to	be	restricted	to	distinct	brain	regions,	suggesting	the	presence	of	
distinct	stem	and	progenitor	niches.	Importantly,	previous	studies	have	identified	the	PT	as	
one	such	proliferation	site	(Grandel	et	al.,	2006).	This,	together	with	my	observation	
(Chapter	3)	that	DA	populations	significantly	increase	in	size	from	55hpf	to	3-months	raises	
the	possibility	that	the	rostral	PT	contains	neural	stem	and	progenitor	cells	that	are	
retained	into	adulthood.	In	this	chapter	I	addressed	this	question	by	examining	expression	
of	neural	stem/progenitor	markers	in	the	rostral	PT,	at	different	stages	through	life.			
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4.2.1	Expression	of	radial	glial	markers	in	the	rostral	PT	
	
Previous	studies	have	shown	that	cells	with	radial	glial	morphology	act	as	neural	
stem/progenitor	cells	in	both	mammals	(Alvarez-Buylla	et	al.,	2001;	Kriegstein	&	Alvarez-
Buylla,	2009)	and	zebrafish	(Grandel	et	al.,	2006;	Pellegrini	et	al.,	2007;	Lam	et	al.,	2009;	
Ganz	et	al.,	2010b).	However	as	yet,	it	is	not	known	if	there	are	radial	glia-like	cells	in	the	
zebrafish	PT.		I	therefore	set	out	to	characterise	the	PT	at	different	stages	in	life,	using	two	
markers	of	radial	glial	cells,	Nestin	and	Her4.	I	aimed	to	determine	whether	radial	glial	cells	
are	found	in	the	PT,	and	if	so,	how	their	position	relates	to	the	distinct	DA	neuronal	
populations	identified	in	Chapter	3.		
	
To	begin	with,	I	examined	expression	of	markers	in	the	5	dpf	larva.	At	this	time,	the	distinct	
DA	neuronal	populations	are	similar	to	those	in	the	55	hpf	embryo,	however	at	5dpf	
individual	radial	glia	are	more	visible	as	populations	become	more	restricted	with	age	(Rink	
&	Wullimann,	2002b).	Nestin	is	an	intermediate	filament	protein	that	is	expressed	by	radial	
glial	cells	(and	is	required	for	the	self-renewal	of	neural	stem	cells)	(Chen	et	al.,	2010;	Park	
et	al.,	2010).	In	the	absence	of	an	anti-Nestin	antibody	that	labels	the	zebrafish,	I	examined	
a	transgenic	nestin:GFP	zebrafish	line	that	has	been	described	previously	(Lam	et	al.,	2009).	
In	5dpf	zebrafish,	Nestin	is	expressed	by	cells	that	line	the	diencephalic	ventricle	and	that	
have	radial	glial-like	morphology:	a	cell	body	at	the	ventricle	and	a	basally-extending	
process	(Fig.4A-C).	Co-labelling	with	anti-Th1	shows	that	Nestin+	radial	glial-like	cells	are	
thus	adjacent	to	or	close	to	DA	neurons	in	the	DC1	(Fig.4.1A),	DC2	(Fig.4.1B),	DC3	and	DC4	
(Fig.4.1C)	populations.		
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Fig.4.1:	Nestin:GFP	is	expressed	in	the	ventricle	of	the	larval	rostral	PT	
A(i-v).				Fluorescent	MIP	of	a	transverse	section	through	the	DC1	population	of	5dpf	
Nestin:GFP	zebrafish	larvae,	labelled	with	DAPI	(blue),	Th1	(red)	and	
Nestin:GFP	(green).	Th1	and	Nestin:GFP	are	shown	without	DAPI	(ii),	DAPI	is	
shown	in	(iii),	Th1	is	shown	in	(iv),	Nestin:GFP	is	shown	in	(v).	Scale	bars	
represent	10	μm.	DA	populations	are	outlined	in	white,	DiV	is	outlined	in	red	
in	(ii).	
B(i-v).					Fluorescent	MIP	of	a	transverse	section	through	the	DC1/DC2	populations	of	
5dpf	Nestin:GFP	zebrafish	larvae,	labelled	with	DAPI	(blue),	Th1	(red)	and	
Nestin:GFP	(green).	Th1	and	Nestin:GFP	are	shown	without	DAPI	(ii),	DAPI	is	
shown	in	(iii),	Th1	is	shown	in	(iv),	Nestin:GFP	is	shown	in	(v).	Scale	bars	
represent	10	μm.	DA	populations	are	outlined	in	white,	DiV	is	outlined	in	red	
in	(ii).	
C(i-v).					Fluorescent	MIP	of	a	transverse	section	through	the	DC3/DC4	populations	of	
5dpf	Nestin:GFP	zebrafish	larvae,	labelled	with	DAPI	(blue),	Th1	(red)	and	
Nestin:GFP	(green).	Th1	and	Nestin:GFP	are	shown	without	DAPI	(ii),	DAPI	is	
shown	in	(iii),	Th1	is	shown	in	(iv),	Nestin:GFP	is	shown	in	(v).	Scale	bars	
represent	10	μm.	DA	populations	are	outlined	in	white,	DiV	is	outlined	in	red	
in	(ii).	
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A	similar	pattern	of	Nestin	expression	is	observed	in	the	adult	PT.	Nestin+	cells	with	radial	
glial	morphology	line	the	diencephalic	ventricle	immediately	adjacent	to	or	close	to	DA	
neurons	in	the	TPp	(Fig.4.2A),	the	DC2	(Fig.4.2B)	and	the	PVO	(Fig.4.2C)	populations.	
Similarly,	they	line	the	lateral	ventricles	adjacent	to	DA	neurons	of	the	DC4	population	
(Fig.4.2D).	In	most	regions	of	the	PT,	all	cells	at	the	ventricle	appear	to	express	Nestin.	The	
exception	is	at	the	level	of	the	PVO,	where	Nestin+	radial	glial	cells	are	extremely	sparse	
(one	to	two	cells)	and	are	surrounded	by	Nestin-	cells	(Fig.42C).		
	
In	summary,	at	both	larval	and	adult	stages,	Nestin+	radial	glial-like	cells	can	be	detected	at	
the	ventricular	zone	throughout	the	rostral	PT,	supporting	the	idea	that	a	Nestin+	
stem/progenitor	population	established	in	early	life	may	persist	into	adulthood	(Fig.4.9	
schematic).	Although	Nestin+	radial	glia	lie	very	close	to	DA	populations	–	in	particular	to	
DC1,	DC3,	TPp,	DC2A	and	PVO	populations,	no	nestin+Th1+	cells	are	detected,	either	in	the	
embryo	or	the	adult.		
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Fig.	4.2:	Nestin:GFP	expression	persists	in	the	ventricle	of	the	adult	rostral	PT	
A(i-v).						Fluorescent	MIP	of	a	transverse	section	through	the	TPp	of	a	6-month	
Nestin:GFP	zebrafish,	labelled	with	DAPI	(blue),	Th1	(red)	and	Nestin:GFP	
(green).	Th1	and	Nestin:GFP	are	shown	without	DAPI	(ii),	DAPI	is	shown	in	
(iii),	Th1	is	shown	in	(iv),	Nestin:GFP	is	shown	in	(v).	Scale	bars	represent	10	
μm.	DA	populations	are	outlined,	DiV	is	outlined	in	red.	Schematics	on	right	
hand	side	indicate	position	of	corresponding	image	in	relation	the	DiV.		
B(i-v).						Fluorescent	MIP	of	a	transverse	section	through	the	DC2	population	of	a	6-
month	Nestin:GFP	zebrafish,	labelled	with	DAPI	(blue),	Th1	(red)	and	
Nestin:GFP	(green).	Th1	and	Nestin:GFP	are	shown	without	DAPI	(ii),	DAPI	is	
shown	in	(iii),	Th1	is	shown	in	(iv),	Nestin:GFP	is	shown	in	(v).	Scale	bars	
represent	10	μm.	DA	populations	are	outlined,	DiV	is	outlined	in	red.	
Schematics	on	right	hand	side	indicate	position	of	corresponding	image	in	
relation	the	DiV.	
C(i-v).						Fluorescent	MIP	of	a	transverse	section	through	PVO	of	a	6-month	Nestin:GFP	
zebrafish,	labelled	with	DAPI	(blue),	Th1	(red)	and	Nestin:GFP	(green).	Th1	
and	Nestin:GFP	are	shown	without	DAPI	(ii),	DAPI	is	shown	in	(iii),	Th1	is	
shown	in	(iv),	Nestin:GFP	is	shown	in	(v).	Scale	bars	represent	10	μm.	DA	
populations	are	outlined,	DiV	is	outlined	in	red.	Schematics	on	right	hand	
side	indicate	position	of	corresponding	image	in	relation	the	DiV.	
D(i-v).						Fluorescent	MIP	of	a	transverse	section	through	the	DC4	population	of	a	6-
month	Nestin:GFP	zebrafish,	labelled	with	DAPI	(blue),	Th1	(red)	and	
Nestin:GFP	(green).	Th1	and	Nestin:GFP	are	shown	without	DAPI	(ii),	DAPI	is	
shown	in	(iii),	Th1	is	shown	in	(iv),	Nestin:GFP	is	shown	in	(v).	Scale	bars	
represent	10	μm.	DA	populations	are	outlined,	DiV	is	outlined	in	red.	
Schematics	on	right	hand	side	indicate	position	of	corresponding	image	in	
relation	the	DiV.	
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I	next	analysed	expression	of	the	zebrafish	basic-helix-loop-helix	transcription	factor	Her4.	
This	protein	is	orthologous	to	mammalian	Hes5,	a	member	of	the	Hairy/Enhancer-of-split	
family.	Hes5/her4	is	expressed	by	Notch-responsive	radial	glial	stem/progenitor	cells	that	
can	generate	neurons	in	the	adult	brain	(Cau	et	al.,	2000;	Basak	&	Taylor,	2007;	Chapouton	
et	al.,	2010;	Ganz	et	al.,	2010a;	Kroehne	et	al.,	2011;	Dirian	et	al.,	2014).	Since	no	Her4	
antibody	has	been	described,	a	her4:mCherry	line	(Kroehne	et	al.,	2011)	was	used	to	
investigate	Her4	expression	in	the	rostral	PT.	In	5	dpf	zebrafish	larvae,	Her4	is	expressed	by	
radial	glial-like	cells	that	line	the	diencephalic	ventricle	(Fig.4.3).	Co-labelling	with	anti-Th1	
reveals	that	Her4+	radial	glia	lie	immediately	adjacent	to/close	to	DA	neurons	in	the	DC1	
(Fig.4.3A),	DC2	(Fig.4.3B),	DC3	and	DC4	(Fig.4.3C)	populations.	Likewise,	in	the	adult	PT,	
Her4	is	expressed	by	radial	glial-like	cells	that	line	the	diencephalic	ventricle	(Fig.4.4A-C)	
and	the	lateral	ventricle	(Fig.4.4D).	At	the	level	of	the	PVO,	exceptionally,	a	double	tram-
line	of	Her4+	cells	are	detected:	those	located	at	a	distance	from	the	ventricle	extend	a	
short	process	towards	it	(Fig.	4.4C).	Co-labelling	with	anti-Th1shows	that	Her4+	radial	glia	
lie	immediately	adjacent	/close	to	DA	neurons	in	the	TPp	(Fig.4.4A),	DC2	(Fig.4.4B)	and	PVO	
(Fig.4.4C)	populations,	and	line	the	lateral	ventricles	adjacent	to	DA	neurons	of	the	DC4	
population	(Fig.4.4D).	Comparison	with	Nestin	suggests	that	Her4+	radial	glia	may	be	a	
subset	of	those	that	express	Nestin	(Fig.4.9	schematic).	
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Fig.	4.3:	Her4.1:mCherry	is	expressed	in	the	ventricle	of	the	larval	rostral	PT	
A(i-v).				Fluorescent	MIP	of	a	transverse	section	through	the	DC1	population	of	5dpf	
Her4.1:mCherry	zebrafish	larvae,	labelled	with	DAPI	(blue),	Th1	(green)	and	
Her4.1	(red).	Th1	and	Her4.1	are	shown	without	DAPI	(ii),	DAPI	is	shown	in	
(iii),	Th1	is	shown	in	(iv),	Her4.1	is	shown	in	(v).	Scale	bars	represent	10	μm.	
DA	populations	are	outlined,	DiV	is	outlined	in	red.	
B(i-v).					Fluorescent	MIP	of	a	transverse	section	through	the	DC1	and	DC2	populations	
of	5dpf	Her4.1:mCherry	zebrafish	larvae,	labelled	with	DAPI	(blue),	Th1	
(green)	and	Her4.1	(red).	Th1	and	Her4.1	are	shown	without	DAPI	(ii),	DAPI	is	
shown	in	(iii),	Th1	is	shown	in	(iv),	Her4.1	is	shown	in	(v).	Scale	bars	
represent	10	μm.	DA	populations	are	outlined,	DiV	is	outlined	in	red.	
C(i-v).					Fluorescent	MIP	of	a	transverse	section	through	the	DC3	and	DC4	populations	
of	5dpf	Her4.1:mCherry	zebrafish	larvae,	labelled	with	DAPI	(blue),	Th1	
(green)	and	Her4.1	(red).	Th1	and	Her4.1	are	shown	without	DAPI	(ii),	DAPI	is	
shown	in	(iii),	Th1	is	shown	in	(iv),	Her4.1	is	shown	in	(v).	Scale	bars	
represent	10	μm.	DA	populations	are	outlined,	DiV	is	outlined	in	red.	
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Fig.	4.4:	Her4.1:mCherry	expression	in	the	ventricle	is	maintained	in	the	adult	rostral	PT	
A(i-v).						Fluorescent	MIP	of	a	transverse	section	through	the	TPp	of	a	6-month	
Her4.1:mCherry	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	Her4.1	
(red).	Th1	and	Her4.1:mCherry	are	shown	without	DAPI	(ii),	DAPI	is	shown	in	
(iii),	Th1	is	shown	in	(iv),	Her4.1:mCherry	is	shown	in	(v).	Scale	bars	represent	
10	μm.	DiV	is	outlined	in	red.	Schematics	on	right	hand	side	indicate	position	
of	corresponding	image	in	relation	the	DiV.		
B(i-v).						Fluorescent	MIP	of	a	transverse	section	through	the	DC2	population	of	a	6-
month	Her4.1:mCherry	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	
Her4.1	(red).	Th1	and	Her4.1:mCherry	are	shown	without	DAPI	(ii),	DAPI	is	
shown	in	(iii),	Th1	is	shown	in	(iv),	Her4.1:mCherry	is	shown	in	(v).	Scale	bars	
represent	10	μm.	DiV	is	outlined	in	red.	Schematics	on	right	hand	side	
indicate	position	of	corresponding	image	in	relation	the	DiV.		
C(i-v).						Fluorescent	MIP	of	a	transverse	section	through	the	TPp	of	a	6-month	
Her4.1:mCherry	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	Her4.1	
(red).	Th1	and	Her4.1:mCherry	are	shown	without	DAPI	(ii),	DAPI	is	shown	in	
(iii),	Th1	is	shown	in	(iv),	Her4.1:mCherry	is	shown	in	(v).	Scale	bars	represent	
10	μm.	DiV	is	outlined	in	red	Schematics	on	right	hand	side	indicate	position	
of	corresponding	image	in	relation	the	DiV.		
D(i-v).						Fluorescent	MIP	of	a	transverse	section	through	the	DC4	population	of	a	6-
month	Her4.1:mCherry	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	
Her4.1	(red).	Th1	and	Her4.1:mCherry	are	shown	without	DAPI	(ii),	DAPI	is	
shown	in	(iii),	Th1	is	shown	in	(iv),	Her4.1:mCherry	is	shown	in	(v).	DiV	is	
outlined	in	red.	Scale	bars	represent	10	μm.	Schematics	on	right	hand	side	
indicate	position	of	corresponding	image	in	relation	the	DiV.		
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In	summary,	at	both	larval	and	adult	stages,	Her4+	radial	glial-like	cells	can	be	observed	in	
the	rostral	PT.	Her4+	radial	glia	are	less	widespread	that	Nestin+	radial	glia	(Fig.4.9	
schematic).	Although	Her4+	radial	glia	lie	very	close	to	DA	populations	–	in	particular,	to	
DC1,	DC3,	TPp,	and	PVO	populations,	no	Her4+Th1+	cells	are	detected,	either	in	the	embryo	
or	the	adult.			
	
4.2.2	Expression	of	DA-progenitor	markers	in	the	rostral	PT	
	
The	paired-like	homeodomain	transcription	factor	Rax	and	the	zebrafish	orthologue,	rx3,	
are	central	to	the	development	of	the	retina	(Mathers	et	al.,	1997;	Zhang	et	al.,	2000;	
Loosli	et	al.,	2003;	Bailey	et	al.,	2004;	Kennedy	et	al.,	2004;	Stigloher	et	al.,	2006;	Medina-
Martinez	et	al.,	2009;	Muranishi	et	al.,	2012)	and	to	the	development	of	ventral	forebrain	
structures,	including	the	hypothalamus	(Mathers	et	al.,	1997;	Zhang	et	al.,	2000;	Medina-
Martinez	et	al.,	2009).	Recent	work	from	the	Placzek	lab,	to	which	I	have	contributed,	has	
shown	that	Rx3	is	required	to	select	a	particular	progenitor	fate,	directing	pea3+	progenitor	
cells	to	shh+pea3-	progenitor	cells	and	supporting	their	survival	and	growth.	In	the	absence	
of	rx3	expression,	anterior/tuberal	hypothalamic	neurons	fail	to	differentiate	(Muthu	et	al.,	
2016).	
	
My	contribution	to	this	study	was	to	ask	whether	populations	of	DA	neurons	in	the	PT	
(which	lies	just	dorsal	and	rostral	to	the	hypothalamus:	Fig.3.1	and	Fig.3.6)	require	Rx3.	
Analysis	of	Th1expression	in	rx3-null	embryos	showed	that	DC1,	DC2	and	DC3	populations	
failed	to	differentiate,	and	that	the	DC4	population	was	either	missing	or	reduced	(note,	
this	work	was	performed	at	the	beginning	of	my	PhD	studies,	when	I	had	not	yet	learned	
how	to	distinguish	each	population).		This	shows	that	progenitors	expressing	rx3	are	
required	for	the	generation	of	rostral	populations	of	DA	neurons	in	the	zebrafish	embryo.	
	
To	build	on	this	work,	which	focused	on	rx3	expression	in	the	hypothalamus,	I	re-analysed	
rx3	expression	in	the	55hpf	embryo,	but	focused	on	the	PT,	and	at	the	same	time,	analysed	
expression	in	the	6-month	fish,	to	determine	whether	rx3+	progenitors	are	maintained	in	
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adulthood.	To	achieve	this,	fluorescent	in	situ	hybridisation	(FISH)	of	rx3	was	performed	on	
sections	through	the	55hpf	embryonic	and	6-month	adult	brain	(Fig.	4.5,4.6).			
	
My	studies	confirm	our	previous	analyses	(Muthu	et	al,	2016).	In	regions	of	the	PT	that	lie	
rostral	to	the	anterior	hypothalamus,	rx3	is	detected	at	very	low	level	(Fig.4.5Av);	in	
regions	of	the	PT	that	lie	dorsal	to	the	anterior	hypothalamus,	no	rx3	is	detected	
(Fig.4.5Bv);	in	regions	of	the	PT	that	overlap	with	the	anterior	hypothalamus,	rx3	is	strongly	
detected	within	domains	previously	termed	Zone	I	and	Zone	II	(Fig.4.5Bv).	Where	rx3	is	
detected,	its	expression	is	in	cells	at,	and	adjacent	to	the	diencephalic	and	the	lateral	
ventricles	(Fig	4.5Bv).		
	
To	directly	compare	expression	of	rx3	with	DA	neuronal	populations,	consecutive	
transverse	sections	were	simultaneously	analysed	for	rx3	and	Th1.	This	reveals	that	the	
DC1,	DC2	and	DC4	DA	neuronal	populations	that	reside	in	the	dorsal	PT,	also	lie	in	domains	
that	express	either	low	levels	of	rx3	(DC1	and	DC2)	or	that	do	not	express	rx3	(DC4)	
(Fig.4.5A,	B).	By	contrast,	DA	neurons	of	the	DC3	population	reside	in	the	ventral	PT/dorsal	
hypothalamus	and	lie	within	or	adjacent	to	rx3+	progenitor	cells	in	Zones	I	and	II	(Fig.4.5).	
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Fig.	4.5:	rx3	is	expressed	within	the	DC3	DA	neuron	domain	at	55hpf	
A(i-v).						Fluorescent	MIP	of	a	transverse	section	through	the	DC1	and	DC2	populations	
of	a	55hpf	zebrafish	embryo,	labelled	with	DAPI	(blue),	Th1	(green)	and	rx3	
(red).	Th1	and	rx3	are	shown	without	DAPI	(ii),	DAPI	is	shown	in	(iii),	Th1	is	
shown	in	(iv),	rx3	is	shown	in	(v).	Scale	bars	represent	10	μm.	DA	populations	
are	outlined,	DiV	is	outlined	in	red.	Low	levels	of	rx3	expression	in	DC1	and	
DC2	populations.	
B(i-v).					Fluorescent	MIP	of	a	transverse	section	through	the	DC3	and	DC4	populations	
of	a	55hpf	zebrafish	embryo,	labelled	with	DAPI	(blue),	Th1	(green)	and	rx3	
(red).	Th1	and	rx3	are	shown	without	DAPI	(ii),	DAPI	is	shown	in	(iii),	Th1	is	
shown	in	(iv),	rx3	is	shown	in	(v).	Scale	bars	represent	10	μm.	DA	populations	
are	outlined,	DiV	is	outlined	in	red.	rx3-expressing	cells	are	observed	in	the	
DC3	domain.	
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Fig.	4.6:	rx3	is	expressed	within	the	PVO	in	adulthood	
A(i-v).						Fluorescent	MIP	of	a	transverse	section	through	the	TPp	of	a	6-month	old	
zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	rx3	(red).	Th1	and	rx3	
are	shown	without	DAPI	(ii),	DAPI	is	shown	in	(iii),	Th1	is	shown	in	(iv),	rx3	is	
shown	in	(v).	DiV	is	outlined	in	red.	Scale	bars	represent	10	μm.	Low	levels	of	
rx3	expression	in	the	TPp.	
B(i-v).						Fluorescent	MIP	of	a	transverse	section	through	the	DC2	population	of	a	6-
month	old	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	rx3	(red).	Th1	
and	rx3	are	shown	without	DAPI	(ii),	DAPI	is	shown	in	(iii),	Th1	is	shown	in	
(iv),	rx3	is	shown	in	(v).	DiV	is	outlined	in	red.	Yellow	asterisks	mark	non-
specific	blood	vessel	labelling	by	secondary	antibody.	Scale	bars	represent	10	
μm.	No	expression	of	rx3	in	the	DC2	domain.	
C(i-v).						Fluorescent	MIP	of	a	transverse	section	through	the	PVO	of	a	6-month	old	
zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	rx3	(red).	Th1	and	rx3	
are	shown	without	DAPI	(ii),	DAPI	is	shown	in	(iii),	Th1	is	shown	in	(iv),	rx3	is	
shown	in	(v).	DiV	is	outlined	in	red.	Scale	bars	represent	10	μm.	rx3	is	
strongly	expressed	in	DA	neurons	of	the	PVO.	
D(i-v).						Fluorescent	MIP	of	a	transverse	section	through	the	DC4	population	of	a	6-
month	old	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	rx3	(red).	Th1	
and	rx3	are	shown	without	DAPI	(ii),	DAPI	is	shown	in	(iii),	Th1	is	shown	in	
(iv),	rx3	is	shown	in	(v).	DiV	is	outlined	in	red.	Scale	bars	represent	10	μm.	No	
expression	of	rx3	in	the	DC4	domain.	
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In	the	adult	PT,	low	levels	of	rx3	can	be	detected	in	the	TPp	(Fig.4.6A)	and	no	expression	is	
detected	in	the	DC2A	or	DC4A	population	(Fig.	4.6B,D).	Strong	expression	of	rx3	is	detected	
within	the	PVO,	where	some	Th1+	DA	neurons	appear	to	co-express	rx3	(Fig.	4.6C,	yellow	
arrowhead).	In	summary,	at	larval	and	adult	stages,	rx3+	cells	can	be	observed	in	the	rostral	
PT,	within	DC3	and	PVO	DA	populations	respectively	(Fig.4.9	schematic).	
	
Many	studies,	including	our	own,	have	shown	that	the	orthopedia	gene,	otp,	and	its	
product,	OTP,	are	expressed	in	DA-progenitors	(Ryu	et	al.,	2007;	Fernandes	et	al.,	2013,	
Muthu	et	al.,	2016).	Zebrafish	have	two	paralogous	otp	genes	(otpa	and	otpb),	and	
expression	of	both	has	been	extensively	characterised	in	the	zebrafish	embryo.	Briefly,	
otpa	and	otpb	expression	domains	show	a	high	level	of	overlap,	and	differences	in	
expression	are	only	observed	in	the	caudal	hypothalamus.	In	the	rostral	PT,	otpa	and	otpb	
are	expressed	by	DC2	and	DC4	neurons	(and	adjacent	Th1-	cells),	but	not	by	DC1	and	DC3	
DA	neurons	(Ryu	et	al.,	2007b;	Fernandes	et	al.,	2013).	OTP	is	required,	in	a	cell-
autonomous	manner,	for	the	differentiation	of	progenitors:	loss	of	function	of	OTP	results	
in	the	loss	of	DC2	and	DC4	populations	(and	also,	loss	of	DC5	and	DC6)	populations	(Ryu	et	
al.,	2007b;	Fernandes	et	al.,	2013).	It	has	not	yet	been	reported	whether	OTP	expression	is	
maintained	into	adulthood	in	the	PT.	
	
Here,	I	analysed	expression	of	OTP	using	an	antibody	against	OTPb	(Blechman	et	al.,	2007).	
I	first	aimed	to	describe	embryonic	OTPb	expression	in	consecutive	transverse	sections	
through	the	rostral	PT;	previous	studies	have	analysed	expression	only	in	wholemount	
view	(Ryu	et	al.,	2007;	Fernandes	et	al.,	2013,	Muthu	et	al.,	2016).		Immunohistochemical	
analysis	of	OTPb	at	55hpf	reveals	expression	in	DC2	and	DC4	DA	neurons,	and	in	adjacent	
Th1-cells	(Fig.4.7A,	B),	and	shows	that	OTPb	cannot	be	detected	in	DC1	or	DC3	DA	neurons	
(Fig.	4.7A,B).	This	data	agrees	with	characterisation	provided	by	previous	studies.		
	
I	next	analysed	expression	of	OTPb	in	the	rostral	PT	of	an	adult	(6-month)	zebrafish.	OTPb	
is	expressed	in	DC2A	and	DC4A	DA	neurons	(Fig.4.8B,D)	and	is	not	detected	in	DA	neurons	
of	the	PVO	(Fig.4.8C).	OTPb	expression	is	also	detected	in	Th1-	cells	immediately	adjacent	
to	these	populations.	These	patterns	mirror	those	in	the	embryo.	Surprisingly,	however,	
and	in	marked	contrast	to	the	embryonic	DC1	population,	OTPb	is	also	detected	in	Th1+	DA	
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neurons	in	the	TPp	(Fig.4.8A).	Indeed,	quantitative	analyses	suggest	that	every	Th1+	DA	
neuron	in	the	TPp	co-expresses	OTPb	(see	Chapter	6).	Therefore,	DC1	and	TPp	populations	
show	markedly	different	progenitor	characteristics.	Together,	these	analyses	suggest	that	
DC1/TPp	populations,	DC2/DC2A	populations,	DC3/PVO	populations	and	DC4/DC4A	
populations	might	each	derive	from	distinct	progenitor	cells	with	particular	characteristics	
(summarised	together	in	Table	4.1;	Fig.	4.9).	
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Fig.	4.7:	OTPb	is	expressed	by	DC2	and	DC4	neurons	and	by	non-Th1-expressing	
progenitors	in	the	embryonic	rostral	PT	
A(i-v).						Fluorescent	MIP	of	a	transverse	section	through	DC1	and	DC2	populations	of	
55hpf	zebrafish	larvae,	labelled	with	DAPI	(blue),	Th1	(green)	and	OTPb	(red).	
Th1	and	OTPb	are	shown	without	DAPI	(ii),	DAPI	is	shown	in	(iii),	Th1	is	
shown	in	(iv),	OTPb	is	shown	in	(v).	Scale	bars	represent	10	μm.	DA	
populations	are	outlined,	DiV	is	outlined	in	red.	DC2	DA	neurons	co-label	
with	OTPb,	DC1	DA	neurons	do	not.	
B(i-v).						Fluorescent	MIP	of	a	transverse	section	through	DC3	and	DC4	populations	of	
55hpf	zebrafish	larvae,	labelled	with	DAPI	(blue),	Th1	(green)	and	OTPb	(red).	
Th1	and	OTPb	are	shown	without	DAPI	(ii),	DAPI	is	shown	in	(iii),	Th1	is	
shown	in	(iv),	OTPb	is	shown	in	(v).	Scale	bars	represent	10	μm.	DA	
populations	are	outlined,	DiV	is	outlined	in	red.	DC4	DA	neurons	co-label	
with	OTPb,	DC3	DA	neurons	do	not.	
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Fig.	4.8:	OTPb	expression	is	detected	in	the	TPp,	DC2A	and	DC4A	DA	neurons	the	adult	
rostral	PT.	
A(i-v).												Fluorescent	MIP	of	a	transverse	section	through	the	TPp	of	a	6-month	
zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	OTPb	(red).	Th1	and	
OTPb	are	shown	without	DAPI	(ii),	DAPI	is	shown	in	(iii),	Th1	is	shown	in	(iv),	
OTPb	is	shown	in	(v).	DiV	is	outlined	in	red.	Scale	bars	represent	10	μm.	
Schematics	on	right	hand	side	indicate	position	of	corresponding	image	in	
relation	the	DiV.	TPp	DA	neurons	co-express	OTPb.	
B(i-v).												Fluorescent	MIP	of	a	transverse	section	through	the	DC2	population	of	a	6-
month	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	OTPb	(red).	Th1	
and	OTPb	are	shown	without	DAPI	(ii),	DAPI	is	shown	in	(iii),	Th1	is	shown	in	
(iv),	OTPb	is	shown	in	(v).	DiV	is	outlined	in	red.	Scale	bars	represent	10	μm.	
Schematics	on	right	hand	side	indicate	position	of	corresponding	image	in	
relation	the	DiV.	DC2	DA	neurons	co-express	OTPb.	
C(i-v).												Fluorescent	MIP	of	a	transverse	section	through	the	PVO	of	a	6-month	
zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	OTPb	(red).	Th1	and	
OTPb	are	shown	without	DAPI	(ii),	DAPI	is	shown	in	(iii),	Th1	is	shown	in	(iv),	
OTPb	is	shown	in	(v).	DiV	is	outlined	in	red.	Scale	bars	represent	10	μm.	
Schematics	on	right	hand	side	indicate	position	of	corresponding	image	in	
relation	the	DiV.	PVO	DA	neurons	do	not	co-express	OTPb.	
D(i-v).												Fluorescent	MIP	of	a	transverse	section	through	the	DC4	population	of	a	6-
month	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	OTPb	(red).	Th1	
and	OTPb	are	shown	without	DAPI	(ii),	DAPI	is	shown	in	(iii),	Th1	is	shown	in	
(iv),	OTPb	is	shown	in	(v).	DiV	is	outlined	in	red.	Scale	bars	represent	10	μm.	
Schematics	on	right	hand	side	indicate	position	of	corresponding	image	in	
relation	the	DiV.	DC4	DA	neurons	co-express	OTPb.	
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Fig.	4.9:	Summary	of	position	of	DC1/TPp,	DC2/DC2A	DC3/PVO	and	DC4/DC4A	DA	neurons	
the	adult	rostral	PT	in	relation	to	populations	of	neural	stem/progenitor	cells.	
Schematics	depicting	expression	domains	in	DA	populations	of	the	rostral	PT	at	
embryonic/larval	(A,B)	and	adult	(C-E)	ages.	Red	circles:	Her4+	cells,	green	circles:	Nestin+	
cells,	yellow	circles:	OTPb+	cells,	small	purple	circles:	rx3	mRNA	expression,	small	round	
grey	cells:	DC1/TPp	DA	neurons,	large	pear	shaped	cells:	DC2/DC2A	or	DC4/DC4A	DA	
neurons,	small	bipolar	cells:	DC3/PVO	DA	neurons.		
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4.3:	Discussion		
	
The	aim	of	this	chapter	was	to	seek	evidence	for	the	existence	of	neural	stem/progenitor	
niches	in	this	region.	To	achieve	this,	sections	of	the	adult	rostral	PT,	and	sections	of	the	
corresponding	embryonic/larval	region,	were	analysed	using	labelling	with	markers	of	
neural	stem	and	progenitor	cells.			
	
First,	my	analyses	of	progenitor	populations	in	the	embryonic	and	adult	PT	using	markers	
of	radial	glial	cells	(Nestin	and	Her4.1),	showed	that	radial	glial-like	cell	populations	are	
present	in	the	embryonic	and	the	adult	rostral	PT.	This	data	supports	the	presence	of	
neural	stem/progenitor	cell	populations	in	the	adult	rostral	PT	that	retain	expression	of	
embryonic	radial	glial	proteins	including	Nestin	and	Her4,	both	of	which	are	pivotal	for	
regulation	of	stem/progenitor	self-renewal	(Kageyama	et	al.,	2008;	Chapouton	et	al.,	2010;	
Park	et	al.,	2010).	My	analyses	show	that	in	DC1/TPp,	DC2/DC2A	and	DC4/DC4A	
populations,	Her4	expression	is	less	widespread	than	Nestin	expression.	One	possibility	is	
that	Her4	and	Nestin	label	different	populations	of	stem/progenitor	cells;	a	second	
possibility	is	that	Her4-expressing	cells	are	a	subset	of	Nestin-expressing	cells.	This	
contrasts	with	the	PVO,	which	is	fundamentally	different	to	the	rest	of	the	PT.	In	the	PVO,	
Nestin	expression	is	restricted	to	one	or	two	cells,	and	Her4	is	expressed	in	a	double	
tramline	appearance,	where	a	proportion	of	cells	are	located	at	a	distance	from	the	
ventricle	and	extend	a	short	process	towards	it.	This	suggests	that	PVO	DA	neurons	may	
derive	from	a	distinct	population	of	progenitor	cells	compared	to	DC1/TPp,	DC2/DC2A	and	
DC4/DC4A	populations.	Indeed,	studies	investigating	proliferation	in	the	zebrafish	larval	PT	
have	shown	a	dorsal	and	ventral	zone	of	proliferation,	suggesting	two	distinct	neural	
stem/progenitor	niches	exist	in	the	PT	(Mueller	&	Wullimann,	2002).	Altogether,	here	my	
studies	provide	evidence	for	distinct	neural	stem/progenitor	populations	in	the	PT,	that	are	
established	in	early	life	and	maintained	to	adulthood.		
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Next,	I	analysed	progenitor	populations	in	the	adult	and	embryonic	PT	using	markers	
involved	in	DA	differentiation,	namely	rx3	and	OTPb.	These	studies	provided	further	
evidence	that	distinct	progenitor	populations	are	present	in	the	embryonic	and	adult	
rostral	PT.	My	analyses	of	rx3	expression	in	the	embryo	agrees	with	previous	studies	
(Muthu	et	al.	2016),	that	showed	rx3	expression	in	the	anterior	hypothalamus	(specifically,	
in	two	zones,	termed	zones	I	and	II).	I	extended	these	studies	by	analysing	embryonic	rx3	
expression	with	a	focus	on	the	PT,	and	also	analysing	rx3	expression	in	the	adult	zebrafish	
PT	to	determine	whether	rx3-expressing	progenitors	are	retained	in	adulthood.	My	data	
showed	that	in	regions	of	the	PT	that	are	rostral	to	the	anterior	hypothalamus,	rx3	is	
detected	at	very	low	levels	(DC1/TPp	and	DC2/DC2A),	and	is	not	detected	in	regions	dorsal	
to	the	anterior	hypothalamus	(DC4/DC4A).	In	regions	of	the	PT	that	overlap	with	the	
anterior	hypothalamus	(DC3	and	the	PVO),	rx3	is	strongly	detected.	This	adds	weight	to	the	
idea	that	DC3	and	PVO	populations	are	related	(Rink	and	Wullimann,	2002b;	Chapter	3),	as	
both	embryonic	and	adult	DA	neurons	reside	in	a	region	of	rx3	expression.	Furthermore,	as	
rx3	expression	is	detected	in	the	PVO,	but	little	to	no	expression	is	observed	in	other	PT	
populations,	this	supports	my	previous	observations	that	the	anterior-ventral	region	of	the	
PT	(containing	DC3/PVO	DA	neurons)	is	fundamentally	different	to	the	rest	of	the	PT.	Since	
Rx3	is	part	of	a	mechanism	that	balances	stem	and	progenitor	cells	in	the	hypothalamus,	
this	strongly	suggests	that	the	anterior-ventral	PT	should	be	defined	as	part	of	the	
hypothalamus.			
	
My	analyses	of	OTPb	expression	agree	with	previous	studies	in	the	zebrafish	embryo	that	
show	OTPb	expression	in	DC2	and	DC4	DA	neurons,	but	not	in	DC1	or	DC3	DA	neurons.	My	
analyses	add	to	this	data	by	investigating	OTPb	expression	in	sections,	where	previous	
studies	have	analysed	wholemount	zebrafish	embryos	(Ryu	et	al.,	2007;	Fernandes	et	al.,	
2013,	Muthu	et	al.,	2016).	In	addition,	my	studies	extend	previous	work,	by	analysing	OTPb	
expression	in	the	adult	PT.	I	show	expression	is	retained	in	DC2A	and	DC4A	DA	neurons,	is	
not	expressed	by	PVO	DA	neurons,	but	intriguingly	is	expressed	by	TPp	DA	neurons.	Firstly,	
this	adds	evidence	that	DC2	and	DC2A;	DC3	and	PVO;	DC4	and	DC4A	DA	neurons	are	related	
(Rink	and	Wullimann,	2002b;	Chapter	3),	but	importantly	shows	that	TPp	DA	neurons	are	
profoundly	distinct	to	DC1	DA	neurons.	Previous	studies	have	shown	that	in	embryonic	
(2dpf)	and	larval	(5dpf)	zebrafish,	DA	neurons	in	the	presumptive	TPp	and	the	ventral	
thalamus	form	a	contiguous	population	(Rink	and	Wullimann,	2002b).	Therefore,	I	propose	
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that	DC1	DA	neurons	at	55hpf	are	predominately	comprised	of	ventral	thalamic	DA	
neurons	and	TPp	DA	neurons	arise	from	a	different	progenitor	population,	in	later	life,	that	
express	OTPb.	Further	studies	are	required	to	determine	at	what	age	OTPb+	TPp	DA	
neurons	first	appear	and	whether	OTPb	is	required	for	their	specification/differentiation.		
	
In	summary,	these	analyses	provide	three	core	conclusions.	First,	the	PT	contains	
populations	of	neural	stem/progenitor	cells	that	can	be	dorso-ventrally	divided	into	at	
least	two	discrete	populations:	ascending	neurons	in	the	dorsal	PT,	composed	of	TPp,	
DC2/DC2A	and	DC4/DC4A	populations	and	local-projecting	neurons	in	the	ventral	PT,	
composed	of	DC3/PVO	DA	neurons.	Second,	the	DC3/PVO	population	is	fundamentally	
different	from	the	rest	of	the	PT:	it	contains	rx3-expressing	progenitors,	it	resides	at	the	
border	of/overlaps	with	the	anterior	hypothalamus	and	it	contains	a	morphologically	
distinct	population	of	Nestin+	and	Her4+	radial	glia.	For	these	reasons,	I	have	proposed	that	
the	PVO	should	be	classed	as	a	hypothalamic	population,	rather	than	a	rostral	PT	
population.	Third,	differences	in	OTPb	expression	show	that	TPp	DA	neurons	are	
profoundly	different	to	DC1	neurons.	I	have	therefore	proposed	that	the	DC1	population	is	
predominately	formed	of	thalamic	DA	neurons	at	embryonic	time	points	and	that	TPp	DA	
neurons	arise	from	a	divergent	progenitor	population	in	later	life.		
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Chapter	5	
	
	
Dopaminergic	neurons	in	the	rostral	PT	are	
generated	throughout	life		
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5.1:	Introduction		
	
The	analysis	outlined	in	chapter	4	provides	initial	evidence	for	the	presence	of	neural	
stem/progenitor	cells	in	the	PT	(including	the	hypothalamic	DC3/PVO	population)	that	
persist	from	the	developing	embryo	to	adulthood.	Recent	studies	have	shown	that	DA	
neurons	of	the	caudal	hypothalamus	are	generated	in	adulthood	(McPherson	et	al.,	2016),	
however,	as	yet,	no	study	has	definitively	answered	the	question	of	whether	DA	neurons	
are	added	to	ascending	dopaminergic	populations	throughout	adult	life	(see	introduction	
section	1.4.3).	Therefore,	I	aimed	to	assess	the	generation	of	DA	neurons	in	the	rostral	PT,	
by	examining	EdU	incorporation.	In	this	chapter,	I	describe	experiments	in	which	I	analysed	
EdU	labelling	in	combination	with	anti-Th1	immunohistochemistry,	to	detect	newborn	DA	
neurons.	DA	generation	at	55hpf	was	examined,	as	DA	neuron	populations	are	well	
established	at	this	stage.	Further,	adult	zebrafish	aged	3-,	6-,	12-	and	22-months	were	
examined,	to	investigate	DA	generation	across	the	zebrafish	lifespan.	I	also	describe	
experiments	in	which	I	used	a	genetic	conditional	lineage	tracing	strategy	to	firmly	
determine	the	evidence	of	de	novo	DA	adult	neurogenesis.			
	
5.2.1	The	generation	of	dopaminergic	neurons	in	the	embryonic	rostral	PT	
A	previous	study	has	characterised	embryonic	generation	of	DA	neurons	in	the	zebrafish,	
using	sequential	pulses	of	EdU	to	resolve	when	neurons	of	specific	DA	groups	become	
postmitotic	during	embryogenesis	(Mahler	et	al.,	2010).	In	this	study,	birthdating	analysis	
(as	defined	by	cells	no	longer	incorporating	EdU	and	expressing	Th1)	showed	that	DA	
neurons	in	the	DC2	population	differentiate	first,	becoming	post-mitotic	at	16hpf,	followed	
by	DC4	DA	neurons	at	24hpf	and	DC1	DA	neurons	at	30hpf.		DC3	DA	neurons	however,	
continuously	label	with	EdU	throughout	development,	suggesting	these	neurons	arise	from	
proliferating	precursor	pools	throughout	embryogenesis	(Mahler	et	al.,	2010).		
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My	observations	in	Chapter	3	that	DC1/TPp,	DC3/PVO	and	DC4/DC4A	populations	increase	
in	size	after	55hpf	do	not	support	the	study	by	Mahler	et	al.	To	resolve	this	discrepancy	I	
took	31hpf	zebrafish	embryos,	pulsed	them	with	EdU	by	injection	into	the	yolk	sac,	chased	
to	55hpf	(Fig.	5.1A,B),	and	analysed	for	Th1+EdU+	neurons	in	sections	through	the	rostral	
PT.	In	contrast	to	the	Mahler	et	al.	study,	Th1+EdU+	DA	neurons	were	detected	in	all	rostral	
PT	populations:	DC1	(Fig.	5.1C),	DC2	(Fig.	5.1D),	DC3	(Fig.	5.1E)	and	DC4	(Fig.	5.1F).	To	
determine	the	level	of	DA	neuron	generation	in	each	population	of	the	rostral	PT,	the	
number	of	Th1+EdU+	DA	neurons	in	each	population	was	quantified.	This	showed	high	
levels	of	DA	neuronal	generation	in	the	DC1	population	(0.6±0.27	out	of	2.4±0.16,	25%;)	
and	the	DC3	population	(8.8±0.93	out	of	15.7±1.13,	56%),	lower	levels	in	the	DC2	
population	(0.7±0.34	out	of	8.2±0.49,	8.5%)	and	lowest	levels	in	the	DC4	populations	
(0.2±0.13	out	of	8.3±0.82,	2%)	(Fig.	5.2).	Together,	these	observations	show	that	DA	
neurons	in	populations	DC1-4	are	still	generated	between	31	and	55hpf,	demonstrating	
that	DC1,	DC2	and	DC4	populations	do	not	become	post-mitotic	as	early	as	previously	
shown.	This	also	shows	that	DC3	precursors	are	the	most	proliferative	population	at	this	
time	point.	
	
	
	
	
	 129	
	
	
	
	
	
	
	
	
	
	
	
	 130	
Fig.	5.1:	Dopaminergic	populations	in	the	rostral	PT	are	added	to	between	31hpf	and	
55hpf.		
A. Schematic	showing	subpopulations	of	DA	neurons	within	the	embryonic	
zebrafish	rostral	PT.	Illustration	adapted	from	Rink	and	Wullimann,	2002.	
B. Schematic	representing	the	EdU	pulse-chase	schedule.	Zebrafish	embryos	
were	injected	with	5nl	of	5mM	EdU	in	HBSS	at	31hpf	and	chased	to	55hpf	
where	embryos	were	fixed	and	sectioned.		
C(i-iv).								Fluorescent	MIP	of	a	transverse	section	through	the	DC1	population	of	the	
55hpf	EdU	injected	embryo,	labelled	with	DAPI	(blue)(shown	individually	in	
(ii)),	Th1	(green)(shown	individually	in	(iii)),	and	EdU	(red)	(shown	
individually	in	(iv)).	DC1	DA	neurons	are	newly	generated.	Scale	bar	
represents	10μm.	
D(i-iv).		 Fluorescent	MIP	of	a	transverse	section	through	the	DC2	population	of	the	
55hpf	EdU	injected	embryo,	labelled	with	DAPI	(blue)(shown	individually	in	
(ii)),	Th1	(green)(shown	individually	in	(iii)),	and	EdU	(red)	(shown	
individually	in	(iv)).	DC2	DA	neurons	are	newly	generated.	Scale	bar	
represents	10μm.	
E(i-iv).		 Fluorescent	MIP	of	a	transverse	section	through	the	DC3	population	of	the	
55hpf	EdU	injected	embryo,	labelled	with	DAPI	(blue)(shown	individually	in	
(ii)),	Th1	(green)(shown	individually	in	(iii)),	and	EdU	(red)	(shown	
individually	in	(iv)).	DC3	DA	neurons	are	newly	generated.	Scale	bar	
represents	10μm.	
F(i-iv).		 Fluorescent	MIP	of	a	transverse	section	through	the	DC4	population	of	the	
55hpf	EdU	injected	embryo,	labelled	with	DAPI	(blue)(shown	individually	in	
(ii)),	Th1	(green)(shown	individually	in	(iii)),	and	EdU	(red)	(shown	
individually	in	(iv)).	DC4	DA	neurons	are	newly	generated.	Scale	bar	
represents	10μm.	
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Fig.	5.2:	Highest	level	of	generation	in	DC3	DA	neurons.		
Bar	graphs	show	the	mean	number	of	EdU+Th1+	cells	and	EdU-Th1+	cells	in	each	population	
of	the	rostral	PT	(n=10	for	each	population).		
		
	
5.2.2	EdU	pulse-chase	studies	provide	evidence	for	the	generation	of	DA	neurons	in	the	
adult	rostral	PT	
	
I	next	sought	to	determine	whether	DA	neurons	of	the	PT	are	generated	throughout	
adulthood.	To	do	this,	I	used	Click-iT	EdU,	in	combination	with	anti-Th1	
immunohistochemistry,	to	detect	newborn	DA	neurons	in	consecutive	sections	through	
the	adult	rostral	PT.	Zebrafish	at	3-,	6-,	12-	and	22-months	of	age	were	analysed,	to	gain	a	
representative	view	across	the	lifespan.	Zebrafish	were	injected	intraperitoneally	(Fig.	
5.3A)	with	EdU	once	daily	for	3	days,	and	subsequently	culled	5-days	post	injection	(Fig.	
5.3B).	I	reasoned	that	a	once-daily	EdU	injection	regime	would	ensure	labelling	of	
infrequently	proliferating	stem/progenitor	cells,	and	that	a	5-day	chase	period	would	allow	
differentiation	of	cycling	progenitors	to	DA	neurons.		
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Fig.	5.3:	Injection	of	EdU	in	adult	zebrafish.		
A. Photograph	showing	intraperitoneal	injection	of	EdU	into	an	adult	anaesthetised	
zebrafish.	Zebrafish	at	3-,	6-,	12-	and	22-months	old	were	injected	with	5µl	of	
10mM	EdU.	
B. Schematic	showing	EdU	pulse-chase	schedule.	EdU	was	injected	once	daily	for	3	
days,	zebrafish	were	replaced	in	tanks	for	5	days	and	sacrificed	on	the	5th	day.		
	
	
	
In	the	3-month	old	zebrafish,	Th1+	neurons	that	were	also	EdU+	could	be	detected	in	the	
TPp	(Fig.5.4A,A’)	and	in	the	PVO	(Fig.5.4C,C’)	(yellow	arrowheads).	Neither	DC2A	
(Fig.5.4B,B’),	nor	DC4A	(Fig.5.4D,D’)	DA	neurons	were	ever	found	to	be	Th1+EdU+.	Similarly,	
at	6-months	of	age,	Th1+	EdU+	DA	neurons	were	detected	in	the	TPp	(Fig.5.5A,A’)	and	in	
the	PVO	(Fig.5.5C,C’),	whereas	no	Th1+	DC2A	(Fig.5.5B,B’)	or	DC4A	(Fig.5.5D,D’)	DA	neurons	
were	EdU+.	At	12-months	of	age,	once	more	the	TPp	(Fig.5.6A,A’)	and	PVO	(Fig.5.6C,C’)	
contained	Th1+	EdU+	DA	neurons,	with	no	DC2A	(Fig.5.6B,B’)	or	DC4A	(Fig.5.6D,D’)	Th1+	DA	
neurons	colabelled	with	EdU.	At	22-months	of	age	however,	no	Th1+	EdU+	neurons	could	
be	detected	in	the	TPp	(Fig.	5.7A,A’),	DC2A	(Fig.5.7B,B’),	PVO	(Fig.5.7C,C’)	or	DC4A	
(Fig.5.7D,D’)	populations.	Together	this	data	shows	that	DA	neurons	in	the	TPp	and	the	
PVO	are	generated	in	adult	life,	whereas	large	magnocellular	DC2A	and	DC4A	neurons	are	
not.	The	lack	of	EdU	incorporation	in	DA	neurons	of	any	population	in	the	rostral	PT	at	22-
months	of	age	suggests	an	age-related	decline	in	DA	neurogenesis.		
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Fig.	5.4:	DA	neurons	are	generated	in	the	TPp	and	the	PVO	of	3-month	old	zebrafish.		
A,A’.						Fluorescent	MIP	of	a	transverse	section	through	the	TPp	of	the	3-month	EdU	
injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	(red),	shown	
without	DAPI	in	A’.	TPp	DA	neurons	are	newly	generated.	Scale	bar	represents	
10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
B,B’.						Fluorescent	MIP	of	a	transverse	section	through	the	DC2	population	of	the	3-
month	EdU	injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	
(red),	shown	without	DAPI	in	B’.	DC2	DA	neurons	are	not	newly	generated.	Scale	
bar	represents	10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
C,C’.						Fluorescent	MIP	of	a	transverse	section	through	the	PVO	of	the	3-month	EdU	
injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	(red),	shown	
without	DAPI	in	C’.	PVO	DA	neurons	are	newly	generated.	Scale	bar	represents	
10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
D,D’.						Fluorescent	MIP	of	a	transverse	section	through	the	DC4	population	of	the	3-
month	EdU	injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	
(red),	shown	without	DAPI	in	D’.	DC4	DA	neurons	are	not	newly	generated.	Scale	
bar	represents	10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
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Fig.	5.5:	DA	neurons	are	generated	in	the	TPp	and	the	PVO	of	6-month	old	zebrafish.		
A,A’.						Fluorescent	MIP	of	a	transverse	section	through	the	TPp	of	the	6-month	EdU	
injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	(red),	shown	
without	DAPI	in	A’.	TPp	DA	neurons	are	newly	generated.	Scale	bar	represents	
10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
B,B’.						Fluorescent	MIP	of	a	transverse	section	through	the	DC2	population	of	the	6-
month	EdU	injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	
(red),	shown	without	DAPI	in	B’.	DC2	DA	neurons	are	not	newly	generated.	Scale	
bar	represents	10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
C,C’.						Fluorescent	MIP	of	a	transverse	section	through	the	PVO	of	the	6-month	EdU	
injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	(red),	shown	
without	DAPI	in	C’.	PVO	DA	neurons	are	newly	generated.	Scale	bar	represents	
10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
D,D’.						Fluorescent	MIP	of	a	transverse	section	through	the	DC4	population	of	the	6-
month	EdU	injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	
(red),	shown	without	DAPI	in	D’.	DC4	DA	neurons	are	not	newly	generated.	Scale	
bar	represents	10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
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Fig.	5.6:	DA	neurons	are	generated	in	the	TPp	and	the	PVO	of	12-month	old	zebrafish.		
A,A’.						Fluorescent	MIP	of	a	transverse	section	through	the	TPp	of	the	12-month	EdU	
injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	(red),	shown	
without	DAPI	in	A’.	TPp	DA	neurons	are	newly	generated.	Scale	bar	represents	
10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
B,B’.						Fluorescent	MIP	of	a	transverse	section	through	the	DC2	population	of	the	12-
month	EdU	injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	
(red),	shown	without	DAPI	in	B’.	DC2	DA	neurons	are	not	newly	generated.	Scale	
bar	represents	10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
C,C’.						Fluorescent	MIP	of	a	transverse	section	through	the	PVO	of	the	12-month	EdU	
injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	(red),	shown	
without	DAPI	in	C’.	PVO	DA	neurons	are	newly	generated.	Scale	bar	represents	
10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
D,D’.						Fluorescent	MIP	of	a	transverse	section	through	the	DC4	population	of	the	12-
month	EdU	injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	
(red),	shown	without	DAPI	in	D’.	DC4	DA	neurons	are	not	newly	generated.	Scale	
bar	represents	10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
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Fig.	5.7:	DA	neurons	are	not	generated	in	the	TPp	and	the	PVO	of	22-month	old	zebrafish.		
A,A’.						Fluorescent	MIP	of	a	transverse	section	through	the	TPp	of	the	22-month	EdU	
injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	(red),	shown	
without	DAPI	in	A’.	TPp	DA	neurons	are	not	newly	generated.	Scale	bar	represents	
10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
B,B’.						Fluorescent	MIP	of	a	transverse	section	through	the	DC2	population	of	the	22-
month	EdU	injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	
(red),	shown	without	DAPI	in	B’.	DC2	DA	neurons	are	not	newly	generated.	Scale	
bar	represents	10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
C,C’.						Fluorescent	MIP	of	a	transverse	section	through	the	PVO	of	the	22-month	EdU	
injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	(red),	shown	
without	DAPI	in	C’.	PVO	DA	neurons	are	not	newly	generated.	Scale	bar	
represents	10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
D,D’.						Fluorescent	MIP	of	a	transverse	section	through	the	DC4	population	of	the	22-
month	EdU	injected	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	EdU	
(red),	shown	without	DAPI	in	D’.	DC4	DA	neurons	are	not	newly	generated.	Scale	
bar	represents	10μm.	Position	of	image	in	relation	to	DiV	is	shown	in	schematic.	
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The	lack	of	de	novo	neurogenesis	of	DA	neurons	in	the	22-month	zebrafish	suggests	that	
the	rate	of	DA	generation	in	the	TPp	and	the	PVO	declines	with	age.	To	investigate	this,	I	
quantified	Th1+	EdU+	DA	neurons	in	the	TPp	(Fig.5.8A)	and	the	PVO	(Fig.	5.8B)	at	3-,	12-	and	
22-months	of	age.	This	revealed	that	in	the	TPp,	the	number	of	newly	generated	DA	
neurons	significantly	decreases	between	3-months	(3±0.37)	and	12-months	of	age	(1±0.58)	
and	between	3-months	(3±0.37)	and	22-months	of	age	(0±0),	but	does	not	significantly	
further	decrease	between	12-months	(1±0.58)	and	22-months	of	age	(0±0)	(Fig.5.8A).	In	
the	PVO,	the	number	of	newly	generated	DA	neurons	significantly	decreases	between	3-
months	(9±0.94)	and	12-months	of	age	(2±0.33)	and	between	3-months	(9±0.94)	and	22-
months	of	age	(0±0),	but	does	not	significantly	further	decrease	between	12-months	
(2±0.33)	and	22-months	of	age	(0±0)	(Fig.5.8B).	This	shows	that	between	3-months	of	age	
and	12-months	of	age,	the	rate	of	DA	generation	significantly	declines	in	both	the	TPp	and	
the	PVO.		
	
Fig.	5.8:	The	rate	of	DA	generation	declines	with	age.		
A. Mean	number	of	Th1+EdU+	DA	neurons	in	the	TPp	at	3-,	12-	and	22-months	of	
age.	The	number	of	newly	generated	DA	neurons	is	significantly	decreased	12-
month	old	zebrafish	compared	to	3-month	old	zebrafish	(p=0.0277,	*,	1-way	
ANOVA,	n=9	for	3-month	brains,	n=3	for	12-month	brains),	and	in	22-month	old	
zebrafish	compared	to	3-month	old	zebrafish	(p=0.0019,	**,	1-way	ANOVA,	n=9	
for	3-month	brains,	n=3	for	22-month	brains).	Error	bars	represent	standard	
deviation.	
B. Mean	number	of	Th1+EdU+	DA	neurons	in	the	PVO	at	3-,	12-	and	22-months	of	
age.	The	number	of	newly	generated	DA	neurons	is	significantly	decreased	12-
month	old	zebrafish	compared	to	3-month	old	zebrafish	(p=0.0039,	**,	1-way	
ANOVA,	n=9	for	3-month	brains,	n=3	for	12-month	brains),	and	in	22-month	old	
zebrafish	compared	to	3-month	old	zebrafish	(p=<0.001,	***,	1-way	ANOVA,	n=9	
for	3-month	brains,	n=3	for	22-month	brains).	Error	bars	represent	standard	
deviation.	
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In	chapter	3,	I	showed	that	there	was	no	significant	difference	in	the	total	number	of	DA	
neurons	in	rostral	PT	populations	between	male	and	female	zebrafish.	Previous	studies	
have	shown	a	sexually	dimorphic	pattern	of	neurogenesis	in	the	telencephalon	in	male	and	
female	zebrafish	(Ampatzis	et	al.,	2012),	however	it	remains	unknown	whether	the	
generation	of	DA	neurons	in	the	diencephalon	is	sexually	dimorphic.	Therefore,	I	asked	
whether	male	and	female	zebrafish	show	differences	in	generation	of	DA	neurons	in	the	
adult	rostral	PT.	To	do	so	I	quantified	Th1+EdU+	DA	neurons	in	the	TPp	and	the	PVO	in	male	
and	female	3-month	old	zebrafish.	Quantification	showed	no	significant	difference	in	the	
number	of	newly	generated	DA	neurons	between	the	male	TPp	(3±0.48)	and	the	female	
TPp	(3±0.71)	or	between	the	male	PVO	(8±1.29)	and	the	female	PVO	(10±1.47).	This	shows	
that	there	are	no	differences	in	the	level	of	generation	of	DA	PT	neurons	between	male	
and	female	zebrafish.	
	
	
	
	
	
	
	
	
	
Fig.	5.9:	No	significant	difference	in	the	number	of	newly	generated	DA	neurons	in	the	
TPp	or	the	PVO.	
The	mean	number	of	Th1+EdU+	cells	in	the	TPp	and	the	PVO	are	quantified	in	15μm	
sections	of	3-month	old	male	and	female	zebrafish.	No	significant	difference	between	the	
number	of	DA	neurons	in	either	subpopulation	in	male	and	female	zebrafish	(error	bars	
represent	standard	deviation,	n=4	males,	n=4	females,	statistically	analysed	by	unpaired	t-
test).	
		
	
	 143	
5.2.3	De	novo	DA	neurogenesis	in	the	adult	rostral	PT	from	Her4+	progenitor	cells	
EdU	pulse-chase	analysis	provides	a	useful	tool	for	studying	cell	proliferation,	but	suffers	
from	the	criticism	that	cells	that	are	undergoing	DNA	repair,	or	programmed	cell	death	
may	incorporate	nucleotide	analogues	(Rakic,	2002;	El-Khodor	et	al.,	2003)	–	i.e.	that	EdU-
labelling	does	not	necessarily	mean	a	cell	is	new-born.	Therefore,	to	confirm	that	DA	
neurons	are	newly-generated	from	stem/progenitor	cells,	I	used	a	conditional	lineage	
tracing	strategy	to	label	progenitors	and	their	progeny	in	the	adult	PT.	Since	Her4	is	widely	
expressed	by	radial-glial	like	cells	lining	the	ventricle	of	the	adult	rostral	PT	(see	Chapter	4	
section	4.2.1),	I	hypothesized	that	DA	neurons	adjacent	to	populations	of	Her4+	
progenitors	may	arise	from	these	cell	populations.	A	zebrafish	line	allowing	conditional	
lineage	tracing	of	Her4+	progenitors	has	been	previously	described.	In	this	line,	tamoxifen-
inducible	Cre	recombinase	is	driven	by	the	her4	promoter	
(Tg(her4:ERT2CreERT2))(Boniface	et	al.,	2009;	Dirian	et	al.,	2014).	This	Her4	line	was	
crossed	to	an	ubiquitous	reporter	line	–	ubi:switch	(Tg(−3,5ubi:loxP-GFP-loxP-
mCherry))(Mosimann	et	al.,	2011):	in	the	absence	of	Cre,	the	ubiquitous	reporter	line	
expresses	GFP	under	control	of	ubiquitin,	and	permanently	switches	to	express	mCherry	
after	a	recombination	event.	This	allows	conditional	labelling	of	Her4+	progenitors	and	
their	progeny	(Fig.5.10A,	5.11A).	Since	EdU	studies	showed	the	highest	level	of	DA	neuron	
generation	in	3-month	old	zebrafish,	I	used	3-month	old	zebrafish	for	conditional	lineage	
tracing,	to	give	the	best	chance	of	detecting	labelled	newborn	DA	neurons.		
Tamoxifen,	diluted	in	sunflower	oil,	or	a	vehicle	control	(oil	only)	were	injected	once	
intraperitoneally	into	3-month	old	Tg(her4:ERT2CreERT2);	Tg(−3,5ubi:loxP-GFP-loxP-
mCherry)	zebrafish,	followed	by	a	32-day	chase	period	to	allow	differentiation	(Fig.	5.10B,	
5.11B).	Zebrafish	brains	were	sectioned	and	anti-mCherry	immunohistochemistry	in	
combination	with	anti-Th1	immunohistochemistry	was	performed	on	consecutive	sections	
to	allow	detection	of	recombined	cells.	In	the	vehicle	control	injected	zebrafish,	no	
expression	of	mCherry	was	observed,	showing	that	there	were	no	recombination	events	in	
zebrafish	that	were	not	treated	with	tamoxifen	(Fig.5.10C,D).	When	recombination	was	
induced	by	injection	of	tamoxifen,	mCherry+Th1+	DA	neurons	were	observed	in	both	the	
TPp	and	in	the	PVO	(Fig.5.11C,D,	yellow	arrows),	showing	that	these	DA	neurons	were	
newly	generated	and	derived	from	Her4+	progenitors.	This	data	definitively	demonstrates	
that	DA	neurons	in	the	TPp	and	the	PVO	are	generated	from	Her4+	stem/progenitor	cells	in	
the	adult	brain.		
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Fig.	5.10:	No	recombination	in	vehicle	only	injected	Tg(her4:ERT2CreERT2);	
Tg(−3,5ubi:loxP-GFP-loxP-mCherry)	zebrafish	
A. Schematic	illustrating	cross	of	zebrafish	lines:	Tg(her4:ERT2CreERT2)	
conditional	lineage	tracing	line	was	crossed	to	the	ubiquitous	reporter	line	
Tg(−3,5ubi:loxP-GFP-loxP-mCherry).	Upon	addition	of	tamoxifen	(4-OHT,	
black	arrow),	gfp	is	excised	and	cells	expressing	her4	will	express	mcherry.		
B. Schematic	illustrating	the	injection	schedule:	in	control	zebrafish,	5µl	of	oil	
with	no	tamoxifen	added	was	injected	intraperitoneally,	zebrafish	were	then	
chased	for	32-days.		
C(i-iv).				Fluorescent	MIP	of	a	transverse	section	through	the	TPp	of	an	oil	injected	3-
month	old	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	mCherry	
(red).	Th1	is	shown	as	a	single	channel	in	(ii),	mCherry	is	shown	in	(iii).	Th1	
(green)	and	mCherry	(red)	are	shown	together	in	(iv).	Asterisks	label	blood	
vessel	non-specific	staining.	Scale	bars	represent	10	μm.	No	recombination	in	
the	TPp	of	oil	injected	zebrafish.	
D(i-iv).				Fluorescent	MIP	of	a	transverse	section	through	the	PVO	of	an	oil	injected	3-
month	old	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	mCherry	
(red).	Th1	is	shown	as	a	single	channel	in	(ii),	mCherry	is	shown	in	(iii).	Th1	
(green)	and	mCherry	(red)	are	shown	together	in	(iv).	Asterisks	label	blood	
vessel	non-specific	staining.	Scale	bars	represent	10	μm.	No	recombination	in	
the	PVO	of	oil	injected	zebrafish.	
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Fig.	5.11:	mCherry	labels	DA	neurons	in	the	TPp	and	the	PVO		in	tamoxifen	injected	
Tg(her4:ERT2CreERT2);	Tg(−3,5ubi:loxP-GFP-loxP-mCherry)	zebrafish	
A. Schematic	illustrating	cross	of	zebrafish	lines:	Tg(her4:ERT2CreERT2)	
conditional	lineage	tracing	line	was	crossed	to	the	ubiquitous	reporter	line	
Tg(−3,5ubi:loxP-GFP-loxP-mCherry).	Upon	addition	of	tamoxifen	(4-OHT,	
black	arrow),	gfp	is	excised	and	cells	expressing	her4	will	express	mcherry.		
B. Schematic	illustrating	the	injection	schedule:	5µl	of	oil	with	10mM	tamoxifen	
was	injected	intraperitoneally,	zebrafish	were	then	chased	for	32-days.		
C(i-iv).				Fluorescent	MIP	of	a	transverse	section	through	the	TPp	of	a	tamoxifen	
injected	3-month	old	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	
mCherry	(red).	Th1	is	shown	as	a	single	channel	in	(ii),	mCherry	is	shown	in	
(iii).	Th1	(green)	and	mCherry	(red)	are	shown	together	in	(iv).	Scale	bars	
represent	10	μm.	mCherry+Th1+	cells	are	observed	in	the	TPp	(yellow	
arrows).	
D(i-iv).				Fluorescent	MIP	of	a	transverse	section	through	the	PVO	of	an	oil	injected	3-
month	old	zebrafish,	labelled	with	DAPI	(blue),	Th1	(green)	and	mCherry	
(red).	Th1	is	shown	as	a	single	channel	in	(ii),	mCherry	is	shown	in	(iii).	Th1	
(green)	and	mCherry	(red)	are	shown	together	in	(iv).	Scale	bars	represent	10	
μm.	mCherry+Th1+	cells	are	observed	in	the	PVO	(yellow	arrows).	
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5.3	Discussion	
	
The	aim	of	this	chapter	was	to	determine	whether	DA	neurons	in	the	rostral	PT	are	
generated	throughout	life	in	the	zebrafish.	To	achieve	this,	EdU	labelling	in	combination	
with	anti-Th1	immunohistochemistry,	was	used	to	detect	newborn	DA	neurons	in	the	
embryo	and	at	various	stages	throughout	adult	life.	Then,	a	genetic	conditional	lineage	
tracing	line	was	used	to	confirm	de	novo	DA	adult	neurogenesis	in	the	adult	zebrafish	PT.	
	
First,	my	analyses	of	DA	neuron	generation	in	the	embryo	using	EdU	pulse	chase	analysis	
revealed	that	DA	neurons	in	populations	DC1-4	are	still	generated	between	31	and	55hpf.	
This	data	disagrees	with	previous	studies	that	show	that	DC1,	DC2	and	DC4	have	become	
post-mitotic	by	16-18hpf,	24-30hpf	and	20-24hpf	respectively	(Mahler	et	al.,	2010).	The	
discrepancies	between	my	data	and	the	studies	performed	by	Mahler	et	al.	are	most	likely	
due	to	different	technical	approaches.	In	my	analyses,	I	injected	EdU	directly	into	the	yolk	
sac,	and	analysed	DA	populations	in	consecutive	sections.	Mahler	et	al.	soaked	embryos	in	
EdU	for	30	minutes,	and	analysed	DA	populations	in	wholemount	tissue.	It	is	possible	that	
EdU	soaking	is	not	sufficient	to	label	all	proliferating	populations,	whereas	injecting	EdU	
directly	into	the	yolk	sac	allows	continued	uptake	into	proliferating	cells,	allowing	more	
chance	of	labelling	slowly-proliferating	progenitors.	Furthermore,	it	is	also	possible	that	
double-labelled	cells	may	be	not	be	detected	when	imaging	wholemount	embryos.		
	
My	analyses	in	chapter	3	shows	a	huge	expansion	in	the	DC1/TPp	population	and	the	
DC3/PVO	population	between	55hpf	and	3-months.	My	embryonic	EdU	analyses	showing	
DC1	and	DC3	DA	neurons	are	still	being	generated	at	55hpf,	support	these	observations	
from	chapter	3.	My	data	shows	that	DC3	DA	neurons	are	generated	at	the	highest	rate	
between	31	and	55hpf.	This	suggests	that	the	DC3	population	begins	to	expand	in	size	
early	in	development.	In	chapter	4,	I	showed	that	DC1	(embryonic)	DA	neurons	and	TPp	
(adult)	DA	neurons	are	fundamentally	different:	adult	TPp	DA	neurons	express	OTPb,	and	
embryonic	DC1	DA	neurons	do	not.	Therefore,	in	contrast	to	DC3,	I	predict	that	the	TPp	
undergoes	a	huge	expansion	in	neuron	number	after	55hpf,	i.e.	late	in	development.		
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Since	I	observed	no	change	in	the	population	size	of	DC2/DC2A	neurons	(chapter	3),	but	I	
observed	EdU-labelled	DC2	DA	neurons	at	55hpf,	it	is	likely	that	the	DA	neurons	added	
between	31	and	55hpf	are	the	last-generated	of	the	population.	From	these	analyses,	
however,	it	remains	possible	however	that	these	neurons	are	continuously	turned	over,	
rather	than	added	to,	and	so	maintain	a	constant	population	size.	My	observations	in	
chapter	3	showed	that	the	DC4/DC4A	DA	neuron	populations	increases	in	size	between	
55hpf	and	3-months,	though	to	a	lesser	extent	than	the	TPp	and	PVO	populations,	
suggesting	restricted	addition	at	embryonic/larval	and/or	juvenile	periods.	Here,	my	
observation	of	EdU-labelled	DC4	DA	neurons	at	embryonic	time	points	supports	this	data.		
	
Next,	my	analyses	of	the	generation	of	DA	neurons	in	the	adult	rostral	PT	using	EdU	
labelling	showed	for	the	first	time	that	two	DA	neuron	populations	are	added	to	in	
adulthood.	One	of	these	populations,	the	TPp,	contains	ascending	DA	neurons.	The	other,	
the	PVO,	is	hypothalamic	in	nature	(chapter	4).	Together,	this	data	shows	that	both	the	
TPp	and	the	PVO	are	still	expanding	in	size	at	3-,	6-	and	12-months,	but	by	22-months	show	
little	to	no	DA	neuron	generation.		
	
Here,	my	analyses	also	show	that	the	large	magnocellular	ascending	DA	neurons	in	DC2A	
and	DC4A	populations	do	not	label	with	EdU	in	adulthood.	This	suggests	that	these	
magnocellular	populations	are	born	early	and	show	little	to	no	generation	in	adult	life.	It	is	
therefore	most	likely	that	the	populations	observed	in	the	adult	zebrafish,	in	particular	
DC2A	DA	neurons,	are	the	same	as	those	observed	in	the	embryonic/larval	zebrafish.	It	is	
possible	that	magnocellular	DC2A	and	DC4A	neurons	are	related	to	other	magnocellular	
primary	neurons,	such	as	Mauthner	cells	providing	motion	and	depth	information,	as	well	
as	startle	response.	Future	work	should	characterise	similarities	in	morphology	and	
function	between	magnocellular	neurons	in	zebrafish.	
	
My	observation	that	no	DA	neurons	are	newly	generated	in	22-month	old	zebrafish	
prompted	me	to	quantify	the	number	of	newly	generated	DA	neurons	in	the	TPp	and	the	
PVO	in	young	adult,	adult	and	aged	adult	life	stages,	to	determine	whether	the	rate	of	DA	
neurogenesis	decreases	with	age.	Here,	I	show	for	the	first	time	that	the	rate	of	DA	
generation	in	zebrafish	does	indeed	decline	with	age.	This	agrees	with	previous	studies	
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that	show	declining	rates	of	neurogenesis	in	mammals	(see	introduction	section	1.4.4)	and	
in	the	zebrafish	telencephalon	(see	introduction	section	1.4.5).	This	shows	that	ageing	is	a	
common	regulatory	factor	between	mammals	and	zebrafish,	and	that	ageing	results	in	a	
reduced	ability	to	generate	DA	neurons	in	both	ascending	and	local-projecting	populations.		
Future	work	should	focus	on	determining	whether	the	declining	rate	of	neuron	generation	
with	age	is	specific	to	DA	neurons.	For	example,	the	rate	of	generation	of	other	neuron	
populations	should	be	quantified	using	a	generic	neuronal	marker	such	as	HuC/D.	This	
would	also	allow	control	for	possible	loss	of	EdU	absorption	in	aged	zebrafish.	
	
Finally,	since	EdU	pulse-chase	analyses	are	limited	(cells	that	are	undergoing	DNA	repair,	or	
programmed	cell	death	may	incorporate	nucleotide	analogues	and	may	therefore	not	be	
truly	newborn),	I	performed	conditional	lineage	tracing	experiments.	My	data	showed	for	
the	first	time	that	Her4+	progenitors	give	rise	to	DA	neurons	in	adulthood	in	two	
populations:	the	ascending	TPp,	and	the	local	PVO.	This	is	in	direct	agreement	with	my	EdU	
analyses,	and	definitively	confirms	that	DA	neurons	are	generated	from	resident	
stem/progenitor	cells	in	the	adult	brain.		Future	work	should	focus	on	the	development	of	
an	OTPb-driven	conditional	lineage	tracing	line.	This	would	allow	direct	tracing	of	OTPb	
expressing	ascending	DA	neurons	in	the	TPp.	
	
In	summary,	these	analyses	provide	three	main	conclusions.	First,	DA	neurons	in	
embryonic	rostral	PT	populations	do	not	become	post-mitotic	as	early	as	previously	shown	
by	other	studies.	Second,	the	TPp	(one	of	the	ascending	DA	neuron	populations)	and	the	
PVO	(the	locally	projecting,	hypothalamic	DA	neuron	population)	are	both	generated	in	
adult	life	from	resident	stem/progenitor	cells,	where	TPp	DA	neurons	are	most	likely	
generated	late	in	development.	Third,	the	magnocellular	ascending	DA	neuron	populations	
(DC2/DC2A	and	DC4/DC4A)	are	not	generated	in	adulthood,	and	are	born	early,	showing	
little	or	no	change	in	population	size	in	adult	life.		
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Chapter	6	
	
	
Impeded	generation	of	adult	dopaminergic	
neurons	in	the	rostral	PT	in	a	genetic	model	of	
Parkinson’s	disease	
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6.1:	Introduction		
	
PD	is	pathologically	defined	by	a	reduced	number	of	DA	neurons	in	the	substantia	nigra.	
The	largest	risk	factor	for	developing	PD	is	ageing;	however	monogenic-inherited	
mutations	have	been	shown	to	cause	PD	in	around	10%	of	cases	(see	introduction	section	
1.2.1).	Many	studies	in	the	past	20	years	have	begun	to	shed	light	onto	the	pathogenesis	of	
PD,	and	it	is	clear	from	these	that	PD	is	a	complex	multisystem	disorder,	most	likely	with	
converging	and	common	mechanisms	involved	in	the	correct	regulation	of	DA	neurons.	
Any	alterations	that	disturb	these	common	mechanisms,	and	subsequently	the	number	or	
function	of	DA	neurons,	could	contribute	to	disease	onset	or	progression.	However,	we	still	
do	not	have	a	clear	understanding	of	underlying	mechanisms.	
	
Recent	evidence	has	shown	that	PD	genes	–	i.e.	genes	whose	dysfunction/dysregulation	
leads	to	PD	-	regulate	neural	stem/progenitor	cells	in	the	adult	brain	(see	introduction	
section	1.4.5).	It	has	therefore	been	hypothesized	that	PD	may	involve	dysregulated	
neurogenesis	as	an	underlying	pathological	mechanism,	and	indeed	several	studies	have	
begun	to	describe	dysregulated	neurogenesis	in	various	brain	regions	in	models	of	PD	
(Introduction	section	1.4.6).	However,	as	yet,	no	study	has	investigated	whether	in	vivo	
adult	generation	of	ascending	DA	neurons	is	impaired	in	a	genetic	model	of	PD.	This	is	
perhaps	in	part	due	to	the	limited	number	of	robust	rodent	PD	models:	many	rodent	PD	
lines	do	not	recapitulate	genetic	forms	of	the	disease	(introduction	section	1.3.1).	The	
work	that	I	describe	in	Chapter	5,	showing	that	ascending	DA	neurons	are	generated	in	the	
adult	rostral	PT,	shows	that	the	zebrafish	provides	an	excellent	model	system	in	which	to	
study	in	vivo	adult	DA	neurogenesis.		Importantly,	a	pink1	knockout	zebrafish	line	that	
robustly	models	PD	has	previously	been	created	by	the	Bandmann	lab	(Flinn	et	al.,	2013).		
	
In	humans,	PINK1	is	expressed	throughout	the	brain	and	autosomal	recessive	inherited	loss	
of	function	mutations	in	PINK1	cause	early	onset	PD	(Valente	et	al.,	2004;	Gandhi	et	al.,	
2006).	Although	PINK1	has	been	linked	to	regulation	of	mitophagy,	mitochondrial	function	
and	oxidative	stress,	the	underlying	mechanisms	of	PINK1-mediated	PD	are	not	yet	fully	
understood	(discussed	in	detail	in	section	1.2.4).	Pink1	knockout	mice	do	not	display	
reductions	in	DA	neuron	number	in	the	substantia	nigra,	and	so	do	not	robustly	model	PD.	
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The	pink1	knockout	zebrafish	line	was	established	in	the	Bandmann	lab	using	the	targeting	
induced	local	lesions	in	genomes	(TILLING)	method	of	mutation.	This	resulted	in	the	
introduction	of	a	premature	stop	codon	in	the	kinase	domain	of	the	zebrafish	pink1	gene,	
and	consequently	inactivation	of	kinase	activity	and	decreased	pink1	mRNA	stability.	Pink1	
deficiency	in	zebrafish	closely	models	manifestations	of	the	human	disease,	with	reduced	
numbers	of	dopaminergic	neurons	in	adult	zebrafish	and	mitochondrial	impairment	(Flinn	
et	al.,	2013).	It	remains	unclear	whether	reduced	DA	neurogenesis	contributes	to	this	
phenotype.	
	
I	therefore	next	aimed	to	determine	whether	de	novo	DA	neuron	generation	is	altered	in	
the	pink1-/-	zebrafish.	In	this	chapter,	I	describe	experiments	in	which	I	analyse	
neurogenesis	of	DA	neurons	in	pink1+/+	and	pink1-/-	zebrafish	by	quantification	of	DA	
population	sizes	throughout	life,	EdU	pulse-chase	experiments,	investigations	into	cell	
death	and	analyses	of	progenitor	populations.	The	key	aim	was	to	determine	whether	
zebrafish	with	mutations	in	pink1	display	reduced	DA	generation.		
	
6.2:	Results		
	
6.2.1	Impeded	increase	in	DA	neuronal	population	sizes	in		
pink1-/-	zebrafish	
	
In	chapter	5,	I	showed	that	new	DA	neurons	are	generated	in	adulthood	at	a	rate	that	
decreases	with	age.	It	is	not	clear	from	these	analyses	however,	whether	newborn	neurons	
are	added	to	existing	populations,	resulting	in	expansion	in	DA	neuron	number,	or	whether	
new	neurons	replace	existing	neurons	resulting	in	a	static	population	size.	I	therefore	first	
quantified	the	number	of	DA	neurons	at	55hpf,	3	months	and	24-months	of	age	in	each	
rostral	PT	subpopulation	in	pink1+/+	zebrafish,	expanding	the	quantification	performed	at	
55hpf	and	3	months	by	increasing	the	number	of	replicates	(see	Chapter	3:	Fig.3.8).	
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Since	DA	neurons	are	generated	in	the	TPp	and	the	PVO	throughout	life	(Chapter	5),	I	first	
counted	DA	neuronal	numbers	in	these	two	populations.	Additionally,	since	I	have	shown	
that	DC1	and	TPp	DA	neuronal	populations	are	fundamentally	different	(Chapter	4),	here	
the	quantification	of	the	number	of	TPp	DA	neurons	at	55hpf	is	0.	Analysis	of	the	number	
of	Th1+	DA	neurons	in	the	TPp	shows	that	in	pink1+/+	zebrafish,	DA	neuron	population	size	
significantly	increases	between	55hpf	and	3-months	from	0	(±0)	to	341	(±42.51),	and	
increases	further	between	3-	and	24-months	of	age	from	341	(±42.51)	to	434(±28.27)	
(Fig.6.1A).	Similarly,	in	the	pink1+/+	PVO,	the	number	of	DA	neurons	increases	between	
55hpf	and	3-months,	from	16	(±3.56)	to	377	(±47.16),	with	further	increase	between	3-	
and	24-months	from	377	(±47.16)	to	485	(±58.58)	(Fig.	6.1A).	Therefore,	DA	neuronal	
numbers	increase	in	the	TPp	and	the	PVO	in	adulthood.	In	chapter	5,	I	showed	that	
magnocellular	DC2A	and	DC4A	neurons	do	not	label	with	EdU	at	3-,	6-,	12-	or	22-months	of	
age	and	so	do	not	appear	to	be	generated	in	adult	life.	To	provide	an	independent	
assessment	of	this,	I	next	analysed	the	size	of	these	PT	populations.	Analysis	of	the	
DC2/DC2A	population	in	pink1+/+	zebrafish	shows	that	the	number	of	Th1+	DA	neurons	
does	not	significantly	increase	between	55hpf	and	3-months	of	age	(from	8±1.55	to	
9±1.05),	or	between	3-	and	24-months	of	age	(from	9±1.05	to	9±1.55)	(Fig.6.1C).	However,	
the	number	of	DA	neurons	in	the	pink1+/+	DC4/DC4A	population	significantly	increases	
between	55hpf	and	3-months	of	age,	from	8(±2.58)	to	20(±1.35),	although	it	does	not	
further	increase	between	3-months	and	24-months	of	age	(20±1.35	to	21±1.17)	(Fig.6.4D).	
These	data	support	my	EdU	analyses,	showing	that	DA	neuronal	numbers	do	not	increase	
in	the	DC2A	or	the	DC4A	populations	in	adulthood.	Additionally,	this	data	strengthens	my	
quantification	in	section	3.2.2,	as	both	sets	of	quantifications	were	performed	at	different	
times	and	on	different	samples	yet	give	comparable	results.	This	suggests	robust	
quantification	methodology.	
	
Next,	I	counted	DA	neuronal	population	sizes	at	the	same	time-points	in	pink1-/-	zebrafish	
to	ask	how	the	numbers	compare	to	the	pink1+/+	fish.	In	the	TPp	of	pink1-/-	zebrafish,	the	
number	of	DA	neurons	increases	between	55hpf	and	3-months	from	0(±0)	to	330(±72.74)	
but	shows	no	further	significant	increase	between	3-months	to	24-months	(330±72.74	to	
364±54.27)	(Fig.6.1A).	Comparison	of	the	total	number	of	DA	neurons	in	the	TPp	at	each	
time	point	between	pink1+/+	and	pink1-/-	zebrafish	shows	that	pink1-/-	zebrafish	have	
significantly	fewer	DA	neurons	in	the	TPp	at	2-years	of	age	(434±28.27	compared	to	
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364±54.27,	a	16.1%	reduction),	but	show	no	difference	at	55hpf	or	3-months	of	age	
(Fig.6.1B).	Similarly	in	the	pink1-/-	PVO,	the	number	of	DA	neurons	increases	between	
55hpf	and	3-months,	from	14(±3.41)	to	343(±37.58),	but	does	not	significantly	increase	
between	3-	and	24-months	(from	343±37.58	to	314±64.01)(Fig6.1B).	Comparison	of	the	
total	number	of	DA	neurons	at	each	time	point	between	pink1+/+	and	pink1-/-	zebrafish	
shows	that	pink1-/-	zebrafish	have	significantly	fewer	DA	neurons	in	the	PVO	at	2-years	of	
age	(485±58.58	compared	to	314±64.01,	a	35.3%	reduction),	but	show	no	difference	at	
55hpf	or	3-months	of	age	(Fig.6.1B).	This	suggests	that	loss	of	PINK1	does	not	alter	the	
generation	of	TPp	and	PVO	neurons	in	early	life	but	has	a	significant	effect	in	adulthood:	in	
contrast	to	pink1+/+	zebrafish,	the	TPp	and	PVO	populations	do	not	expand	in	adult	life	in	
pink1-/-	zebrafish,	resulting	in	fewer	DA	neurons	in	aged	zebrafish.	
			
Quantification	of	DC2/DC2A	DA	neurons	in	the	pink1-/-	zebrafish	shows	that	the	number	of	
DC2/DC2A	DA	neurons	does	not	increase	between	55hpf	and	3-months	of	age	(7±1.37	to	
9±1.57).	However,	between	3-months	and	24-months,	the	number	of	DA	neurons	in	the	
DC2A	population	significantly	decreases	from	9(±1.57)	to	7(±0.85)	(Fig.6.1C).	Comparison	of	
the	total	number	of	DA	neurons	at	each	time	point	between	pink1+/+	and	pink1-/-	
zebrafish	shows	that	pink1-/-	zebrafish	have	significantly	fewer	DA	neurons	in	the	DC2A	
population	at	2-years	of	age	(9±1.55	compared	to	7±0.85,	22.2%	reduction),	but	show	no	
difference	at	55hpf	or	3-months	of	age	(Fig.6.1C).	Quantification	of	DC4/DC4A	DA	neurons	
in	the	pink1-/-	zebrafish	shows	that	the	number	significantly	increases	between	55hpf	and	
3-months,	from	8(±1.95)	to	17(±2.35)	but	does	not	increase	between	3-	and	24-months	of	
age	(17±2.35	to	17±2.15)	(Fig.6.1D).	Comparison	of	the	total	number	of	DA	neurons	at	
each	time	point	between	pink1+/+	and	pink1-/-	zebrafish	shows	that	pink1-/-	zebrafish	
have	significantly	fewer	DA	neurons	in	the	DC4/DC4A	population	at	3-months	of	age	
(20±1.35	compared	to	17±2.35,	a	15%	reduction)	and	at	2-years	of	age	(22±1.17	compared	
to	17±2.15,	a	22.7%	reduction),	but	show	no	difference	at	55hpf	(Fig.6.1D).		
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Fig.	6.1:	Rostral	PT	DA	neuron	population	sizes	throughout	life	in	pink1+/+	and	pink1-/-	
zebrafish.			
A. Mean	number	of	Th1+	DA	neurons	in	the	TPp	at	55hpf,	3-	and	24-months	of	age.	In	
pink1+/+	zebrafish	(black),	the	number	of	DA	neurons	significantly	increases	between	
55hpf	and	3-months	(p=<0.0001,****,	2-way	ANOVA,	n=10	for	both)	and	between	3-
months	and	24-months	(p=0.0001,****,	2-way	ANOVA,	n=10	for	both).	In	pink1-/-	
zebrafish	(red),	the	number	of	DA	neurons	significantly	increases	between	55hpf	and	
3-months	(p=<0.0001,****,	2-way	ANOVA,	n=10	for	both)	but	not	between	3-months	
and	24-months.	pink1-/-	zebrafish	have	significantly	fewer	DA	neurons	than	pink1+/+	
zebrafish	in	the	TPp	at	2-years	of	age	(p=0.0065,**,	2-way	ANOVA,	n=10	for	both).	
Error	bars	represent	standard	deviation.	
B. Mean	number	of	Th1+	DA	neurons	in	the	PVO	at	55hpf,	3-	and	24-months	of	age.	In	
pink1+/+	zebrafish	(black),	the	number	of	DA	neurons	significantly	increases	between	
55hpf	and	3-months	(p=<0.0001,****,	2-way	ANOVA,	n=10	for	both)	and	between	3-
months	and	24-months	(p=<0.0001,****,	2-way	ANOVA,	n=10	for	both).	In	pink1-/-	
zebrafish	(red),	the	number	of	DA	neurons	significantly	increases	between	55hpf	and	
3-months	(p=<0.0001,****,	2-way	ANOVA,	n=10	for	both)	but	not	between	3-months	
and	24-months.	pink1-/-	zebrafish	have	significantly	fewer	DA	neurons	than	pink1+/+	
zebrafish	in	the	PVO	at	2-years	of	age	(p=<0.0001,****,	2-way	ANOVA,	n=10	for	both).	
Error	bars	represent	standard	deviation.	
C. Mean	number	of	Th1+	DA	neurons	in	the	DC2/DC2A	population	at	55hpf,	3-	and	24-
months	of	age.	In	pink1+/+	zebrafish	(black),	the	number	of	DA	neurons	does	not	
significantly	increase	between	55hpf	and	3-months,	or	between	3-months	and	24-
months.	In	pink1-/-	zebrafish	(red),	the	number	of	DA	neurons	does	not	significantly	
increase	between	55hpf	and	3-months,	but	significantly	decreases	between	3-months	
and	24-months	(p=0.0077,**,	2-way	ANOVA,	n=10	for	both).	pink1-/-	zebrafish	have	
significantly	fewer	DA	neurons	than	pink1+/+	zebrafish	in	the	DC2A	population	at	2-
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years	of	age	(p=0.0065,**,	2-way	ANOVA,	n=10	for	both).	Error	bars	represent	
standard	deviation.	
D. Mean	number	of	Th1+	DA	neurons	in	the	DC4/DC4A	population	at	55hpf,	3-	and	24-
months	of	age.	In	pink1+/+	zebrafish	(black),	the	number	of	DA	neurons	significantly	
increases	between	55hpf	and	3-months	(p=<0.0001,****,	2-way	ANOVA,	n=10	for	
both)	but	not	between	3-months	and	24-months.	In	pink1-/-	zebrafish	(red),	the	
number	of	DA	neurons	significantly	increases	between	55hpf	and	3-months	
(p=<0.0001,****,	2-way	ANOVA,	n=10	for	both)	but	not	between	3-months	and	24-
months.	pink1-/-	zebrafish	have	significantly	fewer	DA	neurons	than	pink1+/+	zebrafish	
in	the	DC4A	population	at	3-months	(p=0.0308,*,	2-way	ANOVA,	n=10	for	both)	and	at	
2-years	of	age	(p=<0.0001,****,	2-way	ANOVA,	n=10	for	both).	Error	bars	represent	
standard	deviation.	
	
	
	
Together	these	analyses	show	firstly	that,	like	the	pink1+/+	wild	type,	the	pink1-/-	zebrafish	
does	not	appear	to	add	to	existing	DC2/DC2A	DA	neuron	populations,	but	in	contrast	to	the	
wild	type,	displays	loss	of	DC2A	DA	neurons	in	later	life.	Secondly,	although	the	DC4/DC4A	
population	expands	between	55hpf	and	3-months	in	the	pink1-/-	zebrafish,	at	3-months	
the	number	of	DA	neurons	in	this	population	does	not	reach	that	of	the	pink1+/+	zebrafish,	
suggesting	reduced	early-life	generation	of	these	neurons.		
	
Overall,	this	data	shows	that	in	pink1+/+	zebrafish,	TPp	and	the	PVO	DA	neuron	
populations	expand	with	age,	whereas	the	DC2/DC2A	population	size	does	not	increase	and	
the	DC4/DC4A	population	displays	restricted	expansion	in	early	stages	of	life	(i.e.	before	3-
months	of	age)	but	not	in	later	stages.	My	analyses	also	show	that	pink1-/-	zebrafish	
display	comparable	expansion	of	DA	neuron	populations	in	early	life	stages	in	the	TPp	and	
PVO,	but	fail	to	expand	these	populations	in	later	stages	of	life.	Furthermore,	although	the	
DC4/DC4A	population	increases	in	size	in	early	life	stages	in	the	pink1-/-	zebrafish,	the	
maximum	number	of	DA	neurons	is	lower	than	that	of	pink1+/+	zebrafish.	Finally,	in	pink1-
/-	zebrafish,	the	DC2A	population	display	a	small	reduction	of	the	number	of	DA	neurons	in	
later	life	stages,	suggesting	that	DC2A	DA	neurons	may	be	degenerating	in	zebrafish	lacking	
functional	Pink1.		
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6.2.2	Impeded	adult	DA	neuron	generation	in	the	TPp	and	PVO	of		
pink1-/-	zebrafish	
	
Since	my	observations	show	reduced	DA	neuronal	populations	in	the	TPp	and	the	PVO	
between	3-	and	24-months	of	age,	I	next	performed	EdU	pulse-chase	analyses	on	pink1+/+	
and	pink1-/-	zebrafish	at	3-months	of	age	to	directly	compare	adult	DA	neuronal	
generation	in	these	populations.	To	achieve	this,	pink1+/+	and	pink1-/-	zebrafish	were	
injected	with	EdU	once	daily	for	3-days	and	culled	5-days	post	injection,	and	the	number	of	
Th1+EdU+	neurons	was	quantified	in	consecutive	sections	through	the	TPp	and	the	PVO.	
Quantification	shows	that	the	number	of	newly	generated	Th1+EdU+	DA	neurons	is	
significantly	decreased,	both	in	the	TPp	of	pink1-/-	zebrafish	(1.5±0.29)	compared	to	
pink1+/+	zebrafish	(3.0±0.37)(Fig.6.2A),	and	in	the	PVO	of	pink1-/-	zebrafish	(4.9±0.46)	
compared	to	pink1+/+	zebrafish	(8.6±0.94)(Fig.6.2B).	This	confirms	that	generation	of	DA	
neurons	is	impeded	in	the	TPp	and	the	PVO	of	adult	pink1-/-	zebrafish.		
	
Fig.	6.2:	Zebrafish	lacking	functional	Pink1	have	impeded	generation	of	DA	neurons	in	the	
TPp	and	the	PVO	of	the	rostral	PT.		
A. Mean	number	of	Th1+EdU+	DA	neurons	in	the	TPp	at	3-months	of	age.	The	number	of	
newly	generated	DA	neurons	is	significantly	decreased	pink1-/-	zebrafish	compared	to	
pink1+/+	zebrafish	(p=0.0078,	**,	unpaired	t-test,	n=9).	Error	bars	represent	standard	
deviation.	
B. Mean	number	of	Th1+EdU+	DA	neurons	in	the	PVO	at	3-months	of	age.	The	number	of	
newly	generated	DA	neurons	is	significantly	decreased	pink1-/-	zebrafish	compared	to	
pink1+/+	zebrafish	(p=0.0017,	**,	unpaired	t-test,	n=9).	Error	bars	represent	standard	
deviation.	
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I	next	asked	whether	loss	of	Pink1	results	in	overall	defects	in	proliferation	in	the	TPp	and	
PVO.	To	analyse	this,	I	quantified	the	number	of	EdU+	cells	in	the	TPp	and	the	PVO	in	3-
month	old	pink1+/+	and	pink1-/-	zebrafish.	This	shows	no	significant	difference	in	the	
number	of	EdU+	cells	in	the	TPp	of	pink1-/-	zebrafish	(149±16.95)	compared	to	pink1+/+	
zebrafish	(171.8±16.50)(Fig.	6.3A)	or	in	the	PVO	of	pink1-/-	zebrafish	(128±8.95)	compared	
to	pink1+/+	zebrafish	(142±12.02)(Fig.	6.3B).	This	shows	that,	although	loss	of	Pink1	results	
in	impeded	generation	of	DA	neurons	in	adult	zebrafish,	its	loss	does	not	alter	overall	
levels	of	proliferation	in	the	rostral	PT.	
	
Together	this	data	shows	that	the	generation	of	adult	DA	neurons	is	impeded	in	the	TPp	
and	the	PVO	of	pink1-/-	zebrafish,	but	this	is	not	caused	by	overall	decreases	in	
proliferation.	
	
	
Fig.	6.3:	Loss	of	functional	Pink1	does	not	alter	overall	levels	of	proliferation	in	the	TPp	
and	the	PVO	of	the	rostral	PT.		
A. Mean	number	of	EdU+	cells	in	the	TPp	at	3-months	of	age.	The	overall	number	of	
newly	generated	cells	is	not	significantly	different	in	pink1-/-	zebrafish	compared	to	
pink1+/+	zebrafish.	Error	bars	represent	standard	deviation.	Statistically	analysed	by	
unpaired	t-test,	n=9	for	both	genotypes.	
B. Mean	number	of	EdU+	cells	in	the	PVO	at	3-months	of	age.	The	overall	number	of	
newly	generated	cells	is	not	significantly	different	in	pink1-/-	zebrafish	compared	to	
pink1+/+	zebrafish.	Error	bars	represent	standard	deviation.	Statistically	analysed	by	
unpaired	t-test,	n=9	for	both	genotypes.	
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6.2.3	Analysis	of	cell	death	in	pink+/+	and	pink1-/-	zebrafish	
	
My	analyses	(section	6.2.1)	show	that	pink1-/-	zebrafish	fail	to	expand	DA	neuronal	
population	sizes	in	the	rostral	PT	after	3-months	of	age	and	show	(section	6.2.2)	that	this	is	
due,	at	least	in	part,	to	the	decreased	de	novo	generation	of	DA	neurons	in	adulthood.	
Nonetheless,	this	does	not	preclude	the	possibility	that	loss	of	functional	Pink1	may	also	
result	in	reduced	survival	of	newborn	neurons.		The	apoptosis	of	differentiated	neurons	
may	accompany	impeded	DA	generation,	resulting	in	a	shift	in	the	balance	of	generation	
and	degeneration.	To	determine	whether	newly	generated	DA	neurons	undergo	apoptosis	
(programmed	cell	death)	in	pink1-/-	zebrafish,	I	performed	antibody	labelling	with	cleaved	
caspase-3	(cCaspase)	in	zebrafish	injected	with	EdU	(as	in	section	6.2.2).	Cleaved	caspase-3	
is	an	indicator	of	apoptotic	events	and	is	a	widely-used	marker	for	cells	undergoing	
programmed	cell	death	(Porter	&	Jänicke,	1999).	A	positive	control	is	crucial	when	
performing	apoptosis	experiments,	to	ensure	that	any	negative	observations	are	not	due	
to	failure	of	apoptotic	assay.	Therefore,	I	first	aimed	to	determine	that	I	could	demonstrate	
robust	cCaspase	labelling.		
	
	Zebrafish	embryos	with	an	rx3	gene	knockout	(also	termed	chk	mutants)	have	been	
previously	shown	to	display	increased	cell	death	in	the	hypothalamus	(Muthu	et	al.,	2016),	
therefore	I	used	this	line	as	a	positive	control	for	cCaspase	labelling.	Brain	sections	from	
chk-/-	55hpf	zebrafish	embryos	(as	used	in	Muthu	et	al.,	2016)	show	clear	examples	of	
cCaspase+	cells	in	the	hypothalamus,	compared	to	no	labelling	in	chk+/+	embryos	
(Fig.6.4A,B,	yellow	arrowheads).	This	shows	that	I	can	robustly	demonstrate	cCaspase	
labelling	in	a	positive	control.	Next,	I	performed	cCaspase	labelling	on	3-month	old	
pink1+/+	zebrafish	injected	with	EdU	(as	in	section	6.2.2).	No	cCaspase+EdU+Th1+	cells	were	
observed	in	either	the	TPp	(Fig.6.5Ai-iv,	yellow	arrowheads)	or	the	PVO	(Fig.6.5Bi-iv,	yellow	
arrowheads)	in	3-month	old	zebrafish,	suggesting	newborn	DA	neurons	are	not	undergoing	
apoptosis	in	pink1-/-	zebrafish.	
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Fig.	6.4:	Cleaved	caspase-3	labelling	in	chk-/-	zebrafish	embryos	as	a	positive	control.	
A. Fluorescent	MIP	of	a	transverse	section	through	the	hypothalamus	of	the	55hpf	chk+/+	
embryo,	labelled	with	DAPI	(blue),	Th1	(green)	and	cleaved	caspase-3	(red).	No	cleaved	
caspase-3+	cells	are	observed	in	the	hypothalamus	of	chk+/+	zebrafish	embryos.	Scale	
bar	represents	20μm.	 	
B. Fluorescent	MIP	of	a	transverse	section	through	the	hypothalamus	of	the	55hpf	chk-/-	
embryo,	labelled	with	DAPI	(blue),	Th1	(green)	and	cleaved	caspase-3	(red).	Cleaved	
caspase-3+	cells	are	observed	in	the	hypothalamus	of	chk-/-	zebrafish	embryos.	Scale	
bar	represents	20μm.	 	
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To	ask	whether	the	absence	of	Pink1	promotes	or	triggers	apoptosis,	I	performed	cCaspase	
labelling	of	DA	at	three	stages	throughout	adult	life:	3-,	6-	and	24-months,	and	quantified	
the	number	of	cCaspase+Th1+	cells	in	all	four	populations	of	the	rostral	PT	in	both	pink1+/+	
and	pink1-/-	zebrafish.	No	cCaspase+Th1+	cells	were	detected	in	TPp,	DC2A	or	DC4A	DA	
neuron	populations	at	any	time	point	(not	shown)	in	fish	of	either	genotype.	In	the	3-
month	old	PVO	a	low	number	of	cCaspase+Th1+	cells	were	detected	in	pink1+/+	zebrafish	
(1±0.55),	with	a	higher	number	detected	in	pink1-/-	zebrafish	(7±4.75)(Fig6.6A),	although	
this	did	not	reach	significance.	This	data	is	skewed	by	one	individual,	in	which	a	high	
number	of	cCaspase+Th1+	cells	were	detected	in	the	PVO	(an	example	of	a	section	through	
the	PVO	of	this	individual	is	shown	in	Fig.6.7,	yellow	arrowheads).	At	6-months	of	age,	a	
low	number	of	cCaspase+Th1+	cells	were	detected	in	the	PVO	in	both	pink1+/+	(1.5±0.5)	
and	pink1-/-	zebrafish	(1.5±0.5)(Fig.6.6B),	with	no	statistical	difference	between	
genotypes.	At	24-months	of	age,	a	low	number	of	cCaspase+Th1+	cells	were	detected	in	the	
PVO	in	both	pink1+/+	(0.5±0.5)	and	pink1-/-	zebrafish	(0.5±0.5)(Fig.6.6C),	again	with	no	
statistical	difference	between	genotypes.		
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Fig.	6.6:	Both	pink1+/+	and	pink1-/-	zebrafish	show	low	levels	of	apoptosis	in	the	PVO	
throughout	life,	where	a	small	number	of	pink1-/-	zebrafish	display	increased	apoptosis	
in	the	3-month	PVO.	
A. Mean	number	of	Th1+cCaspase+	DA	neurons	in	the	PVO	at	3-months	of	age.	The	
number	of	apoptotic	DA	neurons	is	not	significantly	different	in	pink1-/-	zebrafish	
compared	to	pink1+/+	zebrafish.	One	individual	skews	the	data.	Error	bars	represent	
range,	n=5	for	both	genotypes.	
B. Mean	number	of	Th1+cCaspase+	DA	neurons	in	the	PVO	at	6-months	of	age.	The	
number	of	apoptotic	DA	neurons	is	not	significantly	different	in	pink1-/-	zebrafish	
compared	to	pink1+/+	zebrafish.	Error	bars	represent	range,	n=2	for	both	genotypes.	
C. Mean	number	of	Th1+cCaspase+	DA	neurons	in	the	PVO	at	24-months	of	age.	The	
number	of	apoptotic	DA	neurons	is	not	significantly	different	in	pink1-/-	zebrafish	
compared	to	pink1+/+	zebrafish.	Error	bars	represent	range,	n=2	for	both	genotypes.	
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Together,	this	data	shows	that	there	is	no	evidence	that	newly	generated	DA	neurons	in	
the	TPp	and	the	PVO	undergo	apoptosis	in	the	adult	pink1-/-	zebrafish.	Furthermore,	there	
is	no	evidence	for	increased	apoptosis	of	any	ascending	DA	neuron	(i.e.	either	newly-born	
or	previously	generated	neuron	in	the	TPp,	DC2A	and	DC4A	populations)	in	the	pink1-/-	
zebrafish	at	young	or	late	adult	stages.	In	the	locally	projecting	PVO,	DA	neuron	apoptosis	
was	observed	in	a	pink1-/-	individual	at	3-months	of	age.	This	suggests	loss	of	Pink1	may	
result	in	increased	cell	death	in	the	PVO	in	a	small	number	of	individuals,	though	this	
requires	further	investigation.		
	
6.2.4	Analysis	of	progenitor	populations	in	pink+/+	and	pink1-/-	zebrafish	
	
My	analysis	of	the	generation	of	DA	neurons	in	pink1-/-	zebrafish	shows	that	adult	DA	
neurogenesis	is	impeded	with	loss	of	functional	Pink1,	whereas	developmental	generation	
of	DA	neurons	appears	to	be	unaltered.	Therefore,	I	next	hypothesised	that	the	impeded	
adult	generation	of	DA	neurons	in	pink1-/-	zebrafish	may	result	from	alterations	to	a	
distinct	population	of	adult	DA	progenitors.		
	
In	chapter	4,	I	showed	that	OTPb	is	expressed	in	DA	neurons	in	the	TPp	(i.e.	the	large	
population	of	ascending	neurons	that	display	de	novo	neurogenesis	throughout	life)	in	
adulthood,	but	not	in	DC1	DA	neurons	during	development.	This	suggests	that	adult	TPp	
DA	neurons	may	arise	from	progenitors	that	are	distinct	from	embryonic	DC1	DA	neuron	
progenitors.	I	therefore	aimed	to	quantify	OTPb+	progenitors	in	pink1+/+	and	pink1-/-	
zebrafish	at	an	early	adult	time-point	(when	there	are	no	obvious	differences	in	TPp	DA	
population	size	in	the	two	genotypes)	and	a	late	adult	time-point	(when	there	are	
difference	in	TPp	DA	population	size	in	the	two	genotypes).	To	achieve	this,	anti-Th1	and	
anti-OTPb	immunohistochemistry	was	performed	in	brain	sections	through	the	TPp	of	3-
month	old	and	24-month	old	pink1+/+	and	pink1-/-	zebrafish.	Subsequently,	the	number	of	
OTPb+	Th1+	DA	neurons	and	the	number	of	OTPb+	Th1-	progenitors	was	quantified	in	the	
TPp	at	both	ages.	At	3-months	of	age,	pink1-/-	zebrafish	have	a	reduced	population	of	
OTPb+	Th1-	progenitors	in	the	TPp	(844±26.5)	compared	to	pink1+/+	siblings	(1342±83)	but	
there	is	no	difference	in	the	number	of	OTPb+	Th1+	DA	neurons	in	pink1-/-	zebrafish	
(271.5±31.5)	compared	to	pink1+/+	siblings	(271.5±31.5)(Fig.6.8A).	By	contrast,	at	2-years	
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of	age,	pink1-/-	zebrafish	have	reduced	populations,	both	of	OTPb+	Th1-	progenitors	
(730.3±142.8)	compared	to	pink1+/+	siblings	(1237±96.29),	and	of	OTPb+	Th1+	DA	neurons	
(435±37.73)	compared	to	pink1+/+	siblings	(315.3±28.89)(Fig.6.8B).	Thus,	pink1-/-	
zebrafish	have	a	reduced	population	of	OTPb+	progenitors	in	the	TPp	at	both	early	adult	
and	late	adult	life	stages	and	a	reduced	population	of	OTPb+Th1+	DA	neurons	in	later	life.	
Together	this	suggests	that	Pink1	is	required	for	the	generation	of	an	adult	OTPb+	
population	of	DA	progenitors.		
	
	
	
	
	
	
	
	
	
	
	
	 168	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Fig.	6.8:	Reduced	population	of	OTPb+	progenitors	in	the	TPp	of	pink1-/-	zebrafish	at	3-
months	and	24-months	of	age.	
A. Mean	number	of	OTP+Th1-	progenitors	and	OTP+Th1+	DA	neurons	in	the	TPp	at	3-
months	of	age.	The	number	of	OTP+Th1-	progenitors	is	significantly	decreased	in	the	
TPp	of	pink1-/-	zebrafish	compared	to	pink1+/+	zebrafish	(p=0.0292,*,	unpaired	t-test),	
but	no	significant	difference	in	the	number	of	OTP+Th1+	DA	neurons.	Error	bars	
represent	standard	deviation,	n=2	for	both	genotypes.	
B. Mean	number	of	OTP+Th1-	progenitors	and	OTP+Th1+	DA	neurons	in	the	TPp	at	24-
months	of	age.	The	number	of	OTP+Th1-	progenitors	is	significantly	decreased	in	the	
TPp	of	pink1-/-	zebrafish	compared	to	pink1+/+	zebrafish	(p=0.0259,*,	unpaired	t-test),	
and	the	number	of	OTP+Th1+	DA	neurons	is	significantly	decreased	(p=0.0453,*,	
unpaired	t-test).	Error	bars	represent	standard	deviation,	n=4	for	both	genotypes.	
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6.3:	Discussion		
	
In	chapter	5,	I	showed	that	new	DA	neurons	are	newly	generated	in	adulthood	in	two	
rostral	PT	populations:	the	ascending	TPp	and	the	locally	projecting,	hypothalamic-like,	
PVO.	The	aim	of	this	chapter	was	to	determine	whether	de	novo	DA	neuronal	generation	is	
altered	in	a	model	of	PD,	the	pink1-/-	zebrafish.	To	achieve	this,	neurogenesis	of	DA	
neurons	in	pink1+/+	and	pink1-/-	zebrafish	was	analysed	by	quantification	of	DA	
population	size,	EdU	pulse-chase	experiments,	investigations	into	cell	death	and	analyses	
of	progenitor	populations.		
	
First,	my	analyses	of	DA	neuronal	population	size	in	the	rostral	PT	showed	that	in	pink1+/+	
zebrafish,	TPp	and	the	PVO	DA	neuron	populations	expand	with	age,	whereas	the	
DC2/DC2A	population	size	does	not	increase	and	the	DC4/DC4A	population	displays	
restricted	expansion	in	early	stages	of	life,	but	not	in	adulthood.	The	growth	in	size	of	the	
TPp	and	the	PVO	suggests	that	DA	neurons	are	added	to	existing	populations,	rather	than	
replacing	DA	neurons	in	the	population.	This	data	agrees	with	my	EdU	pulse-chase	analyses	
of	DA	neuron	generation	(section	5.2.2),	which	shows	that	DA	neurons	are	generated	in	
the	TPp	and	the	PVO	at	3,	6	and	12-months	of	age.	In	contrast,	magnocellular	DA	neuron	
populations	show	little	or	no	increase	in	population	size	in	adulthood.	Together	with	my	
EdU	analyses	in	chapter	5	(section	5.2.2)	demonstrating	no	EdU	labelling	in	DC2A	or	DC4A	
populations,	this	suggests	that	new	DA	neurons	are	not	added	to	these	populations	in	
adult	life.	This	further	suggests	that	the	same,	relatively	small	populations	of,	DC2A	or	DC4A	
DA	neurons	are	retained	throughout	adult	life	and	are	not	turned	over.		
	
Next,	my	analyses	of	DA	neuronal	population	size	in	pink1-/-	zebrafish	revealed	that	pink1-
/-	zebrafish	display	comparable	expansion	of	DA	neuron	populations	in	early	life	stages	in	
the	TPp	and	PVO,	but	fail	to	expand	these	populations	in	adult	stages	of	life	(i.e.	between	
3-	and	24-months).	This	suggests	that	loss	of	Pink1	results	in	impeded	adult	generation	of	
DA	neurons	in	these	populations,	resulting	in	a	smaller	population	sizes	at	24-months.	This	
equates	to	around	a	16%	reduction	in	the	TPp,	and	around	35%	reduction	in	the	PVO.	This	
could	have	significant	impact	on	DA	function.		
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Furthermore,	my	data	shows	that,	although	the	DC4/DC4A	population	increases	in	size	in	
early	life	stages	in	the	pink1-/-	zebrafish,	the	number	of	DA	neurons	at	3-months	is	lower	
than	that	of	pink1+/+	zebrafish.	This	suggests	that	loss	of	Pink1	results	in	impeded	early	life	
expansion	of	DC4	DA	neurons,	resulting	in	a	smaller	population	size	at	3-months	and	at	24-
months.	This	equates	to	a	15-22%	difference	in	population	size.	Additionally,	my	data	
shows	that	in	pink1-/-	zebrafish,	the	DC2A	population	equally	does	not	increase	size	in	early	
life,	but	displays	a	small	reduction	in	size	in	later	life	stages	(i.e.	between	3-	and	24-
months).	This	suggests	that	DC2A	DA	neurons	may	be	degenerating	in	zebrafish	lacking	
functional	Pink1.	Since	my	analyses	in	pink1+/+	zebrafish	shows	that	DC2	DA	neurons	are	
generated	early	and	the	population	does	not	appear	to	turn	over,	this	suggests	that	the	
DC2/DC2A	population	may	be	particularly	susceptible	to	degeneration,	where	lost	DA	
neurons	are	not	replaced.	The	relatively	small	size	of	the	DC2/DC2A	population	means	that	
a	loss	of	even	a	small	number	of	DA	neurons	in	the	pink1-/-	zebrafish,	equates	to	around	a	
22%	reduction	in	population	size.	Again,	this	could	have	significant	impact	on	DA	function.		
	
Since	my	observations	showed	reduced	DA	neuron	population	size	in	the	TPp	and	the	PVO,	
I	next	assessed	DA	neuron	generation	directly	by	EdU	analyses	in	pink1+/+	and	pink1-/-	
zebrafish.	My	studies	showed	reduced	generation	of	DA	neurons	in	the	TPp	and	the	PVO	of	
pink1-/-	zebrafish,	compared	to	pink1+/+	zebrafish.	This	agrees	with	my	data	from	section	
6.2.1,	confirming	that	loss	of	functional	Pink1	results	impedes	generation	of	DA	neurons	in	
one	ascending	DA	neuron	population	(the	TPp)	and	in	one	hypothalamic-like	population	
(the	PVO).	My	data	further	show	that	there	is	no	difference	in	overall	levels	of	proliferation	
in	pink1+/+	and	pink1-/-	zebrafish	in	the	PT,	suggesting	that	loss	of	Pink1	does	not	interfere	
with	proliferative	mechanisms	in	a	non-specific	manner.				
	
My	analyses	(section	6.2.1)	show	that	pink1-/-	zebrafish	fail	to	expand	DA	neuronal	
population	sizes	in	the	rostral	PT	after	3-months	of	age	and	show	(section	6.2.2)	that	this	is	
due,	at	least	in	part,	to	that	the	decreased	de	novo	generation	of	DA	neurons	in	adulthood.	
I	next	assessed	whether	loss	of	functional	Pink1	also	increased	cell	death,	contributing	to	a	
shift	in	the	balance	of	generation	and	degeneration,	either	by	the	reduced	survival	of	
newborn	neurons,	or	by	increased	apoptosis	of	existing	populations.	My	data	shows	no	
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evidence	that	newly	generated	DA	neurons	in	the	TPp	and	the	PVO	undergo	apoptosis	in	
the	adult	pink1-/-	zebrafish.	This	suggests	that	the	impeded	generation	of	DA	neurons	
observed	in	pink1-/-	zebrafish	is	not	due	to	reduced	survival	of	newly	generated	neurons.		
	
Furthermore,	my	data	shows	no	evidence	for	increased	apoptosis	of	any	ascending	DA	
neuron	(i.e.	either	newly-born	or	previously	generated	neuron	in	the	TPp,	DC2A	and	DC4A	
populations)	in	the	pink1-/-	zebrafish	at	young	or	late	adult	stages.	For	the	DC2A	DA	neuron	
population,	this	result	does	not	agree	with	my	previous	data	that	shows	no	generation	of	
DC2A	DA	neurons	but	a	reduced	population	size	in	pink1-/-	zebrafish.	However,	the	
reduction	in	population	size	was	small,	equating	to	around	2	neurons.	It	is	likely	that	DA	
neuronal	death	occurred	at	an	age	that	I	did	not	investigate:	indeed,	the	cCaspase	assay	is	
limited	in	providing	a	‘snapshot’	of	cell	death	at	the	time	of	fixation.	Likewise,	it	is	possible	
that	this	assay	also	did	not	allow	labelling	of	cell	death	in	the	DC4A	population,	which	
showed	a	modest	reduction	in	population	size	of	around	3-5	DA	neurons	in	pink1-/-	
zebrafish.	In	the	third	and	largest	population	of	ascending	DA	neurons	(the	TPp)	however,	
my	observation	of	no	cell	death	together	with	my	observation	of	reduced	generation	
(section	6.2.2)	suggests	that	the	reduced	population	sizes	of	these	neurons	in	pink1-/-	
zebrafish	may	be	caused	by	impeded	DA	generation,	rather	than	solely	by	high	levels	of	
cell	death.		
	
In	the	locally	projecting,	hypothalamic-like	PVO,	a	high	level	of	DA	neuron	apoptosis	was	
observed	in	one	pink1-/-	individual	at	3-months	of	age.	This	suggests	that	loss	of	Pink1	may	
result	in	increased	cell	death	in	the	PVO	in	a	small	number	of	individuals.	Indeed,	the	PVO	
in	pink1-/-	zebrafish	displayed	the	largest	reduction	in	population	size	in	aged	fish,	
equating	to	around	a	35%	decrease.	This	suggests	that	increased	cell	death	of	PVO	DA	
neurons	may	accompany	their	impeded	generation	(section	6.2.2).	It	is	possible	that	the	
position	and	morphology	of	DA	neurons	in	the	PVO	contributes	to	their	susceptibility	to	
cell	death,	as	these	neurons	contact	the	CSF,	and	so	may	be	directly	influenced	by	CSF-
signals.	Since	I	only	observed	the	increase	in	cell	death	in	one	individual,	this	requires	
further	investigation.	However,	since	this	population	is	not	part	of	the	ascending	DA	
neuron	system	and	is	more	hypothalamic	in	nature,	I	did	not	pursue	this	further.		
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In	chapter	4,	I	showed	that	OTPb	is	expressed	in	DA	neurons	in	the	TPp	in	adulthood,	but	
not	by	DC1	DA	neurons	during	development.	Therefore,	my	data	suggests	that	adult	TPp	
DA	neurons	most	likely	arise	from	OTPb-expressing	progenitors	that	are	distinct	from	
embryonic	DC1	DA	neuronal	progenitors.	I	therefore	aimed	to	quantify	OTPb+	progenitors	
in	pink1+/+	and	pink1-/-	zebrafish	at	an	early	adult	time-point	(when	there	are	no	obvious	
differences	in	TPp	DA	population	size	between	the	two	genotypes)	and	a	late	adult	time-
point	(when	there	are	differences	in	TPp	DA	population	size	between	the	two	genotypes).	
My	analyses	showed	that	pink1-/-	zebrafish	have	a	reduced	population	of	OTPb+	
progenitors	in	the	TPp	at	both	early	adult	and	late	adult	life	stages.	This	suggests	that	Pink1	
is	required	for	the	generation	of	an	adult	OTPb+	population	of	progenitors.	Together,	this	
suggests	that	loss	of	Pink1	results	in	a	reduced	population	of	OTPb	progenitors	in	early	life,	
which	may	directly	result	in	reduced	generation	of	DA	neurons.	Reduced	generation	may	
consequently	result	in	failed	expansion	of	the	ascending	population	of	TPp	DA	neurons,	
and	subsequently	a	reduced	population	size	in	later	life.		
	
In	summary,	these	analyses	provide	four	main	conclusions.	First,	whilst	one	of	the	
ascending	populations	(the	TPp)	and	the	local-projecting	PVO	expand	in	adulthood	in	
pink1+/+	zebrafish,	in	pink1-/-	zebrafish,	these	populations	fail	to	expand	in	adult	life.	
Furthermore,	ascending	DC2A	DA	neurons	are	lost	in	adult	life	in	pink1-/-	zebrafish.	Second,	
pink1-/-	zebrafish	have	reduced	adult	generation	of	TPp	and	PVO	DA	neurons.	Third,	newly	
generated	ascending	DA	neurons	in	pink1-/-	zebrafish	do	not	undergo	apoptosis,	and	there	
is	no	increased	cell	death	in	the	TPp,	suggesting	that	reduced	population	size	of	the	TPp	is	
not	caused	by	high	levels	of	cell	death.	In	the	locally	projecting	PVO	however,	increased	
cell	death	may	accompany	impeded	generation.	Fourth,	Pink1	is	required	for	the	
generation	of	adult	OTPb-expressing	progenitors.	
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Chapter	7	
	
	
The	zebrafish	as	a	model	for	Leucine-rich	Repeat	
Kinase-2	(Lrrk2)	deficiency	
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7.1:	Introduction		
	
Mutations	in	the	leucine-rich	repeat	kinase	2	(LRRK2)	are	the	most	common	known	cause	
of	monogenic-inherited	PD,	explaining	between	5-13%	of	familial	and	1-5%	of	sporadic	PD.	
Patients	with	LRRK2	mutations	typically	develop	late-onset	PD,	presenting	with	the	
classical	symptoms	and	signs	of	the	disease	(Kumari	&	Tan,	2009).	The	most	common	
LRRK2	mutation,	the	G2019S	mutation,	results	in	increased	kinase	activity,	due	to	the	
mutation	introducing	a	phosphorylation	site	in	the	kinase	domain	of	the	protein	(Luzón-
Toro	et	al.,	2007).	Although	gain	of	function	mutations	show	the	role	of	LRRK2	in	PD,	the	
biological	role	of	LRRK2	remains	relatively	unclear.	I	therefore	aimed	to	generate	a	
zebrafish	lrrk2	knockout	line,	to	allow	future	investigations	into	the	function	of	Lrrk2	in	
vivo.		
	
7.2:	Zebrafish	lrrk2	orthologue	identification	and	expression	
	
To	identify	the	zebrafish	orthologue	of	LRRK2,	the	sequence	of	the	human	protein	
(ENSP00000298910)	was	aligned	to	the	zebrafish	proteome	using	BLASTP	software.	The	
top	hit	of	this	search	was	annotated	as	Lrrk2	in	the	zebrafish	proteome	
(ENSDARP00000018692),	with	approximately	54%	homology	to	the	human	LRRK2	protein.	
To	further	validate	this,	the	zebrafish	Lrrk2	orthologue	sequence	was	aligned	to	the	human	
proteome,	identifying	the	top	hit	as	the	human	LRRK2	protein	(ENSP00000298910).	From	
ENSEMBL	software,	human	LRRK2	and	zebrafish	lrrk2	have	similar	genetic	structures:	a	
similar	protein	size	(human	2527aa	and	zebrafish	2532aa),	exon	number	(human	51	exons,	
zebrafish	52	exons)	and	transcript	length	(human	9158bp,	zebrafish	8042bp).	Furthermore,	
human	LRRK2	and	Zebrafish	Lrrk2	both	contain	comparable	protein	domains,	namely,	an	
Ankyrin	repeat	domain	(ANK),	a	leucine-rich	repeat	domain	(LRR),	a	Roc	domain,	a	C-
terminal	of	Roc	(COR)	domain,	a	kinase	domain	and	a	WD40-repeat-containing	domain	
(figure	7.1).		
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Human	LRRK2	may	be	alternatively	spliced	into	4	protein	coding	variants,	ranging	in	size	
from	521-2527	amino	acids,	where	the	major	isoform	is	2527	amino	acids	in	length.	
Zebrafish	Lrrk2	may	be	alternatively	spliced	into	3	different	protein	coding	isoforms,	all	of	
which	are	2532	amino	acids	in	length.	To	further	validate	orthology,	zebrafish	lrrk2	and	
human	LRRK2	genetic	loci	were	compared,	to	determine	whether	synteny	exists	between	
genes.	SLC2A13	was	found	to	be	present	in	both	organisms,	located	upstream	of	human	
LRRK2,	yet	downstream	of	lrrk2	in	zebrafish.	No	other	genes	could	be	located	up	to	500kb	
upstream	or	downstream	of	LRRK2/lrrk2	that	were	present	in	both	humans	and	zebrafish	
(figure	7.2).	
Figure	7.1:	Protein	domains	of	human	and	zebrafish	LRRK2/Lrrk2.		
Schematic	demonstrating	domains	within	human	LRRK2	(top)	and	zebrafish	(Zf)	Lrrk2	
(bottom).	
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To	determine	whether	lrrk2	is	expressed	during	development	and	during	adulthood,	lrrk2	
cDNA	from	zebrafish	embryos	(aged	1-,2-,3-,4-	and-5-dpf)	and	lrrk2	cDNA	from	adult	brains	
(3-,6-,9-,12-	and	24-months	of	age)	was	amplified	using	RT-PCR.	Expression	of	lrrk2	was	
detected	at	a	constant	level	in	zebrafish	aged	from	1-5dpf,	with	slightly	higher	expression	
detected	in	adult	zebrafish	brains.	Expression	of	lrrk2	between	3-	and	24-months	of	age	
remained	relatively	constant	(figure	7.3).		
Figure	7.2:	Genomic	loci	of	human	and	zebrafish	LRRK2/lrrk2.		
A:	schematic	demonstrating	position	of	human	LRRK2	and	zebrafish	lrrk2	within	respective	
chromosomes	(indicated	by	red	box).	
	B:	schematic	comparing	genomic	loci	of	human	LRRK2	(top)	and	zebrafish	lrrk2	(bottom)	
orthologues,	coloured	boxes	indicate	surrounding	protein	coding	genes	
	
.	
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7.3:	Using	the	CRISPR/Cas9	system	to	generate	a	lrrk2	knockout	
zebrafish	line	
	
7.3.1:	Introduction	to	CRISPR/Cas9	genome	editing	
	
In	recent	years,	genome	editing	techniques	have	advanced	greatly,	allowing	the	
introduction	of	site-specific	mutations	within	target	genes.	One	such	technique,	CRISPR	
(clustered	regularly	interspaced	short	palindromic	repeats)/Cas9	(CRISPR-associated	
protein-9),	has	become	a	widely-used	device	for	research	in	genetic	disease.	CRISPR/Cas	is	
a	system	that	is	present	in	bacteria,	as	part	of	prokaryotic	immunity	against	viral	
integration	into	the	bacterial	genome.	Briefly,	short	fragments	of	viral	DNA	are	
incorporated	into	the	bacterial	genome	between	short	palindromic	repeats.	Transcribed	
RNA	from	these	sequences	are	used	as	guide	RNA,	and	in	conjunction	with	Cas	proteins,	
allow	recognition	and	cleavage	of	any	invading	nucleic	acids.	This	provides	an	adaptive	
immune	system	against	viral	infection	(Bhaya	et	al.,	2011).		
Figure	7.3:	Expression	of	lrrk2	during	embryonic	development	and	in	entire	brains	from	adult	
zebrafish	at	various	ages.		
RT-PCR	using	cDNA	from	1-5dpf	zebrafish	(left)	and	brains	from	3-24-month	zebrafish	(right),	
with	ef1a as	a	loading	control.			
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This	system	has	recently	been	adapted	to	use	in	eukaryotes,	including	model	organisms,	to	
generate	site-specific	mutations	in	model	organisms.	In	this	adaption,	the	guide	RNA	
sequence	is	altered,	to	allow	targeted	binding	and	cleavage	of	genomic	DNA.	To	achieve	
this,	an	ultramer	is	generated,	containing	a	T7	promoter,	a	target	sequence	and	a	guide	
RNA	(gRNA)	scaffold	(figure	7.4).	The	target	sequence	must	be	unique,	thus	only	resulting	
in	site-specific	cleavage,	and	must	be	immediately	upstream	of	a	protospacer	adjacent	
motif	(PAM)	site,	to	allow	binding	of	the	gRNA-Cas9	complex	(for	Cas9,	the	PAM	sequence	
is	5’	NGG).	The	target	sequence	binds	to	the	desired	site	within	genomic	DNA,	and	the	
guide	RNA	scaffold	recruits	Cas9	endonuclease.	Cas9	cleaves	the	DNA	3	nucleotide	bases	
upstream	of	the	PAM	site	(figure	7.5).	This	cleavage	results	in	activation	of	error	prone	
DNA	repair	mechanisms,	introducing	mutations	into	the	targeted	site	(Wang	et	al.,	2016).	
	
	
	
Figure	7.4:	The	CRISPR/Cas9	genome	editing	system	–	structure	of	ultramer.	
	Schematic	showing	the	structure	of	an	ultramer,	containing	a	T7	promoter	(green),	a	
customized	target	sequence	(red)	and	a	gRNA	scaffold	(blue).	This	ultramer	allows	transcription	
of	the	guide	RNA	that	can	be	injected	into	model	organisms	
.	
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7.3.2:	Design	of	CRISPR/Cas9	target	site	in	the	lrrk2	gene	
	
To	allow	identification	of	successful	CRISPR/Cas9-mediated	mutation,	PAM	sites	located	
close	to	large	restriction	enzyme	sites	(such	as	Mwo1	and	Bsl1)	are	preferable,	so	that	
successful	mutation	will	result	in	disruption	of	the	restriction	enzyme	cut	site.	Since	Bsl1	
sites	contain	PAM	sites	within	the	recognition	sequence	(CCNNNNNNNGG),	a	gRNA	was	
designed	to	a	Bsl1	restriction	enzyme	site	in	exon	20	of	the	zebrafish	lrrk2	gene	(figure	
7.6).	Targeting	this	region	should	result	in	cleavage	of	gDNA	within	the	Bsl1	restriction	site,	
with	introduced	mutations	resulting	in	disruption	of	this	recognition	sequence,	and	an	
inability	of	Bsl1	to	cut	the	DNA.	According	to	Ensembl	software,	exon	20	encodes	a	region	
of	the	Ankyrin	repeat	domain,	the	first	Lrrk2	protein	domain.	The	aim	of	targeting	this	exon	
was	to	create	a	deletion	or	insertion,	causing	a	frameshift	mutation	and	introducing	a	
premature	stop	codon.	This	would	theoretically	ultimately	result	in	a	truncated	Lrrk2	
protein.	
	
Figure	7.5:	Mechanism	of	CRISPR/Cas9	cleavage.		
Schematic	showing	the	guide	RNA	binding	to	the	target	sequence,	allowing	
recruitment	of	Cas9	endonuclease	and	resulting	in	site-specific	cleavage	of	genomic	
DNA	
.	
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7.3.3:	Injection	and	testing	efficiency	of	CRISPR/Cas9–mediated	mutation	of	lrrk2	
	
The	gRNA	was	injected	into	one-cell	stage	wild-type	zebrafish	embryos,	and	to	test	the	
efficiency	of	the	CRISPR,	genomic	DNA	(gDNA)	was	extracted	from	24hpf	injected	and	
uninjected	control	zebrafish.	Exon	20	of	lrrk2	was	amplified	by	PCR	and	digested	with	Bsl1,	
and	PCR	products	were	run	on	an	analytical	gel	to	determine	if	the	restriction	site	had	
been	disrupted	in	CRISPR-injected	zebrafish	(figure	7.7).	PCR	products	from	uninjected	and	
undigested	embryos	produced	a	160bp	fragment,	whereas	PCR	products	from	uninjected	
and	Bsl1	treated	embryos	were	almost	completely	digested,	giving	fragments	of	90bp	+	
70bp.	PCR	products	from	CRISPR	injected	and	Bsl1	treated	embryos	showed	incomplete	
digestion	in	6	out	of	7	embryos	examined,	showing	the	CRISPR	efficiently	introduced	
mutations	into	exon	20,	disrupting	the	Bsl1	recognition	sequence	in	almost	all	embryos	
examined.	
Figure	7.6:	CRISPR	sites	in	the	zebrafish	lrrk2	gene.		
A:	Schematic	showing	an	overview	of	lrrk2	exon	20,	showing	primer	sites	(purple),	
PAM	site	(grey	box)	and	gRNA	binding	site	(red	box).	Bsl1	restriction	site	is	also	
shown.		
B:	Schematic	showing	CRISPR	binding	site	in	more	detail,	where	the	Bsl1	restriction	
enzyme	recognition	sequence	is	shaded	grey	on	the	DNA	and	the	cut	site	is	illustrated	
with	a	red	line.	The	CRISPR	PAM	site	is	illustrated	with	a	grey	box	below	the	
sequence,	and	the	gRNA	site	with	a	red	box	below	the	sequence.	The	CRISPR/Cas9	
cut	site	is	illustrated	with	a	black	dotted	line	
A	
B	
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7.3.4:	lrrk2	CRISPR	founder	identification	
	
To	determine	whether	CRISPR-induced	mutations	were	transmitted	to	the	germ	line,	
CRISPR	injected	embryos	(F0)	were	raised	to	breeding	age	and	outcrossed	to	wild	type	
zebrafish.	Offspring	from	this	outcross	were	raised	in	separate	tanks	and	finclipped	to	
identify	founder	individuals.	DNA	was	extracted	from	F1	fin	clips	and	amplified	by	PCR.	PCR	
products	were	run	on	analytical	gels	to	identify	large	deletions	or	insertions.	PCR	products	
from	the	first	tank	of	F1	fish	revealed	two	samples	containing	deletions	(figure	7.8a).	These	
samples	were	sequenced,	revealing	an	18bp	deletion	in	exon	20	(figure	7.8b).	This	deletion	
however,	was	in	frame,	deeming	these	founders	unsuitable.	
	
Figure	7.7:	CRISPR	analytical	restriction	digest.		
To	test	the	efficiency	of	the	lrrk2	CRISPR,	gDNA	was	extracted	from	CRISPR	injected	and	
control	uninjected	1dpf	embryos.	The	CRISPR	target	site	was	amplified	by	PCR	and	DNA	
was	digested	with	Bsl1	enzyme.	Uninjected	and	undigested	DNA	produced	a	band	of	
approximately	160bp	(lanes	1-4).	Uninjected	controls	digested	with	Bsl1	produced	two	
bands	of	approximately	90bp	+	70bp	(lanes	5-8).	CRISPR	injected	PCR	product	digested	
with	Bsl1	resulted	in	incomplete	digestion	in	6/7	embryos	examined	(lanes	9-15),	showing	
the	Bsl1	restriction	site	was	mutated	in	a	highly	efficient	manner.	
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Figure	7.8:	Founder	identification	by	PCR.		
CRISPR/Cas9	injected	adults	(F0)	were	outcrossed	to	wild	type	individuals.	DNA	was	extracted	
from	the	progeny	and	amplified	by	PCR.	PCR	products	were	run	on	an	analytical	gel	to	identify	
any	large	deletions	or	insertions.	PCR	products	with	potential	deletions/insertions	were	
sequenced.	A:	An	example	of	PCRs	of	gDNA	from	finclips	of	16	F1	individuals	(lanes	1-16).	Wild	
type	PCR	product	gives	a	band	at	160bp.	Arrows	indicate	PCR	products	of	interest	(lanes	3	and	5),	
showing	potential	deletions	–	these	PCR	products	were	sequenced.	B:	Sequencing	of	PCR	
products	revealed	a	18bp	deletion	(red)	in	both	products	sequenced.	Underlined	text	
demonstrates	CRISPR	target	sequence.	This	deletion	was	in	frame	so	these	fish	were	not	selected	
as	founders.	
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Figure	7.9:	Founder	identification	by	PCR.		
CRISPR/Cas9	injected	adults	(F0)	were	outcrossed	to	wild	type	individuals.	DNA	was	
extracted	from	the	progeny	and	amplified	by	PCR.	PCR	products	were	run	on	an	
analytical	gel	to	identify	any	large	deletions	or	insertions.	PCR	products	with	potential	
deletions/insertions	were	sequenced.	A:	An	example	of	PCRs	of	gDNA	from	finclips	of	16	
F1	individuals	(lanes	1-16).	Wild	type	PCR	product	gives	a	band	at	160bp.	Arrow	
indicates	PCR	product	of	interest	(lane	3),	showing	a	potential	insertion	–	this	PCR	
product	was	sequenced.	B:	Sequencing	of	PCR	products	revealed	a	5bp	insertion	(green)	
causing	a	frame	shift	and	disruption	of	Bsl1	restriction	site.	Underlined	text	
demonstrates	CRISPR	target	sequence	
	
.	
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PCR	products	from	the	second	tank	of	F1	fish	revealed	a	sample	appearing	to	contain	an	
insertion	(figure	7.9a).	This	sample	was	sequenced,	revealing	a	5bp	insertion	(figure	7.9b).	
This	insertion	disrupts	the	Bsl1	restriction	site	in	exon	20,	allowing	relatively	easy	
genotyping	(figure	7.10),	and	causes	a	frameshift.	An	online	Attotron	Transcription	and	
Translation	tool	was	used	to	calculate	the	predicted	protein	of	the	F1	5bp	insertion	
mutated	DNA	sequence	(table	7.1).	This	predicted	a	frame	shift,	resulting	in	altered	amino	
acids	and	introduction	of	a	premature	stop	codon.	This	suggests	this	mutation	may	
produce	a	truncated	protein.		
	
	
	
	
	
	
	
	
	
Figure	7.10:	Genotyping	of	lrrk2	mutation	by	Bsl1	restriction	digest.		
DNA	was	extracted	and	amplified	by	PCR	from	lrrk2+/+,	lrrk2+/-,	and	lrrk2-/-	
individuals.	PCR	product	was	digested	with	Bsl1	enzyme.	Wild	type	lrrk2	(+/+)	is	fully	
digested	by	Bsl1,	giving	two	fragments	of	90bp	+	70bp.	Individuals	that	are	
heterozygous	for	the	5bp	insertion	(+/-)	are	partially	digested	by	Bsl1,	giving	fragments	
of	90bp	+	70bp	+	160bp.	The	band	at	160bp	forms	a	heteroduplex	caused	by	genetic	
recombination	of	the	wild	type	and	mutated	DNA	strand.	DNA	from	Individuals	
homozygous	for	the	5bp	insertion	(-/-)	are	not	digested	by	Bsl1.	
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Table	7.1:	Predicted	exon	20	protein	sequence	with	5bp	insertion.		
The	predicted	protein	amino	acid	sequence	of	wild	type	exon	20	DNA	sequence	and	of	
CRISPR-induced	5bp	insertion	(green)	DNA	sequence.	The	5bp	insertion	results	in	
predicted	alteration	of	amino	acids	(italic)	compared	to	wild	type,	and	introduction	of	
a	premature	stop	codon	(indicated	by	“---“	in	protein	sequence,	highlighted	in	red	and	
underlined).	CRISPR	target	site	is	also	indicated	in	DNA	sequence	by	underlining	DNA	
bases.	
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7.3.5:	Confirmation	of	lrrk2	knockout	
	
The	5bp	insertion	leads	to	frameshift	and	introduction	of	a	premature	stop	codon	in	exon	
20	of	lrrk2,	potentially	resulting	in	a	truncated	Lrrk2	protein.	qPCR	was	used	to	
demonstrate	that	the	premature	stop	codon	leads	to	nonsense	mediated	decay	of	lrrk2	
transcript.	RNA	was	extracted	from	3-month	old	lrrk2+/+	and	lrrk2-/-	zebrafish	brains	(1	
brain	per	replicate,	3	replicates	per	genotype),	and	cDNA	was	generated	from	the	RNA.	
qPCR	on	lrrk2+/+	and	lrrk2-/-		brains	showed	a	95%	decrease	(p=0.0111)	in	lrrk2	transcript	
level	in	lrrk2-/-	brains,	compared	to	lrrk2+/+	controls	(figure	7.11).	This	indicates	that	lrrk2	
mRNA	trancript	is	unstable,	due	to	the	introduction	of	the	premature	stop	codon,	
furthermore	suggesting	loss	of	function	of	Lrrk2	protein.	The	qPCR	primers	are	predicted	to	
amplify	all	three	varients	of	Lrrk2,	suggesting	effective	knockdown	of	all	lrrk2	transcript.	
	
	
	
	
	
	
	
	
	
	
Figure	7.11:	qPCR	of	lrrk2	transcript	in	lrrk+/+	and	lrrk2-/-	brains.		
qPCR	was	used	to	investigate	the	effect	of	the	5bp	insertion	on	the	lrrk2	mRNA	
transcript.	qPCR		on	lrrk2+/+	and	lrrk2-/-		brains	showed	a	95%	decrease	(p=0.0111,	
unpaired	t-test)	in	lrrk2	transcript	level	in	lrrk2-/-	brains,	compared	to	lrrk2+/+	
controls.	Data	normalised	to	the	reference	gene,	ef1a. 
.	
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7.4:	Discussion	
	
The	aim	of	this	study	was	to	generate	a	lrrk2	deficient	zebrafish	line.	To	do	this,	lrrk2	
expression	was	evaluated	in	embryonic	and	adult	zebrafish,	and	a	lrrk2	knockout	line	was	
generated	using	CRISPR/Cas9	technology.		
	
Zebrafish	were	found	to	possess	a	lrrk2	orthologue,	with	conserved	protein	structure	and	
similarities	in	protein	size,	exon	number	and	transcript	length.	Furthermore,	zebrafish	lrrk2	
also	has	relatively	well	conserved	gene	synteny.	Expression	of	lrrk2	in	zebrafish	embryos	
was	constant	from	1dpf	to	5dpf,	and	was	found	to	persist	throughout	adult	stages	of	life.		
	
A	zebrafish	lrrk2	knockout	was	successfully	generated	in	this	study	by	use	of	CRISPR/Cas9	
technology.	Exon	20	of	the	zebrafish	lrrk2	gene	was	targeted	by	CRISPR/Cas9,	resulting	in	
introduction	of	a	5bp	insertion.	This	insertion	disrupted	a	Bsl1	restriction	site	and	resulted	
in	a	frameshift.	This	insertion	was	predicted	to	result	in	the	introduction	of	a	premature	
stop	codon	and	protein	sequencing	predicted	a	truncated	Lrrk2	protein.	Knockout	of	lrrk2	
was	confirmed	using	qPCR,	which	showed	a	95%	decrease	in	lrrk2	mRNA	transcript	levels	in	
lrrk2-/-	zebrafish.		
	
Future	work	is	required	to	determine	the	role	of	Lrrk2	in	regulation	of	neurogenesis	in	PD.	
The	lrrk2	knockout	zebrafish	line	generated	in	this	study	would	not	be	appropriate	for	
directly	modelling	PD,	as	the	most	common	mutations	in	lrrk2	in	PD	result	in	gain	of	
function	of	kinase	activity	(see	section	1.2.5).	This	lrrk2	knockout	zebrafish	line	however,	
would	be	a	valuable	tool	for	analysing	the	complex	biological	role	of	Lrrk2	in	the	regulation	
of	dopaminergic	neurogenesis.	For	example,	previous	studies	in	midbrain-derived	neural	
progenitor	cell	cultures	have	shown	LRRK2	knockdown	results	in	impeded	differentiation	
of	DA	neurons	(Milosevic	et	al.,	2009).	It	would	certainly	be	interesting	to	determine	
whether	differentiation	or	generation	of	ascending	DA	neuron	populations	was	impeded	in	
this	lrrk2	knockout	zebrafish	line.	To	investigate	this,	EdU	analysis	and	genetic	lineage	
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tracing	of	PT	DA	neurons	should	be	performed	on	lrrk2	knockout	zebrafish,	followed	by	
analysis	of	stem/progenitor	populations.	
	
In	the	course	of	performing	my	studies,	another	lrrk2	knockout	zebrafish	line	was	created	
(Suzzi	et	al.,	2017).	In	this	line,	the	authors	used	the	CRISPR/Cas9	technique	to	remove	the	
entire	coding	domain	of	lrrk2.	This	contrasts	with	my	lrrk2	knockout	zebrafish	line,	which	
contains	a	5bp	insertion,	resulting	in	frameshift	and	nonsense	mediated	decay	of	mRNA	
transcript.	My	zebrafish	line	requires	further	characterisation,	to	determine	whether	lrrk2	
knockout	zebrafish	have	fewer	DA	neurons	in	the	PT.	However,	it	would	be	interesting	to	
identify	variances	in	phenotype	caused	by	the	different	mutation	types.	Furthermore,	
recent	advances	in	CRISPR/Cas9-mediated	homology	that	direct	knock-in	of	point	
mutations	in	zebrafish,	can	allow	site	directed	editing	of	single	nucleotides	(Armstrong	et	
al.,	2016).	In	this	case,	the	generation	of	a	G2019S	point	mutation	zebrafish	is	possible,	
potentially	allowing	overexpression	of	Lrrk2.	It	would	therefore	be	fascinating	to	
determine	whether	lrrk2	overexpression	resulted	in	alterations	to	DA	neurogenesis	in	
embryonic	and	adult	zebrafish.		
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Chapter	8	
	
	
Final	Discussion	
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In	the	studies	presented	in	this	thesis	I	have:	
	
1. Robustly	defined	and	compared	morphological	and	positional	similarities	
between	embryonic	and	adult	PT	DA	neuron	populations.		
2. Shown	through	analysis	of	stem/progenitor	markers	that	distinct	populations	
of	stem	and	progenitor	cells	reside	in	the	adult	PT.	Moreover,	on	the	basis	of	
expression	of	stem/progenitor	markers,	I	have	demonstrated	(a)	that	the	PVO	
is	fundamentally	different	from	the	rest	of	the	PT	and	is	likely	to	be	
hypothalamic	in	nature,	and	(b)	that	adult	TPp	DA	neurons	are	profoundly	
different	from	embryonic	DC1	DA	neurons	due	to	differences	in	OTPb	
expression.		
3. Shown	that	DA	neurons	are	newly-generated	in	one	of	the	ascending	DA	
neuron	populations	(the	TPp)	and	the	local-projecting	PVO	population	in	adult	
life	from	resident	stem/progenitor	cells,	whereas	magnocellular	DA	neurons	
are	not.	I	have	further	shown	that	DA	neurons	in	embryonic	PT	populations	do	
not	become	post-mitotic	as	early	as	previously	suggested	by	other	studies.	
4. Demonstrated	that	loss	of	Pink1	results	in	failed	expansion	of	the	ascending	
TPp	and	the	local-projecting	PVO	in	adult	life,	and	results	in	a	loss	of	ascending	
magnocellular	DC2A	DA	neurons	in	adult	life.	I	have	further	shown	that	the	
smaller	population	size	of	the	TPp	in	pink1-/-	zebrafish	is	not	caused	by	
increased	cell	death,	and	have	provided	evidence	that	loss	of	Pink1	results	in	
the	impeded	adult	generation	of	ascending	DA	neurons	due	to	failed	
generation	of	adult	populations	of	progenitors.		
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8.1:	Discussion		
	
8.1.1	Ascending	DA	neurons	are	generated	in	adult	life	
	
In	rodent	models,	previous	attempts	have	been	made	to	determine	whether	there	is	de	
novo	generation	of	ascending	dopaminergic	neurons	in	the	substantia	nigra,	but	the	
conclusions	of	these	studies	have	been	conflicting	(Kay	&	Blum,	2000;	Lie	et	al.,	2002;	Zhao	
et	al.,	2003;	Frielingsdorf	et	al.,	2004;	Yoshimi	et	al.,	2005;	Shan	et	al.,	2006).	Moreover,	no	
study	has	used	conditional	lineage	tracing	to	determine	whether	de	novo	generation	of	
ascending	DA	neurons	occurs	from	identified	populations	of	stem/progenitor	cells.		
	
Using	conditional	lineage	tracing,	together	with	EdU	analyses,	I	have	shown	for	the	first	
time	that	DA	neurons	in	the	largest	ascending	population,	the	TPp,	are	newly	generated	
from	Her4-expressing	stem/progenitor	cells	in	adult	zebrafish.	I	have	further	shown	that	
the	TPp	expands	in	size	during	development,	and	continues	to	expand	in	adult	life.	The	
growth	of	this	population	suggests	that	DA	neurons	are	added	to	the	existing	population,	
rather	than	replacing	DA	neurons.	Importantly,	I	have	also	demonstrated	that	there	is	very	
little	or	no	death	of	DA	neurons	in	the	TPp,	further	suggesting	that	the	TPp	undergoes	
growth	not	replacement	of	DA	neurons.	The	wider	significance	of	these	results	will	be	
discussed	below.		
	
My	studies	show	that	DA	neurons	in	the	zebrafish	ascending	TPp	are	added	to	in	adult	life.	
It	is	generally	accepted	that	DA	neurons	in	the	TPp	(together	with	DC2/DC2A	and	DC4/DC4A	
DA	neurons)	represent	the	mammalian	ascending	nigrostriatal	system.	This	is	due	to	the	
fact	that	DA	neurons	within	these	populations	project	to	a	region	of	the	ventral	
telencephalon	termed	the	subpallium,	thought	to	be	homologous	to	the	striatum	(Rink	&	
Wullimann,	2001b;	Ganz	et	al.,	2010a).	The	substantia	nigra	is	a	region	that	degenerates	in	
PD,	therefore	stimulation	of	endogenous	DA	neurogenesis	in	the	adult	brain	offers	an	
attractive	target	for	PD	treatment.	In	mouse	models,	the	low	rate	of	neurogenesis	has	
made	studying	generation	of	ascending	DA	neurons	difficult.	In	contrast,	zebrafish	have	a	
higher	rate	of	constitutive	neurogenesis,	allowing	investigation	into	DA	generation.	
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It	should	be	noted	however,	that	key	differences	exist	between	mammals	and	zebrafish.	
First,	the	exact	homology	between	DA	populations	in	both	species	is	not	yet	fully	
understood.	From	fish	to	mammals,	the	DA	systems	have	significantly	evolved:	mammals	
develop	DA	neurons	in	the	midbrain,	whereas	zebrafish	develop	DA	neurons	only	in	the	
forebrain	(Smeets	&	González,	2000).	Importantly,	signalling	pathways	shown	to	be	crucial	
for	the	development	of	ventral	midbrain	(VM)	DA	neurons	in	mammals	do	not	appear	to	
regulate	ventral	diencephalic	(vDC)	neurons	in	a	comparable	manner.	For	example,	in	
mammals	Nurr1	and	Pitx3	are	specifically	required	for	the	transition	of	VM	DA	progenitors	
to	DA	neurons:	loss	of	Nurr1	results	in	failed	VM	dopaminergic	specification,	while	loss	of	
Pitx3	results	in	the	absence	of	SNpc	DA	neurons	(Hwang	et	al.,	2003;	Smits	et	al.,	2003;	
Hegarty	et	al.,	2013).	However	in	zebrafish,	loss	of	Nurr1	results	in	altered	spatial	
organisation	of	vDC	DA	neuron	populations	but	does	not	reduce	population	numbers,	and	
loss	of	Pitx3	has	no	effect	on	the	number	of	vDC	DA	neurons	(Filippi	et	al.,	2007).	It	is	
therefore	likely	that	some	transcriptional	regulatory	mechanisms	of	ascending	DA	neuron	
development	are	not	fully	evolutionarily	conserved	between	mammals	and	zebrafish.			
	
One	transcription	factor	that	is	crucial	to	the	development	of	ascending	DA	neuronal	
populations	in	zebrafish	is	OTP.	In	zebrafish,	OTP	is	required	for	the	development	of	the	
ascending	DC2	and	DC4	DA	populations	and	also	the	hypothalamic	DC5	and	DC6	DA	
populations	(Ryu	et	al.,	2007a).	Here,	I	have	shown	for	the	first	time	that	ascending	TPp	DA	
neurons	also	express	OTPb	in	the	adult	zebrafish,	although	embryonic	DC1	neurons	do	not.	
This	shows	that,	in	zebrafish,	the	largest	ascending	DA	neuron	population	expressed	OTPb	
and	arises	later	in	development.	However,	two	issues	remain	outstanding	and	require	
further	study.	First,	as	yet,	no	study	has	ascertained	if	the	TPp	DA	population	is	lost	in	the	
absence	of	OTP.	Second,	it	is	not	clear	whether	ascending	OTPb+	DA	neurons	exist	in	other	
species.	In	the	embryonic	mouse,	OTP	is		expressed	in,	and	required	for	the	development	
of	the	hypothalamic	A11	DA	population,	but	there	is	little	evidence	to	suggest	that	OTP	is	
expressed	in,	or	required	for	the	development	of	DA	neurons	of	the	substantia	nigra	(Ryu	
et	al.,	2007a).	This	suggests	two	possibilities:	either	(a)	OTP-dependent	DA	neurons	are	not	
represented	in	the	mammalian	substantia	nigra	or	(b)	OTP	is	required	only	for	generation	
of	DA	populations	that	arise	later	in	development,	and	have	therefore	been	missed	in	
previous	studies	(the	Ryu	et	al.	study	analyses	OTP	expression	in	embryonic	periods).	In	
support	of	the	latter	possibility,	one	study	has,	in	fact,	shown	that	OTP	is	expressed	by	a	
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small	population	of	neurons	within	the	nigrostriatal	bundle	of	the	postnatal	mouse	VM	
(Wang	&	Lufkin,	2000).	Although	it	is	not	clear	whether	these	are	DA	neurons,	it	is	possible	
that	an	OTP-dependent	nigrostriatal	DA	population	arises	in	late	prenatal/postnatal	life	in	
mammals.	Further	characterisation	of	the	molecular	characteristics	of	VM	and	vDC	DA	
neurons	will	help	to	further	elucidate	homology	between	zebrafish	and	mammalian	DA	
populations.		
	
The	second	key	difference	between	mammals	and	zebrafish	is	the	growth	of	ascending	DA	
neuron	populations	in	the	adult	brain.	A	study	by	Zhao	et	al.	demonstrated	that	the	
number	of	DA	neurons	in	the	substantia	nigra	of	the	mouse	stayed	constant	in	adult	life.	
This	suggests	that,	if	DA	neurogenesis	does	occur	in	the	mammalian	substantia	nigra,	it	
acts	to	maintain	a	static	population	size,	potentially	balancing	apoptosis.	By	contrast,	in	
zebrafish,	my	analyses	of	population	size	and	cell	death	show	that	new	DA	neurons	add	to,	
rather	than	replace,	existing	DA	neuron	populations	in	the	adult	zebrafish	TPp.	This	
highlights	a	significant	regulatory	difference	between	mammals	and	zebrafish,	agreeing	
with	multiple	studies	in	the	telencephalon	that	show	the	zebrafish	displays	a	more	
constitutive	form	of	neurogenesis	(Grandel	et	al.,	2006;	Chapouton	et	al.,	2011).	Further	
studies	are	required	to	determine	the	mechanisms	that	allow	additive	DA	neurogenesis	in	
the	zebrafish	PT	compared	to	the	mammalian	substantia	nigra.	My	data,	showing	that	no	
cell	death	of	ascending	DA	neurons	occurs	in	the	zebrafish,	contrasts	with	studies	in	
mammals,	where	cell	death	of	ascending	DA	neurons	is	observed	and	suggests	that	
regulation	of	programmed	cell	death	could	be	one	mechanistic	difference.		
	
A	third	difference	between	mammalian	and	zebrafish	ascending	neurons	is	the	position	of	
ascending	DA	neurons.	My	analyses	from	chapter	4	show	that	neurons	in	the	neurogenic	
populations	of	the	zebrafish	PT	(the	TPp	and	the	PVO)	both	reside	immediately	adjacent	to	
the	diencephalic	ventricle	and	to	radial	glial	progenitors.	This	spatial	organisation	may	
provide	a	more	permissive	environment	for	dopaminergic	neurogenesis,	potentially	
allowing	newborn	DA	neurons	to	survive	or	stimulating	resident	stem/progenitor	cells	to	
generate	DA	neurons.	
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Studies	of	proliferative	zones	in	the	telencephalon	have	shown	that	the	rate	of	formation	
of	new	cells	depends	on	dorso-ventral	position	of	the	region	in	question.	The	most	
proliferative	region	is	found	in	the	medial	subpallium	(Vv)	(Adolf	et	al.,	2006;	Grandel	et	al.,	
2006),	where	progenitors	in	this	zone,	but	not	in	more	dorsal	regions,	have	been	shown	to	
be	directly	regulated	by	FGF	signalling	(Ganz	et	al.,	2010a).	This	suggests	FGF	signalling	
could	be	the	cause	of	a	higher	proliferation	rate	in	this	region	of	the	telencephalon.	It	is	
not	clear	whether	growth	factors	such	as	FGF	regulate	proliferation	in	the	zebrafish	PT	or	
the	mammalian	substantia	nigra,	however	FGF	has	been	shown	to	stimulate	neurogenesis	
in	other	regions	of	the	mammalian	brain,	such	as	the	hypothalamus	(Robins	et	al.,	2013).	
This	highlights	FGF	as	a	potential	stimulant	for	adult	neurogenesis	of	DA	neurons,	though	
this	requires	further	investigation.	Future	studies	in	both	species	could	elucidate	the	
differences	in	mechanisms	that	regulate	different	rates	of	neurogenesis.	Understanding	
this	is	crucial	to	the	development	of	new	treatments	that	stimulate	endogenous	
neurogenesis	to	replenish	neurons	in	adult	life,	which	could	offer	appealing	new	strategies	
to	treat	neurodegenerative	disease.		
	
8.1.2	DA	neurogenesis	is	impeded	in	PD	
	
A	recent	study	showed	that	loss	of	Pink1	results	in	reduced	neurogenesis	in	the	mouse	
hippocampus	(Agnihotri	et	al.,	2017)	and	numerous	studies	have	shown	that	PD	genes	can	
regulate	neural	stem/progenitor	cells	in	the	adult	brain	(Le	Grand	et	al.,	2015).	However,	
until	now,	no	study	has	investigated	whether	in	vivo	generation	of	ascending	DA	neurons	is	
reduced	in	PD.	Here,	my	analyses	show	that	loss	of	Pink1	results	in	impeded	in	vivo	adult	
generation	of	ascending	DA	neurons	and	of	local-projecting	DA	neurons.	How	could	this	be	
relevant	for	the	development	or	progression	of	PD?		
	
Firstly,	any	disruption	in	the	number	of	DA	neurons	could	significantly	disrupt	DA	system	
function.	In	PD,	loss	of	dopamine	signalling	due	to	loss	of	DA	neurons,	results	in	the	
cardinal	motor	features	of	PD.	Thus,	impeded	generation	of	DA	neurons	could	contribute	
to	DA	neuronal	loss	in	PD.	In	chapter	6,	I	showed	that	zebrafish	lacking	functional	Pink1	fail	
to	expand	both	the	ascending	TPp	and	the	local-projecting	PVO	DA	neuron	populations	in	
adulthood.	This	resulted	in	a	significant	reduction	in	population	size	by	2-years	of	age.	This	
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suggests	that	failed	adult	generation	of	ascending	DA	neurons	results	in	a	smaller	
population	size,	and	consequently	could	result	in	reduced	dopaminergic	signalling.	As	
discussed	above,	I	have	shown	that	zebrafish	ascending	DA	populations	undergo	growth,	
not	replacement.	In	this	respect,	any	reductions	in	DA	neurogenesis	would	be	even	more	
significant.	For	instance,	if	DA	neurons	apoptose	and	are	not	efficiently	replaced,	this	
would	result	in	a	net	loss	of	DA	neuron	number.		
	
As	mentioned	above,	Agnihortri	et	al.	(2017)	showed	that	loss	of	Pink1	in	the	adult	mouse	
hippocampus	results	in	impeded	differentiation	to	neurons,	reduced	generation	of	late	
stage	progenitors	and	increased	generation	of	oligodendrocytes.	This	suggests	that	loss	of	
Pink1	does	not	solely	reduce	DA	neurogenesis.	Nonetheless,	this	finding	is	significant,	as	
the	non-motor	symptoms	that	characterise	PD	are	not	thought	to	be	directly	related	to	
degeneration	of	the	nigrostriatal	DA	system.	Instead,	non-motor	processes	that	are	
affected	in	PD,	including	sense	of	smell,	mood	and	regulation	of	sleep	cycle,	directly	rely	on	
the	function	of	regions	such	as	the	olfactory	system,	hippocampus	and	hypothalamus	
(Winner	et	al.,	2011a).	It	is	therefore	feasible	that	dysfunctional	neurogenesis	in	these	
systems	could	contribute	to	non-motor	symptoms	in	PD,	though	this	certainly	requires	
further	investigation.		
	
Understanding	the	mechanisms	that	cause	reduced	neurogenesis	in	organisms	with	
mutations	in	PD-genes	could	help	to	direct	future	research.	The	study	by	Agnihortri	et	al.	
elucidates	one	potential	mechanism	for	reduced	hippocampal	neurogenesis	in	mice	lacking	
functional	PINK1.	Here	the	authors	show	that	neural	stem	cells	(NSCs)	from	PINK1	
knockout	mice	display	decreased	mitochondrial	membrane	potential	and	elevated	
glycolysis,	suggesting	that	loss	of	PINK1	results	in	deficits	in	mitochondrial	function	in	NSCs	
(Agnihotri	et	al.,	2017).	As	discussed	in	the	Introduction,	previous	studies	have	shown	that	
PINK1	is	crucial	to	mitophagy	in	DA	neurons:	PINK1	functions	with	Parkin	to	initiate	
mitophagy,	labelling	dysfunctional	mitochondria	for	recycling.	However,	the	PINK1/Parkin	
pathway	can	also	regulate	mitochondrial	dynamics,	increasing	mitochondrial	fusion	at	the	
expense	of	fission	(Poole	et	al.,	2008).	Though	the	exact	mechanism	of	this	is	not	known,	it	
is	thought	that	the	PINK1/Parkin	pathway	may	regulate	the	ubiquitination	of	proteins	
involved	in	mitochondrial	fusion,	such	as	Mitofusin	1/2	(Mfn1/2)	(Poole	et	al.,	2008;	Gegg	
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et	al.,	2010;	Yu	et	al.,	2011).	Therefore,	lack	of	functional	PINK1	results	in	a	tip	in	the	
balance	of	mitochondrial	fusion/fission	dynamics	toward	more	fusion.		
	
Mitochondria	continually	change	shape	through	combined	actions	of	fusion	(a	process	of	
fusing	mitochondria	together,	forming	a	single	closed	network)	and	fission	(a	process	of	
mitochondrial	fragmentation,	resulting	in	large	numbers	of	small	mitochondria)(Bliek	et	al.,	
2013).	One	major	role	of	mitochondrial	dynamics	is	likely	to	be	to	share	organelle	
contents,	to	replace	damaged	or	lost	components;	another	is	to	allow	fragmentation	of	
mitochondria	upon	programmed	cell	death	(Scott	&	Youle,	2010).	However,	recently,	
regulation	of	mitochondrial	fusion	and	fission	has	also	been	implicated	in	the	regulation	of	
adult	NSCs.	One	study	has	shown	that	mitochondrial	dynamics	are	crucial	to	regulation	of	
neural	stem	cell	identity	and	fate	decisions,	where	deletion	of	Mfn1/2	in	the	adult	
hippocampus	resulted	in	depletion	of	NSCs	and	reduced	neurogenesis	(Khacho	et	al.,	
2016).	This	suggests	that	mitochondrial	fusion	is	necessary	for	maintenance	of	NSC	self-
renewal.	Thus,	loss	of	functional	PINK1	could	result	in	a	tip	in	the	balance	of	mitochondrial	
dynamics	toward	fusion,	and	subsequently	push	NSCs	toward	self-renewal	at	the	expense	
of	generation	of	progenitors.	In	this	respect,	it	is	most	likely	that	there	would	already	be	a	
reduced	population	of	progenitors	in	early	life,	as	NSCs	would	fail	to	generate	extensive	
progenitor	pools	in	development.	My	analyses	disagree	with	this,	as	I	have	shown	that	loss	
of	Pink1	does	not	alter	embryonic/juvenile	generation	of	DA	neurons.		
	
However,	there	is	an	alternative	hypothesis	for	the	mechanism	of	reduced	neurogenesis	
associated	with	lack	of	functional	PINK1.	In	the	introductory	section	1.4.6,	I	discussed	a	
study	that	showed	that	PINK1	can	interact	with	Notch	in	a	non-canonical	pathway	in	
Drosophila.	In	this	pathway,	PINK1	is	involved	in	the	recruitment	of	Notch	to	the	
mitochondrial	membrane,	resulting	in	activation	of	mTORC2/AKT	signalling,	and	promotion	
of	self-renewal	(Lee	et	al.,	2013).	In	this	case,	loss	of	PINK1	could	result	in	reduced	
Notch/mTORC2/AKT	signalling,	reduced	self-renewal	and	subsequently	an	exhaustion	of	
the	NSC	pool.	This	phenotype	could	result	in	initial	generation	of	neurons	and	progenitors	
in	early	life	from	proliferating	progenitor	pools,	but	an	exhaustion	in	later	life.	My	studies	
showing	normal	embryonic/juvenile	development,	followed	by	failed	expansion	of	
neuronal	populations	in	later	life	support	this	hypothesis.	Indeed,	I	have	also	shown	that	
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DA	neurons	in	the	wild	type	TPp	and	PVO	arise	from	resident	stem/progenitor	cells	that	
express	her4,	a	gene	that	is	directly	regulated	by	Notch	signalling	(Kageyama	et	al.,	2008),	
further	implicating	an	involvement	for	Notch	in	the	regulation	of	PT	DA	neurogenesis.	
Thus,	here	I	propose	that	loss	of	Pink1	results	in	reduced	non-canonical	Notch	signalling,	
reduced	mTORC2/AKT	signalling,	reduced	self-renewal	capacity	and	exhaustion	of	NSC	
populations	(Figure	8.1).	Further	studies	are	required	to	test	this	hypothesis,	and	these	will	
be	discussed	below.		
	
	
	
	
	
	
	
	
Figure	8.1:	Schematic	illustrating	a	proposed	mechanism	of	reduced	DA	neurogenesis	in	
adult	life	in	pink1	knockout	zebrafish.		
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8.2	Future	directions	
	
8.2.1	Dopaminergic	populations	in	the	zebrafish	and	mammalian	brain	
	
The	zebrafish	is	a	powerful	tool	to	study	DA	neurogenesis.	For	example,	zebrafish	and	
mammals	share	similar	functional	organisation	of	the	DA	neuron	system	and	also	share	
many	of	the	mechanisms	that	regulate	neurogenesis.	
Furthermore,	there	are	several	readily-available	conditional	lineage	tracing	lines	that	allow	
reliable	and	robust	analysis	of	neurogenic	potential.	My	analyses	of	DA	neurogenesis	begin	
to	provide	evidence	that	ascending	DA	neurons	can	be	generated	in	the	adult	vertebrate	
brain.	However,	as	discussed	above,	the	exact	homology	between	mammalian	and	
zebrafish	DA	neuron	populations	is	yet	to	be	fully	elucidated.	Furthermore,	the	precise	role	
and	function	of	each	DA	neuron	population	in	the	zebrafish	brain	is	not	yet	known.	
Understanding	this	could	provide	novel	insight	into	the	neurogenic	potential	of	ascending	
DA	neuron	populations.	To	this	end,	future	studies	should	be	directed	towards	analysing	
the	molecular	characteristics	of	ascending	DA	neurons	in	the	adult	mammalian	and	
zebrafish	brain.	An	initial	study	could	focus	on	determining	whether	a	subset	of	DA	
neurons	in	the	adult	mammalian	substantia	nigra	express	OTP.	Further	analyses	of	the	
molecular	characteristics	of	DA	populations	in	the	adult	zebrafish	brain	could	allow	
generation	of	conditional	knockout	zebrafish	lines,	allowing	interpretation	of	the	
functional	implication	of	loss	of	particular	DA	neuron	subsets.	Future	studies	should	also	
be	directed	towards	understanding	the	differences	in	proliferative	and	neurogenic	
potential	between	zebrafish	and	mammals.	Here,	an	initial	study	could	focus	on	assessing	
whether	growth	factors,	such	as	FGF,	are	expressed	in	the	PT	and	the	substantia	nigra.	
Certainly,	in	the	embryo,	Fgf3	is	expressed	in	the	PT	(Muthu	et	al.,	2016),	while	in	
mammals,	FGF2	and	FGF20	are	expressed	in	the	substantia	nigra	and	have	been	implicated	
in	the	survival	of	midbrain	DA	neurons	(Ohmachi	et	al.,	2000;	Timmer	et	al.,	2007).	
However,	as	yet,	no	study	has	systematically	characterised	FGF	signalling	through	life,	or	
examined	its	potential	role	in	the	maintenance	of	stem/progenitor	populations.	
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8.2.2	The	functional	role	of	adult	DA	neurogenesis	and	the	implications	of	its	
dysregulation	in	PD	
	
In	chapter	5,	I	showed	that	DA	neurons	in	ascending	and	locally	projecting	populations	of	
the	zebrafish	PT	are	generated	in	adulthood.	Subsequently,	in	chapter	6,	I	demonstrated	
that	adult	DA	neurogenesis	of	these	populations	of	DA	neurons	was	reduced	in	zebrafish	
lacking	functional	Pink1.	On	this	basis,	I	hypothesise	that	reduced	DA	neurogenesis	
contributes	to	the	pathogenesis	of	PD.	However,	this	raises	several	important	questions:	
(a)	are	newly	generated	DA	neurons	incorporated	into	existing	neuronal	networks?;	(b)	
what	is	the	functional	significance	of	adult	DA	neurogenesis?;	(c)	does	disruption	of	DA	
neurogenesis	contribute	to	reduced	DA	signalling	in	PD?	Thus,	future	experiments	should	
be	directed	at	answering	these	questions.	Further,	and	on	a	smaller	scale,	I	hypothesise	
that	reduced	DA	neurogenesis	in	zebrafish	lacking	functional	Pink1	is	in	part	caused	by	
reduced	non-canonical	Notch	signalling	and	subsequently	reduced	self-renewal	of	NSCs.	
Further	experiments	could	be	performed	to	test	this	hypothesis.	An	initial	study	could	
focus	on	crossing	the	Her4	conditional	lineage	tracing	line	to	the	pink1	knockout	zebrafish	
line,	to	quantify	the	number	of	DA	neurons	arising	from	Her4-expressing	stem/progenitor	
cells	in	pink1+/+	and	pink1-/-	zebrafish.	These	types	of	study	will	help	to	move	forwards	
our	understanding	of	the	role	of	de	novo	neurogenesis	in	the	adult	brain,	and	the	impact	
of	its	dysregulation	in	neurodegenerative	disease.		
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